,Unnamed: 0,drug1,drug2,smiles1,smiles2,event_id,MeSH_ID,Sign,Pattern,description
1086,1086,DB13946,DB00035,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,N=C(N)NCCCC(NC(=O)C1CCCN1C(=O)C1CSSCCC(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1095,1095,DB00067,DB00190,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,CC(Cc1ccc(O)c(O)c1)(NN)C(=O)O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1096,1096,DB00067,DB00449,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1097,1097,DB00067,DB00668,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1098,1098,DB00067,DB00816,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,CC(C)NCC(O)c1cc(O)cc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1099,1099,DB00067,DB00841,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1100,1100,DB00067,DB00988,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1101,1101,DB00067,DB01064,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,CC(C)NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1102,1102,DB00067,DB01235,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1103,1103,DB00067,DB04840,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,N=C(N)N1CCc2ccccc2C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1104,1104,DB00067,DB06262,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1105,1105,DB00067,DB06707,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1106,1106,DB00067,DB06814,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1107,1107,DB00067,DB12313,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1108,1108,DB00184,DB00067,CN1CCCC1c1cccnc1,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1109,1109,DB00657,DB00067,CNC1(C)C2CCC(C2)C1(C)C,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1110,1110,DB01090,DB00067,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1111,1111,DB01116,DB00067,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
1112,1112,DB01199,DB00067,COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3N(C)CC2)CC[N+]1(C)C,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
2434,2434,DB13946,DB00091,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
2914,2914,DB00104,DB09083,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COc1cc2c(cc1OC)CC(=O)N(CCCN(C)CC1Cc3cc(OC)c(OC)cc31)CC2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2915,2915,DB00104,DB00195,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2916,2916,DB00104,DB00568,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,C(=Cc1ccccc1)CN1CCN(C(c2ccccc2)c2ccccc2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2917,2917,DB00104,DB00571,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)NCC(O)COc1cccc2ccccc12,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2918,2918,DB00104,DB01115,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2919,2919,DB00104,DB01193,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2920,2920,DB00104,DB01580,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,C=CCOc1ccccc1OCC(O)CNC(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2921,2921,DB00104,DB04825,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2922,2922,DB00104,DB04842,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2923,2923,DB00104,DB06712,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2924,2924,DB00104,DB00211,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2925,2925,DB00104,DB00230,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)CC(CN)CC(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2926,2926,DB00104,DB00335,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2927,2927,DB00104,DB00436,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2928,2928,DB00104,DB00528,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2929,2929,DB00104,DB00598,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2930,2930,DB00104,DB00633,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,Cc1cccc(C(C)c2c[nH]cn2)c1C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2931,2931,DB00104,DB00653,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,O=S(=O)([O-])[O-].[Mg+2],39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2932,2932,DB00104,DB00708,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2933,2933,DB00104,DB00899,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2934,2934,DB00104,DB00960,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)NCC(O)COc1cccc2[nH]ccc12,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2935,2935,DB00104,DB00968,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2936,2936,DB00104,DB00989,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCN(C)C(=O)Oc1cccc(C(C)N(C)C)c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2937,2937,DB00104,DB01018,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2938,2938,DB00104,DB01297,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2939,2939,DB00104,DB01359,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2940,2940,DB00104,DB04743,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2941,2941,DB00104,DB04838,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2942,2942,DB00104,DB04841,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2943,2943,DB00104,DB04861,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2944,2944,DB00104,DB04920,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2945,2945,DB00104,DB06152,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2946,2946,DB00104,DB06218,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COCC(NC(C)=O)C(=O)NCc1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2947,2947,DB00104,DB06663,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,NCCCCC1NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(c2ccccc2)NC(=O)C2CC(OC(=O)NCCN)CN2C(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(OCc3ccccc3)cc2)NC1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2948,2948,DB00104,DB06791,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(N)Cc2ccc3ccccc3c2)CSSCC(C(=O)NC(C(N)=O)C(C)O)NC1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2949,2949,DB00104,DB09216,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2950,2950,DB00104,DB09238,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2951,2951,DB00104,DB09351,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2952,2952,DB00104,DB00489,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2953,2953,DB00104,DB01244,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2954,2954,DB00104,DB00187,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2955,2955,DB00104,DB00347,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CN1C(=O)OC(C)(C)C1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2956,2956,DB00104,DB00674,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COc1ccc2c3c1OC1CC(O)C=CC31CCN(C)C2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2957,2957,DB00104,DB00697,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,Clc1ccc2nsnc2c1NC1=NCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2958,2958,DB00104,DB00825,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC1CCC(C(C)C)C(O)C1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2959,2959,DB00104,DB01074,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2960,2960,DB00104,DB01158,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC[N+](C)(C)Cc1ccccc1Br,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2961,2961,DB00104,DB05246,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CN1C(=O)CC(C)(c2ccccc2)C1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2962,2962,DB00104,DB09089,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2963,2963,DB00104,DB09090,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2964,2964,DB00104,DB09236,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2965,2965,DB00104,DB13766,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2966,2966,DB00104,DB00343,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2967,2967,DB00104,DB00393,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2968,2968,DB00104,DB00836,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2969,2969,DB00104,DB01182,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2970,2970,DB00104,DB00270,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2971,2971,DB00104,DB00373,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2972,2972,DB00104,DB00555,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2973,2973,DB00104,DB00622,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2974,2974,DB00104,DB00909,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,NS(=O)(=O)Cc1noc2ccccc12,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2975,2975,DB00104,DB01054,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2976,2976,DB00104,DB04846,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2977,2977,DB00104,DB00381,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2978,2978,DB00104,DB00612,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2979,2979,DB00104,DB00661,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2980,2980,DB00104,DB00843,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2981,2981,DB00104,DB01136,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2982,2982,DB00104,DB01203,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2983,2983,DB00104,DB08868,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2984,2984,DB00104,DB08896,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2985,2985,DB00104,DB00401,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2986,2986,DB00104,DB00575,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,Clc1cccc(Cl)c1NC1=NCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2987,2987,DB00104,DB00593,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCC1(C)CC(=O)NC1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2988,2988,DB00104,DB00802,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2989,2989,DB00104,DB01023,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2990,2990,DB00104,DB00264,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,COCCc1ccc(OCC(O)CNC(C)C)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2991,2991,DB00104,DB01118,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2992,2992,DB00104,DB04855,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2993,2993,DB00104,DB08865,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2994,2994,DB00104,DB00521,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2995,2995,DB00104,DB01210,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(C)(C)NCC(O)COc1cccc2c1CCCC2=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
2996,2996,DB00104,DB01214,CC(O)C(CO)NC(=O)C1CSSCC(NC(=O)C(N)Cc2ccccc2)C(=O)NC(Cc2ccccc2)C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N1,CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
4187,4187,DB00150,DB00402,NC(Cc1c[nH]c2ccccc12)C(=O)O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
4190,4190,DB00924,DB00150,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(Cc1c[nH]c2ccccc12)C(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
4193,4193,DB00502,DB00150,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NC(Cc1c[nH]c2ccccc12)C(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
4689,4689,DB13946,DB00159,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
5394,5394,DB00755,DB00170,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,CC1=CC(=O)c2ccccc2C1=O,60,D013927,increase,1,the risk or severity of thrombosis can be increased when #drug1 is combined with #drug2.
6486,6486,DB06711,DB00176,c1ccc2c(CC3=NCCN3)cccc2c1,COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
6491,6491,DB00176,DB00402,COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
6497,6497,DB00924,DB00176,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
6510,6510,DB00502,DB00176,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
6756,6756,DB00177,DB01235,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
6936,6936,DB00484,DB00177,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
6938,6938,DB00862,DB00177,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
6939,6939,DB00975,DB00177,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
6940,6940,DB06267,DB00177,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
6941,6941,DB12010,DB00177,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7269,7269,DB00695,DB00177,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
7270,7270,DB00246,DB00177,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)C(C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7278,7278,DB00178,DB01235,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
7511,7511,DB00484,DB00178,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7512,7512,DB01592,DB00178,[Fe],CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
7516,7516,DB00203,DB00178,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7518,7518,DB00862,DB00178,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7519,7519,DB06237,DB00178,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7520,7520,DB06267,DB00178,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7521,7521,DB12010,DB00178,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7522,7522,DB00975,DB00178,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7638,7638,DB00246,DB00178,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
7884,7884,DB00202,DB00180,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7885,7885,DB00416,DB00180,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7886,7886,DB00565,DB00180,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7887,7887,DB00728,DB00180,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7888,7888,DB00732,DB00180,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7889,7889,DB01135,DB00180,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7890,7890,DB01226,DB00180,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7891,7891,DB01336,DB00180,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7892,7892,DB01339,DB00180,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7893,7893,DB04834,DB00180,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
7894,7894,DB11156,DB00180,CN1CCCN=C1C=Cc1cccs1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
8736,8736,DB00181,DB00402,NCC(CC(=O)O)c1ccc(Cl)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
8738,8738,DB00924,DB00181,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NCC(CC(=O)O)c1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
8741,8741,DB00181,DB00193,NCC(CC(=O)O)c1ccc(Cl)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
8743,8743,DB00502,DB00181,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NCC(CC(=O)O)c1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
8857,8857,DB09042,DB00182,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
8982,8982,DB00391,DB00182,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8983,8983,DB00409,DB00182,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8984,8984,DB01618,DB00182,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8985,8985,DB06077,DB00182,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8986,8986,DB06288,DB00182,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8987,8987,DB11376,DB00182,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8988,8988,DB12401,DB00182,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8989,8989,DB12867,DB00182,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8990,8990,DB13256,DB00182,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8991,8991,DB13273,DB00182,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8992,8992,DB06144,DB00182,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8993,8993,DB00623,DB00182,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8994,8994,DB00433,DB00182,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8995,8995,DB00933,DB00182,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8996,8996,DB00372,DB00182,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8997,8997,DB00408,DB00182,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8998,8998,DB00508,DB00182,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
8999,8999,DB00680,DB00182,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9000,9000,DB01063,DB00182,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9001,9001,DB01623,DB00182,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9002,9002,DB04842,DB00182,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9003,9003,DB09225,DB00182,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9004,9004,DB11540,DB00182,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9005,9005,DB12710,DB00182,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9006,9006,DB13213,DB00182,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9022,9022,DB00614,DB00182,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9023,9023,DB00721,DB00182,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9024,9024,DB00752,DB00182,NC1CC1c1ccccc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9025,9025,DB00780,DB00182,NNCCc1ccccc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9026,9026,DB00805,DB00182,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9027,9027,DB01168,DB00182,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9028,9028,DB01171,DB00182,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9029,9029,DB01247,DB00182,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9030,9030,DB01367,DB00182,C#CCNC1CCc2ccccc21,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9031,9031,DB01626,DB00182,C#CCN(C)Cc1ccccc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9032,9032,DB04820,DB00182,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9033,9033,DB06654,DB00182,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
9194,9194,DB00850,DB00182,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9196,9196,DB01621,DB00182,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
9321,9321,DB13946,DB00182,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
10586,10586,DB06711,DB00186,c1ccc2c(CC3=NCCN3)cccc2c1,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
10587,10587,DB00186,DB00402,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
10623,10623,DB00924,DB00186,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
10627,10627,DB00186,DB00388,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
10629,10629,DB00186,DB00193,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
10632,10632,DB00502,DB00186,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
10634,10634,DB00186,DB06283,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
10713,10713,DB00187,DB01235,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
10798,10798,DB00484,DB00187,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
10892,10892,DB00203,DB00187,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
10894,10894,DB06237,DB00187,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
10895,10895,DB06267,DB00187,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
10896,10896,DB12010,DB00187,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
11182,11182,DB13967,DB00187,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
12770,12770,DB06711,DB00189,c1ccc2c(CC3=NCCN3)cccc2c1,C#CC(O)(C=CCl)CC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
12771,12771,DB00189,DB00402,C#CC(O)(C=CCl)CC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
12773,12773,DB00924,DB00189,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C#CC(O)(C=CCl)CC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
12776,12776,DB00189,DB00193,C#CC(O)(C=CCl)CC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
12778,12778,DB00502,DB00189,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C#CC(O)(C=CCl)CC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
12779,12779,DB00189,DB06283,C#CC(O)(C=CCl)CC,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13107,13107,DB09042,DB00191,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13234,13234,DB00372,DB00191,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13235,13235,DB00391,DB00191,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13236,13236,DB00409,DB00191,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13237,13237,DB00433,DB00191,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13238,13238,DB00508,DB00191,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13239,13239,DB00623,DB00191,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13240,13240,DB00680,DB00191,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13241,13241,DB00850,DB00191,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13242,13242,DB00933,DB00191,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13243,13243,DB01063,DB00191,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13244,13244,DB01618,DB00191,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13245,13245,DB01621,DB00191,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13246,13246,DB01623,DB00191,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13247,13247,DB06077,DB00191,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13248,13248,DB06288,DB00191,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13249,13249,DB11376,DB00191,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13250,13250,DB11540,DB00191,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13251,13251,DB12401,DB00191,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13252,13252,DB12710,DB00191,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13253,13253,DB12867,DB00191,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13254,13254,DB13213,DB00191,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13255,13255,DB13256,DB00191,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13256,13256,DB13273,DB00191,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13280,13280,DB00614,DB00191,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13281,13281,DB00721,DB00191,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13282,13282,DB00752,DB00191,NC1CC1c1ccccc1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13283,13283,DB00780,DB00191,NNCCc1ccccc1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13284,13284,DB00805,DB00191,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13285,13285,DB01168,DB00191,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13286,13286,DB01171,DB00191,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13287,13287,DB01247,DB00191,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13288,13288,DB01367,DB00191,C#CCNC1CCc2ccccc21,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13289,13289,DB01626,DB00191,C#CCN(C)Cc1ccccc1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13290,13290,DB04820,DB00191,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13291,13291,DB06654,DB00191,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13324,13324,DB00408,DB00191,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13327,13327,DB04842,DB00191,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13329,13329,DB06144,DB00191,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13331,13331,DB09225,DB00191,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CC(C)(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
13392,13392,DB13946,DB00191,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
13476,13476,DB00193,DB00761,COc1cccc(C2(O)CCCCC2CN(C)C)c1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
13644,13644,DB00193,DB00402,COc1cccc(C2(O)CCCCC2CN(C)C)c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13965,13965,DB00450,DB00193,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13966,13966,DB09117,DB00193,CC1OC(C)OC(C)O1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13967,13967,DB09072,DB00193,O=C([O-])CCCO.[Na+],COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13968,13968,DB01452,DB00193,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13969,13969,DB00202,DB00193,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13970,13970,DB00969,DB00193,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13971,13971,DB11699,DB00193,CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13972,13972,DB00391,DB00193,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13973,13973,DB00484,DB00193,Brc1c(NC2=NCCN2)ccc2nccnc12,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13974,13974,DB01161,DB00193,CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13975,13975,DB00372,DB00193,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13976,13976,DB00433,DB00193,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13977,13977,DB00680,DB00193,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13978,13978,DB00831,DB00193,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13979,13979,DB00933,DB00193,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13980,13980,DB01063,DB00193,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13981,13981,DB01246,DB00193,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13982,13982,DB01608,DB00193,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13983,13983,DB01614,DB00193,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13984,13984,DB11540,DB00193,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13985,13985,DB12710,DB00193,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13986,13986,DB13213,DB00193,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13987,13987,DB00483,DB00193,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-],COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13988,13988,DB00508,DB00193,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13989,13989,DB00527,DB00193,CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13990,13990,DB00941,DB00193,C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13991,13991,DB01199,DB00193,COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3N(C)CC2)CC[N+]1(C)C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13992,13992,DB01245,DB00193,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13993,13993,DB01337,DB00193,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1[N+]1(C)CCCCC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13994,13994,DB01338,DB00193,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC(N3CC[N+](C)(C)CC3)C4OC(C)=O)C2(C)CC1N1CC[N+](C)(C)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13995,13995,DB00434,DB00193,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13996,13996,DB00728,DB00193,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13997,13997,DB00771,DB00193,C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13998,13998,DB00777,DB00193,CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
13999,13999,DB00835,DB00193,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14000,14000,DB01135,DB00193,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14001,14001,DB01226,DB00193,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14002,14002,DB01336,DB00193,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14003,14003,DB04834,DB00193,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14004,14004,DB00228,DB00193,FC(F)OC(F)(F)C(F)Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14005,14005,DB00237,DB00193,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14006,14006,DB00292,DB00193,CCOC(=O)c1cncn1C(C)c1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14007,14007,DB00306,DB00193,C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14008,14008,DB00323,DB00193,Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14009,14009,DB00341,DB00193,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14010,14010,DB00347,DB00193,CN1C(=O)OC(C)(C)C1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14011,14011,DB00356,DB00193,O=c1[nH]c2cc(Cl)ccc2o1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14012,14012,DB00371,DB00193,CCCC(C)(COC(N)=O)COC(N)=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14013,14013,DB00409,DB00193,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14014,14014,DB00416,DB00193,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14015,14015,DB00423,DB00193,COc1ccccc1OCC(O)COC(N)=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14016,14016,DB00427,DB00193,Cc1ccc(C(=CCN2CCCC2)c2ccccn2)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14017,14017,DB00565,DB00193,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14018,14018,DB00617,DB00193,CCC1(C)OC(=O)N(C)C1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14019,14019,DB00645,DB00193,CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14020,14020,DB00662,DB00193,COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14021,14021,DB00697,DB00193,Clc1ccc2nsnc2c1NC1=NCCN1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14022,14022,DB00732,DB00193,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14023,14023,DB00737,DB00193,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14024,14024,DB00740,DB00193,Nc1nc2ccc(OC(F)(F)F)cc2s1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14025,14025,DB00748,DB00193,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14026,14026,DB00832,DB00193,CN1C(=O)CC(c2ccccc2)C1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14027,14027,DB00906,DB00193,Cc1ccsc1C(=CCCN1CCCC(C(=O)O)C1)c1sccc1C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14028,14028,DB00909,DB00193,NS(=O)(=O)Cc1noc2ccccc12,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14029,14029,DB00962,DB00193,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14030,14030,DB00980,DB00193,CCC(=O)NCCC1CCc2ccc3c(c21)CCO3,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14031,14031,DB00985,DB00193,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14032,14032,DB00996,DB00193,NCC1(CC(=O)O)CCCCC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14033,14033,DB01018,DB00193,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14034,14034,DB01028,DB00193,COC(F)(F)C(Cl)Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14035,14035,DB01065,DB00193,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14036,14036,DB01080,DB00193,C=CC(N)CCC(=O)O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14037,14037,DB01106,DB00193,CC1CN(C2CCC(C#N)(c3ccc(F)cc3)CC2)CCC1(C(=O)O)c1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14038,14038,DB01107,DB00193,CCC1(CC)C(=O)NCC(C)C1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14039,14039,DB01121,DB00193,NC(=O)NC(=O)Cc1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14040,14040,DB01154,DB00193,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14041,14041,DB01159,DB00193,FC(F)(F)C(Cl)Br,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14042,14042,DB01176,DB00193,CN1CCN(C(c2ccccc2)c2ccccc2)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14043,14043,DB01178,DB00193,CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14044,14044,DB01189,DB00193,FC(F)OC(F)C(F)(F)F,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14045,14045,DB01198,DB00193,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14046,14046,DB01219,DB00193,O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14047,14047,DB01236,DB00193,FCOC(C(F)(F)F)C(F)(F)F,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14048,14048,DB01353,DB00193,CCCCC1(CC)C(=O)NC(=O)NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14049,14049,DB01437,DB00193,CCC1(c2ccccc2)CCC(=O)NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14050,14050,DB01440,DB00193,O=C(O)CCCO,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14051,14051,DB01495,DB00193,Cc1cc(=O)n(-c2ccccc2)n1C.OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14052,14052,DB01501,DB00193,N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14053,14053,DB01563,DB00193,OC(O)C(Cl)(Cl)Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14054,14054,DB01618,DB00193,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14055,14055,DB02959,DB00193,NC(Cc1c[nH]c2ccc(O)cc12)C(=O)O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14056,14056,DB04827,DB00193,CCOC(N)=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14057,14057,DB04841,DB00193,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14058,14058,DB04953,DB00193,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14059,14059,DB05246,DB00193,CN1C(=O)CC(C)(c2ccccc2)C1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14060,14060,DB05541,DB00193,CCCC1CC(=O)N(C(CC)C(N)=O)C1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14061,14061,DB06077,DB00193,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14062,14062,DB06218,DB00193,COCC(NC(C)=O)C(=O)NCc1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14063,14063,DB06283,DB00193,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14064,14064,DB06288,DB00193,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14065,14065,DB06690,DB00193,[N-]=[N+]=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14066,14066,DB06716,DB00193,CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14067,14067,DB06753,DB00193,O=P(O)(O)OCC(Cl)(Cl)Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14068,14068,DB06797,DB00193,CCC(C)C(C)(COC(N)=O)COC(N)=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14069,14069,DB08329,DB00193,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14070,14070,DB08872,DB00193,CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14071,14071,DB09071,DB00193,CCC(=O)NCC1CC1c1cccc2c1CCO2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14072,14072,DB11156,DB00193,CN1CCCN=C1C=Cc1cccs1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14073,14073,DB11371,DB00193,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3C(=O)CC12C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14074,14074,DB11376,DB00193,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14075,14075,DB11428,DB00193,Cc1cccc(C(C)c2cnc[nH]2)c1C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14076,14076,DB11477,DB00193,Cc1cccc(C)c1NC1=NCCCS1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14077,14077,DB11543,DB00193,Fc1cccc(Br)c1NC1=NCCN1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14078,14078,DB11549,DB00193,CCNC1(c2cccs2)CCCCC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14079,14079,DB11552,DB00193,CCOC(=O)c1cccc(N)c1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14080,14080,DB11555,DB00193,Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14081,14081,DB11556,DB00193,Cc1cccc(Cc2cnc[nH]2)c1C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14082,14082,DB11859,DB00193,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14083,14083,DB12867,DB00193,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14084,14084,DB13221,DB00193,C=CCC(C(=O)NC(N)=O)C(C)C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14085,14085,DB13253,DB00193,C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14086,14086,DB13256,DB00193,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14087,14087,DB13273,DB00193,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14088,14088,DB13323,DB00193,ClC=C(Cl)Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14089,14089,DB01616,DB00193,CCN(CCCc1ccccc1)CCCc1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14090,14090,DB04821,DB00193,CN1Cc2c(N)cccc2C(c2ccccc2)C1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14091,14091,DB06594,DB00193,COc1ccc2cccc(CCNC(C)=O)c2c1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14092,14092,DB13219,DB00193,CN(C)CC(Oc1ccccc1)Oc1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14093,14093,DB13520,DB00193,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14094,14094,DB00753,DB00193,FC(F)OC(Cl)C(F)(F)F,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14095,14095,DB00470,DB00193,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14096,14096,DB00486,DB00193,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14097,14097,DB00967,DB00193,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14098,14098,DB00231,DB00193,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14099,14099,DB00404,DB00193,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14100,14100,DB00475,DB00193,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14101,14101,DB00628,DB00193,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14102,14102,DB00690,DB00193,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14103,14103,DB00801,DB00193,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14104,14104,DB00842,DB00193,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14105,14105,DB00897,DB00193,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14106,14106,DB01068,DB00193,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14107,14107,DB01215,DB00193,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14108,14108,DB01544,DB00193,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14109,14109,DB01558,DB00193,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14110,14110,DB01559,DB00193,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14111,14111,DB01588,DB00193,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14112,14112,DB01589,DB00193,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14113,14113,DB01595,DB00193,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14114,14114,DB12537,DB00193,C1=Cc2ccccc2NN=C1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14115,14115,DB13872,DB00193,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14116,14116,DB00206,DB00193,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14117,14117,DB00747,DB00193,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14118,14118,DB01239,DB00193,CN(C)CCC=C1c2ccccc2Sc2ccc(Cl)cc21,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14119,14119,DB06770,DB00193,OCc1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14120,14120,DB01339,DB00193,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14121,14121,DB08910,DB00193,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14122,14122,DB12401,DB00193,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14123,14123,DB00555,DB00193,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14124,14124,DB00961,DB00193,Cc1cccc(C)c1NC(=O)C1CCCCN1C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14125,14125,DB01002,DB00193,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14126,14126,DB01359,DB00193,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14128,14128,DB14509,DB00193,O=C([O-])[O-].[Li+].[Li+],COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14129,14129,DB00532,DB00193,CCC1(c2ccccc2)NC(=O)N(C)C1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14130,14130,DB00247,DB00193,CCC(CO)NC(=O)C1C=C2c3cccc4c3c(cn4C)CC2N(C)C1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14131,14131,DB00593,DB00193,CCC1(C)CC(=O)NC1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14132,14132,DB00296,DB00193,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14133,14133,DB00856,DB00193,OCC(O)COc1ccc(Cl)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14134,14134,DB13259,DB00193,CCCl,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14135,14135,DB13583,DB00193,Cc1ccccc1OCC(O)CO,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14137,14137,DB01086,DB00193,CCOC(=O)c1ccc(N)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14138,14138,DB09009,DB00193,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14139,14139,DB11148,DB00193,CCCCOC(=O)c1ccc(N)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14140,14140,DB09085,DB00193,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14141,14141,DB00474,DB00193,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14142,14142,DB00750,DB00193,CCCNC(C)C(=O)Nc1ccccc1C,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14143,14143,DB00892,DB00193,CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14144,14144,DB09345,DB00193,CCCCOc1ccc(OCCCN2CCOCC2)cc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14145,14145,DB00807,DB00193,CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14146,14146,DB11304,DB00193,OCCOc1ccccc1,COc1cccc(C2(O)CCCCC2CN(C)C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
14161,14161,DB00195,DB01235,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
14257,14257,DB00484,DB00195,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
14342,14342,DB00203,DB00195,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
14344,14344,DB06237,DB00195,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
14345,14345,DB06267,DB00195,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
14346,14346,DB12010,DB00195,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
14347,14347,DB00862,DB00195,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
14568,14568,DB13967,DB00195,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
16247,16247,DB00198,DB01032,CCOC(=O)C1=CC(OC(CC)CC)C(NC(C)=O)C(N)C1,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
17025,17025,DB00201,DB04854,Cn1c(=O)c2c(ncn2C)n(C)c1=O,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
17748,17748,DB00202,DB00394,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17749,17749,DB00202,DB00443,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17751,17751,DB00202,DB00591,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17752,17752,DB00202,DB00620,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17753,17753,DB00202,DB00635,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17754,17754,DB00202,DB00687,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17755,17755,DB00202,DB00741,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17756,17756,DB00202,DB00860,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17757,17757,DB00202,DB00959,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17758,17758,DB00202,DB01108,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17759,17759,DB00202,DB01222,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17760,17760,DB00202,DB01234,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17761,17761,DB00202,DB01380,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17762,17762,DB00202,DB01410,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17763,17763,DB00202,DB08906,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17764,17764,DB00202,DB09091,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17765,17765,DB00202,DB09378,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17766,17766,DB00202,DB09383,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17767,17767,DB00202,DB11487,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17768,17768,DB00202,DB11529,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17769,17769,DB00202,DB11921,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17770,17770,DB00202,DB13867,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17771,17771,DB00202,DB14512,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17772,17772,DB00202,DB14539,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17773,17773,DB00202,DB14541,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17774,17774,DB00202,DB14545,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17775,17775,DB00202,DB14631,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17776,17776,DB00202,DB14644,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17777,17777,DB00202,DB14646,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17778,17778,DB00202,DB14669,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17779,17779,DB00202,DB01013,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17780,17780,DB00202,DB01047,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17781,17781,DB00202,DB14540,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17782,17782,DB00202,DB00547,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17783,17783,DB00202,DB08971,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17784,17784,DB00202,DB15566,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17785,17785,DB00202,DB00324,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17786,17786,DB00202,DB09095,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17787,17787,DB00202,DB00663,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17788,17788,DB00202,DB14643,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17817,17817,DB00202,DB00402,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
17819,17819,DB00924,DB00202,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
17823,17823,DB00502,DB00202,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
17827,17827,DB00202,DB14649,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
17858,17858,DB00203,DB00217,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CN=C(NC)NCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17859,17859,DB00203,DB00226,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NC(N)=NCC1COC2(CCCCC2)O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17860,17860,DB00203,DB00275,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17861,17861,DB00203,DB00310,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17862,17862,DB00203,DB00325,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17863,17863,DB00203,DB00335,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17864,17864,DB00203,DB00350,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17865,17865,DB00203,DB00374,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCCCCC(O)CCC1C(O)CC2Cc3c(cccc3OCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17866,17866,DB00203,DB00436,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17867,17867,DB00203,DB00492,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17868,17868,DB00203,DB00519,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17869,17869,DB00203,DB00524,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17870,17870,DB00203,DB00542,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17871,17871,DB00203,DB00606,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17872,17872,DB00203,DB00629,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NC(N)=NN=Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17873,17873,DB00203,DB00691,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17874,17874,DB00203,DB00722,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17875,17875,DB00203,DB00765,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(N)(Cc1ccc(O)cc1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17876,17876,DB00203,DB00774,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17877,17877,DB00203,DB00790,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17878,17878,DB00203,DB00796,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17879,17879,DB00203,DB00800,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17880,17880,DB00203,DB00880,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17881,17881,DB00203,DB00881,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17882,17882,DB00203,DB00960,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(C)NCC(O)COc1cccc2[nH]ccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17883,17883,DB00203,DB00966,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17884,17884,DB00203,DB00999,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17885,17885,DB00203,DB01021,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17886,17886,DB00203,DB01089,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17887,17887,DB00203,DB01119,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17888,17888,DB00203,DB01158,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC[N+](C)(C)Cc1ccccc1Br,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17889,17889,DB00203,DB01180,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17890,17890,DB00203,DB01203,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17891,17891,DB00203,DB01297,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17892,17892,DB00203,DB01324,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17893,17893,DB00203,DB01340,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17894,17894,DB00203,DB01348,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17895,17895,DB00203,DB01359,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17896,17896,DB00203,DB01626,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,C#CCN(C)Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17897,17897,DB00203,DB04840,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,N=C(N)N1CCc2ccccc2C1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17898,17898,DB00203,DB04846,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17899,17899,DB00203,DB04948,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17900,17900,DB00203,DB09242,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,COc1nc(C)nc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17901,17901,DB00203,DB09477,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17902,17902,DB00203,DB11738,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,C1COC(NC(C2CC2)C2CC2)=N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17903,17903,DB00203,DB12945,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NNc1nnc(NN)c2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17904,17904,DB00203,DB13166,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17905,17905,DB00203,DB13211,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,N=C(N)NCC1COc2ccccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17906,17906,DB00203,DB13532,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17907,17907,DB00203,DB13801,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17908,17908,DB00203,DB00401,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17909,17909,DB00203,DB01054,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17910,17910,DB00203,DB00695,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17911,17911,DB00203,DB00700,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17912,17912,DB00203,DB00808,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17913,17913,DB00203,DB01018,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17914,17914,DB00203,DB01170,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NC(N)=NCCN1CCCCCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17915,17915,DB00203,DB06762,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CC(NC(=Nc1ccncc1)NC#N)C(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17916,17916,DB00203,DB08932,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17917,17917,DB00203,DB09026,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17918,17918,DB00203,DB09236,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17919,17919,DB00203,DB01029,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17920,17920,DB00203,DB00678,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17921,17921,DB00203,DB00381,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17922,17922,DB00203,DB00393,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17923,17923,DB00203,DB01275,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,NNc1nncc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17924,17924,DB00203,DB00657,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CNC1(C)C2CCC(C2)C1(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17925,17925,DB00203,DB01090,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17926,17926,DB00203,DB01116,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
17927,17927,DB00203,DB08822,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
18571,18571,DB00203,DB00388,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
19326,19326,DB00206,DB01235,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
19498,19498,DB00484,DB00206,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
19512,19512,DB12010,DB00206,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
20154,20154,DB00206,DB00402,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
20156,20156,DB00924,DB00206,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
20166,20166,DB00502,DB00206,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
20170,20170,DB00206,DB06283,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
21263,21263,DB00209,DB00761,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
21362,21362,DB00209,DB00470,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
21363,21363,DB00209,DB00486,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
21364,21364,DB00209,DB06155,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
21365,21365,DB00209,DB09061,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
21846,21846,DB00209,DB14881,O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
22060,22060,DB09042,DB00211,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22068,22068,DB13114,DB00211,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22069,22069,DB13225,DB00211,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22070,22070,DB13246,DB00211,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22071,22071,DB00321,DB00211,CN(C)CCC=C1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22072,22072,DB00344,DB00211,CNCCCC1c2ccccc2C=Cc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22073,22073,DB00458,DB00211,CN(C)CCCN1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22074,22074,DB00540,DB00211,CNCCC=C1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22075,22075,DB00543,DB00211,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22076,22076,DB00726,DB00211,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22077,22077,DB01142,DB00211,CN(C)CCC=C1c2ccccc2COc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22078,22078,DB01151,DB00211,CNCCCN1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22079,22079,DB01242,DB00211,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22080,22080,DB09167,DB00211,CN(C)CCC=C1c2ccccc2CSc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
22178,22178,DB00614,DB00211,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22179,22179,DB00721,DB00211,CCN(CC)CCOC(=O)c1ccc(N)cc1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22180,22180,DB00752,DB00211,NC1CC1c1ccccc1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22181,22181,DB00780,DB00211,NNCCc1ccccc1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22182,22182,DB00805,DB00211,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22183,22183,DB01037,DB00211,C#CCN(C)C(C)Cc1ccccc1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22184,22184,DB01168,DB00211,CNNCc1ccc(C(=O)NC(C)C)cc1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22185,22185,DB01171,DB00211,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22186,22186,DB01247,DB00211,Cc1cc(C(=O)NNCc2ccccc2)no1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22187,22187,DB01367,DB00211,C#CCNC1CCc2ccccc21,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22188,22188,DB01626,DB00211,C#CCN(C)Cc1ccccc1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22189,22189,DB04820,DB00211,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22190,22190,DB06654,DB00211,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22191,22191,DB09241,DB00211,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22268,22268,DB13946,DB00211,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc(OC)c(C(O)CNC(=O)CN)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
22466,22466,DB00214,DB01235,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
22623,22623,DB00484,DB00214,Brc1c(NC2=NCCN2)ccc2nccnc12,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
22624,22624,DB00862,DB00214,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
22625,22625,DB00975,DB00214,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
22626,22626,DB06267,DB00214,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
22627,22627,DB12010,DB00214,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
22794,22794,DB00214,DB00282,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,NCCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
22795,22795,DB00214,DB00399,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
22796,22796,DB00214,DB00630,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
22797,22797,DB00214,DB00710,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
22798,22798,DB00214,DB00720,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,O=P(O)(O)C(Cl)(Cl)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
22799,22799,DB00214,DB00884,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
22800,22800,DB00214,DB01077,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,CC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
22801,22801,DB00214,DB01133,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
22987,22987,DB00246,DB00214,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
22990,22990,DB00214,DB06283,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
23880,23880,DB00215,DB00402,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
23886,23886,DB00924,DB00215,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
24136,24136,DB00216,DB06262,CN1CCCC1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
24774,24774,DB13946,DB00216,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CCCC1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
24776,24776,DB00216,DB00402,CN1CCCC1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
24778,24778,DB00924,DB00216,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCCC1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
24787,24787,DB00502,DB00216,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCCC1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
25034,25034,DB00484,DB00217,Brc1c(NC2=NCCN2)ccc2nccnc12,CN=C(NC)NCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
25036,25036,DB00862,DB00217,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CN=C(NC)NCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
25037,25037,DB00975,DB00217,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CN=C(NC)NCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
25038,25038,DB06237,DB00217,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CN=C(NC)NCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
25039,25039,DB06267,DB00217,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CN=C(NC)NCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
25040,25040,DB12010,DB00217,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CN=C(NC)NCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
25157,25157,DB13946,DB00217,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN=C(NC)NCc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
25204,25204,DB00246,DB00217,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CN=C(NC)NCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
25751,25751,DB00219,DB00470,CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
25752,25752,DB00219,DB00486,CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
25753,25753,DB00219,DB06155,CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
25754,25754,DB00219,DB09061,CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
26089,26089,DB00219,DB00761,CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
26151,26151,DB00219,DB14881,CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
26163,26163,DB00531,DB00220,O=P1(N(CCCl)CCCl)NCCCO1,Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
26172,26172,DB00615,DB00220,COC1C=COC2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O,Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
26918,26918,DB16165,DB00220,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,Cc1c(O)cccc1C(=O)NC(CSc1ccccc1)C(O)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
27308,27308,DB13946,DB00221,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(NC(C)C)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
27768,27768,DB00531,DB00224,O=P1(N(CCCl)CCCl)NCCCO1,CC(C)(C)NC(=O)C1CN(Cc2cccnc2)CCN1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
27777,27777,DB00615,DB00224,COC1C=COC2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O,CC(C)(C)NC(=O)C1CN(Cc2cccnc2)CCN1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
28424,28424,DB16165,DB00224,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)(C)NC(=O)C1CN(Cc2cccnc2)CCN1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
28654,28654,DB00484,DB00226,Brc1c(NC2=NCCN2)ccc2nccnc12,NC(N)=NCC1COC2(CCCCC2)O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
28656,28656,DB00862,DB00226,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NC(N)=NCC1COC2(CCCCC2)O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
28657,28657,DB00975,DB00226,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NC(N)=NCC1COC2(CCCCC2)O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
28658,28658,DB06237,DB00226,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NC(N)=NCC1COC2(CCCCC2)O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
28659,28659,DB06267,DB00226,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NC(N)=NCC1COC2(CCCCC2)O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
28660,28660,DB12010,DB00226,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NC(N)=NCC1COC2(CCCCC2)O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
28776,28776,DB00246,DB00226,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NC(N)=NCC1COC2(CCCCC2)O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
29613,29613,DB00422,DB00228,COC(=O)C(c1ccccc1)C1CCCCN1,FC(F)OC(F)(F)C(F)Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
30032,30032,DB00228,DB00402,FC(F)OC(F)(F)C(F)Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30035,30035,DB00924,DB00228,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,FC(F)OC(F)(F)C(F)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30041,30041,DB00502,DB00228,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,FC(F)OC(F)(F)C(F)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30057,30057,DB16629,DB00228,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,FC(F)OC(F)(F)C(F)Cl,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
30488,30488,DB06711,DB00230,c1ccc2c(CC3=NCCN3)cccc2c1,CC(C)CC(CN)CC(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30956,30956,DB06711,DB00231,c1ccc2c(CC3=NCCN3)cccc2c1,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30957,30957,DB00231,DB00402,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30959,30959,DB00924,DB00231,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30962,30962,DB00231,DB00388,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
30964,30964,DB00502,DB00231,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30965,30965,DB00231,DB06283,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
30972,30972,DB00233,DB01009,Nc1ccc(C(=O)O)c(O)c1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
30973,30973,DB00233,DB09214,Nc1ccc(C(=O)O)c(O)c1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
31045,31045,DB00233,DB00936,Nc1ccc(C(=O)O)c(O)c1,O=C(O)c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
31046,31046,DB00233,DB01250,Nc1ccc(C(=O)O)c(O)c1,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
31047,31047,DB00233,DB01294,Nc1ccc(C(=O)O)c(O)c1,O=C1O[Bi](O)Oc2ccccc21,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
31048,31048,DB00233,DB06807,Nc1ccc(C(=O)O)c(O)c1,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
31049,31049,DB00233,DB09543,Nc1ccc(C(=O)O)c(O)c1,COC(=O)c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
31050,31050,DB00233,DB14006,Nc1ccc(C(=O)O)c(O)c1,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
31570,31570,DB00234,DB00402,CCOc1ccccc1OC(c1ccccc1)C1CNCCO1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
31572,31572,DB00924,DB00234,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOc1ccccc1OC(c1ccccc1)C1CNCCO1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
31578,31578,DB00502,DB00234,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCOc1ccccc1OC(c1ccccc1)C1CNCCO1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
31742,31742,DB00237,DB00999,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32202,32202,DB00237,DB00524,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32204,32204,DB00237,DB00808,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32206,32206,DB00237,DB00310,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32208,32208,DB00237,DB00436,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32209,32209,DB00237,DB00562,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32213,32213,DB00237,DB00774,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32215,32215,DB00237,DB00880,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32216,32216,DB00237,DB01021,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32218,32218,DB00237,DB01324,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32219,32219,DB00237,DB01325,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32221,32221,DB00237,DB13532,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
32228,32228,DB06711,DB00237,c1ccc2c(CC3=NCCN3)cccc2c1,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
32230,32230,DB00237,DB00402,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
32232,32232,DB00924,DB00237,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
32236,32236,DB00502,DB00237,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
32237,32237,DB00237,DB06283,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
33043,33043,DB00241,DB00310,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33044,33044,DB00241,DB00436,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33045,33045,DB00241,DB00524,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33046,33046,DB00241,DB00562,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33047,33047,DB00241,DB00774,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33048,33048,DB00241,DB00808,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33049,33049,DB00241,DB00880,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33050,33050,DB00241,DB00999,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33051,33051,DB00241,DB01021,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33052,33052,DB00241,DB01324,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33053,33053,DB00241,DB01325,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33054,33054,DB00241,DB13532,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
33600,33600,DB06711,DB00241,c1ccc2c(CC3=NCCN3)cccc2c1,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
33602,33602,DB00241,DB00402,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
33637,33637,DB00924,DB00241,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
33646,33646,DB00502,DB00241,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
33649,33649,DB00241,DB06283,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
34760,34760,DB00244,DB01009,Nc1ccc(O)c(C(=O)O)c1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
34761,34761,DB00244,DB09214,Nc1ccc(O)c(C(=O)O)c1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
34989,34989,DB13946,DB00244,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Nc1ccc(O)c(C(=O)O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
35012,35012,DB00245,DB00761,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
35088,35088,DB00245,DB00470,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
35089,35089,DB00245,DB00486,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
35090,35090,DB00245,DB06155,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
35091,35091,DB00245,DB09061,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
35720,35720,DB00245,DB14881,CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
35746,35746,DB00246,DB00761,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
35805,35805,DB00246,DB06262,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
36061,36061,DB13946,DB00246,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
36063,36063,DB00246,DB00402,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
36069,36069,DB00924,DB00246,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
36600,36600,DB00246,DB00275,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36601,36601,DB00246,DB00310,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36602,36602,DB00246,DB00325,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36603,36603,DB00246,DB00350,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36604,36604,DB00246,DB00436,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36605,36605,DB00246,DB00492,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36606,36606,DB00246,DB00519,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36607,36607,DB00246,DB00524,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36608,36608,DB00246,DB00542,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36609,36609,DB00246,DB00606,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36610,36610,DB00246,DB00657,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CNC1(C)C2CCC(C2)C1(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36611,36611,DB00246,DB00722,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36612,36612,DB00246,DB00727,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36613,36613,DB00246,DB00774,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36614,36614,DB00246,DB00796,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36615,36615,DB00246,DB00876,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36616,36616,DB00246,DB00880,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36617,36617,DB00246,DB00881,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36618,36618,DB00246,DB00966,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36619,36619,DB00246,DB01021,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36620,36620,DB00246,DB01089,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36621,36621,DB00246,DB01090,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36622,36622,DB00246,DB01116,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36623,36623,DB00246,DB01119,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36624,36624,DB00246,DB01240,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36625,36625,DB00246,DB01324,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36626,36626,DB00246,DB01340,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36627,36627,DB00246,DB01348,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36628,36628,DB00246,DB09220,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,O=C(NCCO[N+](=O)[O-])c1cccnc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36629,36629,DB00246,DB09477,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36630,36630,DB00246,DB13166,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36631,36631,DB00246,DB13211,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,N=C(N)NCC1COc2ccccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36632,36632,DB00246,DB13532,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36633,36633,DB00246,DB13801,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36634,36634,DB00246,DB00765,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(N)(Cc1ccc(O)cc1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36635,36635,DB00246,DB01180,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36636,36636,DB00246,DB00629,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NC(N)=NN=Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36637,36637,DB00246,DB00968,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36638,36638,DB00246,DB09242,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COc1nc(C)nc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36639,36639,DB00246,DB11738,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,C1COC(NC(C2CC2)C2CC2)=N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36640,36640,DB00246,DB00264,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COCCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36641,36641,DB00246,DB00335,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36642,36642,DB00246,DB01203,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36643,36643,DB00246,DB01297,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36644,36644,DB00246,DB04861,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36645,36645,DB00246,DB00790,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36646,36646,DB00246,DB00457,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36647,36647,DB00246,DB00590,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36648,36648,DB00246,DB00598,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36649,36649,DB00246,DB00692,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36650,36650,DB00246,DB00797,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,c1ccc(CC2=NCCN2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36651,36651,DB00246,DB00925,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(COc1ccccc1)N(CCCl)Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36652,36652,DB00246,DB01136,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36653,36653,DB00246,DB01162,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36654,36654,DB00246,DB08950,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36655,36655,DB00246,DB00559,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36656,36656,DB00246,DB01029,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36657,36657,DB00246,DB01275,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NNc1nncc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36658,36658,DB00246,DB06268,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36659,36659,DB00246,DB00401,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36660,36660,DB00246,DB00695,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36661,36661,DB00246,DB00584,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36662,36662,DB00246,DB01197,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(CS)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36663,36663,DB00246,DB09238,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36664,36664,DB00246,DB00528,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36665,36665,DB00246,DB06403,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COC(c1ccccc1)(c1ccccc1)C(Oc1nc(C)cc(C)n1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36666,36666,DB00246,DB00612,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36667,36667,DB00246,DB01170,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NC(N)=NCCN1CCCCCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36668,36668,DB00246,DB06762,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(NC(=Nc1ccncc1)NC#N)C(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36669,36669,DB00246,DB08931,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36670,36670,DB00246,DB08932,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36671,36671,DB00246,DB09026,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36672,36672,DB00246,DB11362,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36673,36673,DB00246,DB04840,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,N=C(N)N1CCc2ccccc2C1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36674,36674,DB00246,DB12945,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,NNc1nnc(NN)c2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36675,36675,DB00246,DB00820,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2ccc3c(c2)OCO3)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36676,36676,DB00246,DB00287,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(O)COc1cccc(C(F)(F)F)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36677,36677,DB00246,DB00869,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCNC1CC(C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36678,36678,DB00246,DB00905,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCNC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(O)CCc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36679,36679,DB00246,DB01214,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36680,36680,DB00246,DB06826,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCCCCCCC(=O)CCC1C(O)CC(O)C1CC=CCCCC(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
36681,36681,DB00246,DB08822,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
37716,37716,DB13946,DB00247,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(CO)NC(=O)C1C=C2c3cccc4c3c(cn4C)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
37718,37718,DB00247,DB00402,CCC(CO)NC(=O)C1C=C2c3cccc4c3c(cn4C)CC2N(C)C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
37720,37720,DB00924,DB00247,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(CO)NC(=O)C1C=C2c3cccc4c3c(cn4C)CC2N(C)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
37726,37726,DB00502,DB00247,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(CO)NC(=O)C1C=C2c3cccc4c3c(cn4C)CC2N(C)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
37957,37957,DB00248,DB06262,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
37968,37968,DB00248,DB00320,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37969,37969,DB00248,DB00589,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37970,37970,DB00248,DB00714,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37971,37971,DB00248,DB00800,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37972,37972,DB00248,DB01186,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37973,37973,DB00248,DB01200,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37974,37974,DB00248,DB09097,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37975,37975,DB00248,DB09128,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37976,37976,DB00248,DB11273,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37977,37977,DB00248,DB12313,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
37978,37978,DB00248,DB13520,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
38353,38353,DB00248,DB01238,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
38680,38680,DB13946,DB00248,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
38683,38683,DB00248,DB00402,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
38686,38686,DB00924,DB00248,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
38694,38694,DB00502,DB00248,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
39340,39340,DB00252,DB00273,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
39915,39915,DB00252,DB00402,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
39943,39943,DB00924,DB00252,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
40069,40069,DB00502,DB00252,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
40073,40073,DB00252,DB06283,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
42833,42833,DB00264,DB01235,COCCc1ccc(OCC(O)CNC(C)C)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
42910,42910,DB00484,DB00264,Brc1c(NC2=NCCN2)ccc2nccnc12,COCCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
42986,42986,DB06267,DB00264,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COCCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
42988,42988,DB00862,DB00264,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COCCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
42989,42989,DB06237,DB00264,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COCCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
42990,42990,DB12010,DB00264,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COCCc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
43281,43281,DB13967,DB00264,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,COCCc1ccc(OCC(O)CNC(C)C)cc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
43804,43804,DB00266,DB06701,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
43961,43961,DB00268,DB01235,CCCN(CCC)CCc1cccc2c1CC(=O)N2,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
44250,44250,DB00268,DB00800,CCCN(CCC)CCc1cccc2c1CC(=O)N2,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
44251,44251,DB00268,DB09097,CCCN(CCC)CCc1cccc2c1CC(=O)N2,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
44252,44252,DB00268,DB11273,CCCN(CCC)CCc1cccc2c1CC(=O)N2,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
44253,44253,DB00268,DB12313,CCCN(CCC)CCc1cccc2c1CC(=O)N2,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
44254,44254,DB00268,DB00413,CCCN(CCC)CCc1cccc2c1CC(=O)N2,CCCNC1CCc2nc(N)sc2C1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
44504,44504,DB00270,DB01235,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
44616,44616,DB00484,DB00270,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
45038,45038,DB00270,DB00388,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
45480,45480,DB01320,DB00273,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
45913,45913,DB00273,DB00402,CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
45950,45950,DB00924,DB00273,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
45968,45968,DB00502,DB00273,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
45971,45971,DB00273,DB06283,CC1(C)OC2COC3(COS(N)(=O)=O)OC(C)(C)OC3C2O1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
46108,46108,DB00275,DB01235,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
46297,46297,DB00484,DB00275,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
46299,46299,DB00862,DB00275,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
46300,46300,DB06237,DB00275,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
46301,46301,DB06267,DB00275,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
46302,46302,DB12010,DB00275,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
46413,46413,DB00695,DB00275,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
46598,46598,DB00277,DB04854,Cn1c(=O)c2[nH]cnc2n(C)c1=O,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
47363,47363,DB01221,DB00279,CNC1(c2ccccc2Cl)CCCCC1=O,NC(Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
47447,47447,DB00280,DB00761,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
47521,47521,DB00280,DB00470,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
47522,47522,DB00280,DB00486,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
47523,47523,DB00280,DB06155,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
47524,47524,DB00280,DB09061,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
48169,48169,DB00280,DB14881,CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
48886,48886,DB00281,DB00402,CCN(CC)CC(=O)Nc1c(C)cccc1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
48889,48889,DB00924,DB00281,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CC)CC(=O)Nc1c(C)cccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
48897,48897,DB00502,DB00281,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CC)CC(=O)Nc1c(C)cccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
49053,49053,DB00282,DB09139,NCCC(O)(P(=O)(O)O)P(=O)(O)O,O=P(O)(O)C(O)P(=O)(O)O.[Tc],132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
49057,49057,DB02925,DB00282,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,NCCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
49795,49795,DB00283,DB00402,CN1CCCC1CCOC(C)(c1ccccc1)c1ccc(Cl)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
49800,49800,DB00924,DB00283,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCCC1CCOC(C)(c1ccccc1)c1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
50817,50817,DB00285,DB00402,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
50822,50822,DB00924,DB00285,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
50827,50827,DB01151,DB00285,CNCCCN1c2ccccc2CCc2ccccc21,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
51718,51718,DB13946,DB00289,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNCCC(Oc1ccccc1C)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
52612,52612,DB06711,DB00292,c1ccc2c(CC3=NCCN3)cccc2c1,CCOC(=O)c1cncn1C(C)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
52613,52613,DB13946,DB00292,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCOC(=O)c1cncn1C(C)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
52615,52615,DB00292,DB00402,CCOC(=O)c1cncn1C(C)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
52617,52617,DB00924,DB00292,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOC(=O)c1cncn1C(C)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
52621,52621,DB00502,DB00292,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCOC(=O)c1cncn1C(C)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
52622,52622,DB00292,DB06283,CCOC(=O)c1cncn1C(C)c1ccccc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
53026,53026,DB00295,DB01235,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
53191,53191,DB00372,DB00295,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53192,53192,DB00433,DB00295,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53193,53193,DB00623,DB00295,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53194,53194,DB00680,DB00295,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53195,53195,DB00831,DB00295,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53196,53196,DB00850,DB00295,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53197,53197,DB00933,DB00295,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53198,53198,DB01063,DB00295,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53199,53199,DB01246,DB00295,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53200,53200,DB01608,DB00295,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53201,53201,DB01614,DB00295,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53202,53202,DB01621,DB00295,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53203,53203,DB11540,DB00295,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53204,53204,DB12710,DB00295,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53205,53205,DB13213,DB00295,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53221,53221,DB00758,DB00295,COC(=O)C(c1ccccc1Cl)N1CCc2sccc2C1,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,152,D044967&D008660,decrease&decrease,2,the serum concentration of the active metabolites of #drug1 can be decreased when #drug1 is used in combination with #drug2.
53421,53421,DB00679,DB00295,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
53768,53768,DB00295,DB00402,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
53771,53771,DB00924,DB00295,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
53776,53776,DB00502,DB00295,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCC23c4c5ccc(O)c4OC2C(O)C=CC3C1C5,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
53832,53832,DB00296,DB01235,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
54412,54412,DB00296,DB00402,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
54414,54414,DB00924,DB00296,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
54419,54419,DB00502,DB00296,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCN1CCCCC1C(=O)Nc1c(C)cccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
54493,54493,DB00297,DB01235,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
55100,55100,DB00297,DB00402,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
55103,55103,DB00924,DB00297,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
55111,55111,DB00502,DB00297,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
55181,55181,DB13946,DB00298,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
55182,55182,DB00924,DB00298,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
55185,55185,DB00502,DB00298,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
55186,55186,DB00298,DB06283,Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
56973,56973,DB06711,DB00306,c1ccc2c(CC3=NCCN3)cccc2c1,C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
56974,56974,DB00306,DB00402,C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
56976,56976,DB00924,DB00306,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
56979,56979,DB00502,DB00306,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
56980,56980,DB00306,DB06283,C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
58167,58167,DB00310,DB01235,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58271,58271,DB00310,DB00391,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58329,58329,DB00484,DB00310,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
58344,58344,DB00862,DB00310,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
58345,58345,DB00975,DB00310,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
58346,58346,DB06237,DB00310,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
58347,58347,DB06267,DB00310,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
58348,58348,DB12010,DB00310,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
58418,58418,DB00898,DB00310,CCO,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58424,58424,DB00312,DB00310,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58425,58425,DB00418,DB00310,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58426,58426,DB00474,DB00310,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58427,58427,DB00599,DB00310,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58428,58428,DB00794,DB00310,CCC1(c2ccccc2)C(=O)NCNC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58429,58429,DB00849,DB00310,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58430,58430,DB01154,DB00310,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58431,58431,DB01174,DB00310,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58432,58432,DB01351,DB00310,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58539,58539,DB00310,DB06283,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
58619,58619,DB00312,DB00436,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58620,58620,DB00312,DB00524,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58621,58621,DB00312,DB00562,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58622,58622,DB00312,DB00774,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58623,58623,DB00312,DB00880,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58624,58624,DB00312,DB00999,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58625,58625,DB00312,DB01021,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58626,58626,DB00312,DB01324,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58627,58627,DB00312,DB01325,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58628,58628,DB00312,DB13532,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
58991,58991,DB06711,DB00312,c1ccc2c(CC3=NCCN3)cccc2c1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
58994,58994,DB00312,DB00402,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
59027,59027,DB00924,DB00312,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
59036,59036,DB00502,DB00312,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
59040,59040,DB00312,DB06283,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
59531,59531,DB00776,DB00313,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,CCCC(CCC)C(=O)O,152,D044967&D008660,decrease&decrease,2,the serum concentration of the active metabolites of #drug1 can be decreased when #drug1 is used in combination with #drug2.
60289,60289,DB00313,DB00402,CCCC(CCC)C(=O)O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
60328,60328,DB00924,DB00313,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCC(CCC)C(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
60340,60340,DB00313,DB06283,CCCC(CCC)C(=O)O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
60695,60695,DB00315,DB06262,CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
61175,61175,DB13946,DB00315,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
61176,61176,DB00315,DB00402,CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
61178,61178,DB00924,DB00315,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
61180,61180,DB00502,DB00315,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)CCc1c[nH]c2ccc(CC3COC(=O)N3)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
62259,62259,DB00433,DB00318,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62260,62260,DB00623,DB00318,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62261,62261,DB00680,DB00318,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62262,62262,DB00831,DB00318,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62263,62263,DB00850,DB00318,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62264,62264,DB00933,DB00318,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62265,62265,DB01063,DB00318,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62266,62266,DB01246,DB00318,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62267,62267,DB01608,DB00318,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62268,62268,DB01614,DB00318,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62269,62269,DB01621,DB00318,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62270,62270,DB11540,DB00318,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62271,62271,DB12710,DB00318,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62272,62272,DB13213,DB00318,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62432,62432,DB00372,DB00318,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
62643,62643,DB00318,DB00402,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
62645,62645,DB00924,DB00318,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
62649,62649,DB00502,DB00318,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc2c3c1OC1C(O)C=CC4C(C2)N(C)CCC341,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
62908,62908,DB00320,DB06262,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
62919,62919,DB00320,DB00589,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
62920,62920,DB00320,DB00714,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
62921,62921,DB00320,DB00800,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
62922,62922,DB00320,DB01186,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
62923,62923,DB00320,DB09097,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
62924,62924,DB00320,DB11273,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
62925,62925,DB00320,DB12313,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
62926,62926,DB00320,DB13520,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
63611,63611,DB13946,DB00320,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
63612,63612,DB00320,DB00402,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
63616,63616,DB00924,DB00320,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
63624,63624,DB00502,DB00320,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3cccc4[nH]cc(c34)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
63718,63718,DB00321,DB00761,CN(C)CCC=C1c2ccccc2CCc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
63732,63732,DB00488,DB00321,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CN(C)CCC=C1c2ccccc2CCc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
63784,63784,DB00321,DB00368,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63785,63785,DB00321,DB00388,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63786,63786,DB00321,DB00610,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63787,63787,DB00321,DB00723,CN(C)CCC=C1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63788,63788,DB00321,DB00841,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63789,63789,DB00321,DB00935,CN(C)CCC=C1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63790,63790,DB00321,DB06262,CN(C)CCC=C1c2ccccc2CCc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63791,63791,DB00321,DB06694,CN(C)CCC=C1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63792,63792,DB00321,DB06706,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63793,63793,DB00321,DB06711,CN(C)CCC=C1c2ccccc2CCc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63794,63794,DB00321,DB06764,CN(C)CCC=C1c2ccccc2CCc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63795,63795,DB00321,DB00668,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63796,63796,DB00321,DB01253,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
63797,63797,DB00321,DB01186,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
64592,64592,DB13946,DB00321,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCC=C1c2ccccc2CCc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
64595,64595,DB00321,DB00402,CN(C)CCC=C1c2ccccc2CCc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
64603,64603,DB00924,DB00321,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCC=C1c2ccccc2CCc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
65054,65054,DB00323,DB01235,Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
65526,65526,DB00323,DB00402,Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
65528,65528,DB00924,DB00323,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
65531,65531,DB00502,DB00323,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
65773,65773,DB00416,DB00324,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65774,65774,DB00565,DB00324,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65775,65775,DB00728,DB00324,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65776,65776,DB00732,DB00324,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65777,65777,DB01135,DB00324,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65778,65778,DB01226,DB00324,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65779,65779,DB01336,DB00324,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65780,65780,DB01339,DB00324,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65781,65781,DB04834,DB00324,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65782,65782,DB11156,DB00324,CN1CCCN=C1C=Cc1cccs1,CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
65857,65857,DB00325,DB01235,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
66062,66062,DB00484,DB00325,Brc1c(NC2=NCCN2)ccc2nccnc12,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
66064,66064,DB00862,DB00325,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
66065,66065,DB00975,DB00325,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
66066,66066,DB06237,DB00325,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
66067,66067,DB06267,DB00325,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
66068,66068,DB12010,DB00325,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,N#C[Fe-2](C#N)(C#N)(C#N)(C#N)N=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
66370,66370,DB00372,DB00327,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66371,66371,DB00433,DB00327,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66372,66372,DB00623,DB00327,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66373,66373,DB00680,DB00327,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66374,66374,DB00831,DB00327,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66375,66375,DB00850,DB00327,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66376,66376,DB00933,DB00327,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66377,66377,DB01063,DB00327,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66378,66378,DB01246,DB00327,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66379,66379,DB01608,DB00327,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66380,66380,DB01614,DB00327,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66381,66381,DB01621,DB00327,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66382,66382,DB11540,DB00327,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66383,66383,DB12710,DB00327,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66384,66384,DB13213,DB00327,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66409,66409,DB00679,DB00327,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
66725,66725,DB00327,DB00402,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
66729,66729,DB00924,DB00327,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
66730,66730,DB00502,DB00327,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3C1C5,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
67333,67333,DB13946,DB00328,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
67949,67949,DB00332,DB00761,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
68078,68078,DB00332,DB00470,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
68079,68079,DB00332,DB00486,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
68080,68080,DB00332,DB06155,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
68081,68081,DB00332,DB09061,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
68408,68408,DB00332,DB14881,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
69261,69261,DB00334,DB01235,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
69293,69293,DB00334,DB00761,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
70058,70058,DB00334,DB00402,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
70064,70064,DB00924,DB00334,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
70070,70070,DB00334,DB06283,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
70086,70086,DB00335,DB01235,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
70171,70171,DB00484,DB00335,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
70254,70254,DB00862,DB00335,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
70255,70255,DB06237,DB00335,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
70256,70256,DB06267,DB00335,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
70257,70257,DB12010,DB00335,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
70458,70458,DB13967,DB00335,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
71313,71313,DB00340,DB00761,CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
71403,71403,DB00340,DB00470,CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
71404,71404,DB00340,DB00486,CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
71405,71405,DB00340,DB06155,CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
71406,71406,DB00340,DB09061,CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
71740,71740,DB00340,DB14881,CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
72294,72294,DB00341,DB00402,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
72299,72299,DB00924,DB00341,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
72333,72333,DB00342,DB00761,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
72414,72414,DB00342,DB00486,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
73279,73279,DB16165,DB00342,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
73304,73304,DB00343,DB01235,COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
73430,73430,DB00484,DB00343,Brc1c(NC2=NCCN2)ccc2nccnc12,COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
73431,73431,DB00975,DB00343,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
74030,74030,DB00343,DB00388,COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
74347,74347,DB00488,DB00344,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CNCCCC1c2ccccc2C=Cc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
74363,74363,DB00344,DB00368,CNCCCC1c2ccccc2C=Cc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74364,74364,DB00344,DB00388,CNCCCC1c2ccccc2C=Cc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74365,74365,DB00344,DB00610,CNCCCC1c2ccccc2C=Cc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74366,74366,DB00344,DB00668,CNCCCC1c2ccccc2C=Cc2ccccc21,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74367,74367,DB00344,DB00723,CNCCCC1c2ccccc2C=Cc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74368,74368,DB00344,DB00841,CNCCCC1c2ccccc2C=Cc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74369,74369,DB00344,DB00935,CNCCCC1c2ccccc2C=Cc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74370,74370,DB00344,DB01200,CNCCCC1c2ccccc2C=Cc2ccccc21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74371,74371,DB00344,DB01253,CNCCCC1c2ccccc2C=Cc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74372,74372,DB00344,DB06262,CNCCCC1c2ccccc2C=Cc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74373,74373,DB00344,DB06694,CNCCCC1c2ccccc2C=Cc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74374,74374,DB00344,DB06706,CNCCCC1c2ccccc2C=Cc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74375,74375,DB00344,DB06711,CNCCCC1c2ccccc2C=Cc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74376,74376,DB00344,DB06764,CNCCCC1c2ccccc2C=Cc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74377,74377,DB00344,DB01186,CNCCCC1c2ccccc2C=Cc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
74963,74963,DB13946,DB00344,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNCCCC1c2ccccc2C=Cc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
74964,74964,DB00344,DB00402,CNCCCC1c2ccccc2C=Cc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
74971,74971,DB00924,DB00344,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNCCCC1c2ccccc2C=Cc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
76309,76309,DB00347,DB00402,CN1C(=O)OC(C)(C)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
76346,76346,DB00924,DB00347,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)OC(C)(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
76349,76349,DB00347,DB00388,CN1C(=O)OC(C)(C)C1=O,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
76367,76367,DB00347,DB06283,CN1C(=O)OC(C)(C)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
77112,77112,DB06711,DB00349,c1ccc2c(CC3=NCCN3)cccc2c1,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
77115,77115,DB00349,DB00402,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
77122,77122,DB00924,DB00349,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
77125,77125,DB00349,DB00388,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
77132,77132,DB00502,DB00349,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
77135,77135,DB00349,DB06283,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
77191,77191,DB00350,DB01235,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
77432,77432,DB00484,DB00350,Brc1c(NC2=NCCN2)ccc2nccnc12,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
77434,77434,DB00862,DB00350,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
77435,77435,DB00975,DB00350,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
77436,77436,DB06237,DB00350,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
77437,77437,DB06267,DB00350,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
78410,78410,DB13946,DB00353,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
78481,78481,DB00354,DB00761,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
78566,78566,DB00354,DB00470,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
78567,78567,DB00354,DB00486,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
78568,78568,DB00354,DB06155,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
78569,78569,DB00354,DB09061,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
79081,79081,DB00354,DB14881,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
79677,79677,DB00356,DB00402,O=c1[nH]c2cc(Cl)ccc2o1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
79679,79679,DB00924,DB00356,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=c1[nH]c2cc(Cl)ccc2o1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
79686,79686,DB00502,DB00356,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=c1[nH]c2cc(Cl)ccc2o1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
81657,81657,DB00363,DB01235,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
81736,81736,DB00363,DB00761,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
82471,82471,DB13946,DB00363,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
82475,82475,DB00363,DB00402,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
82484,82484,DB00924,DB00363,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
82508,82508,DB00363,DB06283,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
83510,83510,DB00366,DB00761,CN(C)CCOC(C)(c1ccccc1)c1ccccn1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
84302,84302,DB00614,DB00368,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84303,84303,DB00721,DB00368,CCN(CC)CCOC(=O)c1ccc(N)cc1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84304,84304,DB00752,DB00368,NC1CC1c1ccccc1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84305,84305,DB00780,DB00368,NNCCc1ccccc1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84306,84306,DB00805,DB00368,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84307,84307,DB01037,DB00368,C#CCN(C)C(C)Cc1ccccc1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84308,84308,DB01168,DB00368,CNNCc1ccc(C(=O)NC(C)C)cc1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84309,84309,DB01171,DB00368,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84310,84310,DB01247,DB00368,Cc1cc(C(=O)NNCc2ccccc2)no1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84311,84311,DB01367,DB00368,C#CCNC1CCc2ccccc21,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84312,84312,DB01626,DB00368,C#CCN(C)Cc1ccccc1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84313,84313,DB04820,DB00368,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84314,84314,DB06654,DB00368,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84315,84315,DB09241,DB00368,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84317,84317,DB09042,DB00368,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
84324,84324,DB00458,DB00368,CN(C)CCCN1c2ccccc2CCc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84325,84325,DB00540,DB00368,CNCCC=C1c2ccccc2CCc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84326,84326,DB00543,DB00368,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84327,84327,DB00726,DB00368,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84328,84328,DB01142,DB00368,CN(C)CCC=C1c2ccccc2COc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84329,84329,DB01151,DB00368,CNCCCN1c2ccccc2CCc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84330,84330,DB01242,DB00368,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84331,84331,DB09167,DB00368,CN(C)CCC=C1c2ccccc2CSc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84332,84332,DB13114,DB00368,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84333,84333,DB13225,DB00368,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84334,84334,DB13246,DB00368,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,NCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
84526,84526,DB13946,DB00368,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
85552,85552,DB13946,DB00370,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CCN2c3ncccc3Cc3ccccc3C2C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
85555,85555,DB00370,DB00402,CN1CCN2c3ncccc3Cc3ccccc3C2C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86000,86000,DB06711,DB00371,c1ccc2c(CC3=NCCN3)cccc2c1,CCCC(C)(COC(N)=O)COC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86001,86001,DB00371,DB00402,CCCC(C)(COC(N)=O)COC(N)=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86003,86003,DB00924,DB00371,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCC(C)(COC(N)=O)COC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86006,86006,DB00502,DB00371,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCC(C)(COC(N)=O)COC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86007,86007,DB00371,DB06283,CCCC(C)(COC(N)=O)COC(N)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86067,86067,DB00372,DB00497,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86068,86068,DB00372,DB00611,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86069,86069,DB00372,DB00647,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86070,86070,DB00372,DB00652,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86071,86071,DB00372,DB00704,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86072,86072,DB00372,DB00708,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86073,86073,DB00372,DB00802,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86074,86074,DB00372,DB00844,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86075,86075,DB00372,DB00854,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86076,86076,DB00372,DB00899,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86077,86077,DB00372,DB01081,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86078,86078,DB00372,DB01192,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86079,86079,DB00372,DB01209,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86080,86080,DB00372,DB01227,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86081,86081,DB00372,DB01452,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86082,86082,DB00372,DB01497,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86083,86083,DB00372,DB01535,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86084,86084,DB00372,DB01551,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86085,86085,DB00372,DB09272,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86086,86086,DB00372,DB11609,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86087,86087,DB00372,DB12492,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86088,86088,DB00372,DB15465,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86089,86089,DB00372,DB09049,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86162,86162,DB00372,DB00852,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86163,86163,DB00372,DB00865,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86164,86164,DB00372,DB00937,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86165,86165,DB00372,DB01255,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86166,86166,DB00372,DB01365,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86167,86167,DB00372,DB01576,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86168,86168,DB00372,DB01577,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86169,86169,DB00372,DB09480,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86170,86170,DB00372,DB13624,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86171,86171,DB00372,DB01579,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
86379,86379,DB00372,DB00454,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86380,86380,DB00372,DB00813,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
86417,86417,DB00372,DB00402,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86419,86419,DB00924,DB00372,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86447,86447,DB00502,DB00372,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86448,86448,DB00372,DB06283,CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
86451,86451,DB00373,DB01235,CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
86511,86511,DB00484,DB00373,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
86585,86585,DB06237,DB00373,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
86586,86586,DB06267,DB00373,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
86587,86587,DB12010,DB00373,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
86791,86791,DB13967,DB00373,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
87000,87000,DB00373,DB00575,CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1,Clc1cccc(Cl)c1NC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
87258,87258,DB00484,DB00374,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCCCC(O)CCC1C(O)CC2Cc3c(cccc3OCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
87259,87259,DB06237,DB00374,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCCCC(O)CCC1C(O)CC2Cc3c(cccc3OCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
87260,87260,DB06267,DB00374,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCCCC(O)CCC1C(O)CC2Cc3c(cccc3OCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
87261,87261,DB12010,DB00374,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCCCC(O)CCC1C(O)CC2Cc3c(cccc3OCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
87779,87779,DB00376,DB00761,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
87866,87866,DB00376,DB00470,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
87867,87867,DB00376,DB00486,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
87868,87868,DB00376,DB06155,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
87869,87869,DB00376,DB09061,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
88193,88193,DB00376,DB14881,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
88662,88662,DB00377,DB00402,O=C1c2cccc3c2C(CCC3)CN1C1CN2CCC1CC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
88664,88664,DB00924,DB00377,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1c2cccc3c2C(CCC3)CN1C1CN2CCC1CC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
88669,88669,DB00502,DB00377,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1c2cccc3c2C(CCC3)CN1C1CN2CCC1CC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
89382,89382,DB00381,DB01235,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
89581,89581,DB00484,DB00381,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
89582,89582,DB06267,DB00381,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
89583,89583,DB12010,DB00381,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
89585,89585,DB06237,DB00381,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
89586,89586,DB00975,DB00381,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
89587,89587,DB00862,DB00381,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
89836,89836,DB00381,DB00388,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
90275,90275,DB00383,DB00470,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
90276,90276,DB00383,DB00486,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
90277,90277,DB00383,DB06155,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
90278,90278,DB00383,DB09061,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
90578,90578,DB00383,DB00761,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
90636,90636,DB00383,DB14881,CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
90639,90639,DB00384,DB01235,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
90957,90957,DB00384,DB06283,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
90973,90973,DB00387,DB00761,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
91058,91058,DB00387,DB00470,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
91059,91059,DB00387,DB00486,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
91060,91060,DB00387,DB06155,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
91061,91061,DB00387,DB09061,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
91384,91384,DB00387,DB14881,OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
91551,91551,DB09042,DB00388,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91556,91556,DB00458,DB00388,CN(C)CCCN1c2ccccc2CCc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91557,91557,DB00540,DB00388,CNCCC=C1c2ccccc2CCc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91558,91558,DB00543,DB00388,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91559,91559,DB00726,DB00388,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91560,91560,DB01142,DB00388,CN(C)CCC=C1c2ccccc2COc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91561,91561,DB01151,DB00388,CNCCCN1c2ccccc2CCc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91562,91562,DB01242,DB00388,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91563,91563,DB09167,DB00388,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91564,91564,DB13114,DB00388,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91565,91565,DB13225,DB00388,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91566,91566,DB13246,DB00388,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CNCC(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
91606,91606,DB00614,DB00388,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91607,91607,DB00721,DB00388,CCN(CC)CCOC(=O)c1ccc(N)cc1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91608,91608,DB00752,DB00388,NC1CC1c1ccccc1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91609,91609,DB00780,DB00388,NNCCc1ccccc1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91610,91610,DB00805,DB00388,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91611,91611,DB01037,DB00388,C#CCN(C)C(C)Cc1ccccc1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91612,91612,DB01168,DB00388,CNNCc1ccc(C(=O)NC(C)C)cc1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91613,91613,DB01171,DB00388,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91614,91614,DB01247,DB00388,Cc1cc(C(=O)NNCc2ccccc2)no1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91615,91615,DB01367,DB00388,C#CCNC1CCc2ccccc21,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91616,91616,DB01626,DB00388,C#CCN(C)Cc1ccccc1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91617,91617,DB04820,DB00388,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91618,91618,DB06654,DB00388,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91619,91619,DB09241,DB00388,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91781,91781,DB13946,DB00388,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
91833,91833,DB00820,DB00388,CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2ccc3c(c2)OCO3)C1=O,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91834,91834,DB00862,DB00388,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91835,91835,DB00975,DB00388,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91836,91836,DB06237,DB00388,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91837,91837,DB06267,DB00388,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91838,91838,DB12010,DB00388,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91839,91839,DB00393,DB00388,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91840,91840,DB00401,DB00388,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91841,91841,DB00528,DB00388,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91842,91842,DB01054,DB00388,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91843,91843,DB01244,DB00388,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91844,91844,DB06712,DB00388,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91845,91845,DB09236,DB00388,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91846,91846,DB09238,DB00388,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91847,91847,DB04743,DB00388,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91848,91848,DB06694,DB00388,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91849,91849,DB06152,DB00388,CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91850,91850,DB00622,DB00388,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91851,91851,DB00661,DB00388,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91852,91852,DB01023,DB00388,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91853,91853,DB01136,DB00388,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91854,91854,DB00909,DB00388,NS(=O)(=O)Cc1noc2ccccc12,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91855,91855,DB09089,DB00388,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91856,91856,DB00568,DB00388,C(=Cc1ccccc1)CN1CCN(C(c2ccccc2)c2ccccc2)CC1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91857,91857,DB01118,DB00388,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91858,91858,DB04841,DB00388,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91859,91859,DB01115,DB00388,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91860,91860,DB00593,DB00388,CCC1(C)CC(=O)NC1=O,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91861,91861,DB00653,DB00388,O=S(=O)([O-])[O-].[Mg+2],CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91862,91862,DB00836,DB00388,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91863,91863,DB01074,DB00388,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91864,91864,DB04825,DB00388,CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91865,91865,DB04838,DB00388,CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91866,91866,DB04842,DB00388,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91867,91867,DB04920,DB00388,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91868,91868,DB05246,DB00388,CN1C(=O)CC(C)(c2ccccc2)C1=O,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91869,91869,DB06283,DB00388,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91870,91870,DB09090,DB00388,COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91871,91871,DB13766,DB00388,Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91872,91872,DB01558,DB00388,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91873,91873,DB00404,DB00388,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91874,91874,DB00475,DB00388,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91875,91875,DB00628,DB00388,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91876,91876,DB00683,DB00388,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91877,91877,DB00690,DB00388,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91878,91878,DB00801,DB00388,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91879,91879,DB00829,DB00388,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91880,91880,DB00842,DB00388,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91881,91881,DB00897,DB00388,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91882,91882,DB01068,DB00388,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91883,91883,DB01215,DB00388,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91884,91884,DB01544,DB00388,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91885,91885,DB01559,DB00388,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91886,91886,DB01587,DB00388,CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91887,91887,DB01588,DB00388,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91888,91888,DB01589,DB00388,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91889,91889,DB01595,DB00388,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91890,91890,DB12537,DB00388,C1=Cc2ccccc2NN=C1,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91891,91891,DB13872,DB00388,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
91892,91892,DB12404,DB00388,COC(=O)CCC1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21,CNCC(O)c1cccc(O)c1,95,D006973,decrease,1,the risk or severity of hypertension can be decreased when #drug1 is combined with #drug2.
92546,92546,DB00436,DB00391,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92547,92547,DB00524,DB00391,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92548,92548,DB00562,DB00391,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92549,92549,DB00774,DB00391,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92550,92550,DB00808,DB00391,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92551,92551,DB00880,DB00391,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92552,92552,DB00999,DB00391,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92553,92553,DB01021,DB00391,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92554,92554,DB01324,DB00391,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92555,92555,DB01325,DB00391,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92556,92556,DB13532,DB00391,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
92607,92607,DB00391,DB00852,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92608,92608,DB00391,DB00865,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92609,92609,DB00391,DB00937,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92610,92610,DB00391,DB01255,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92611,92611,DB00391,DB01365,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92612,92612,DB00391,DB01576,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92613,92613,DB00391,DB01577,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92614,92614,DB00391,DB09480,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92615,92615,DB00391,DB13624,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92616,92616,DB00391,DB01579,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
92995,92995,DB00391,DB00402,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
93001,93001,DB00924,DB00391,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
93004,93004,DB00391,DB06283,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
93012,93012,DB00392,DB00761,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
93073,93073,DB00392,DB00470,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
93074,93074,DB00392,DB00486,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
93075,93075,DB00392,DB06155,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
93076,93076,DB00392,DB09061,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
93392,93392,DB00392,DB14881,CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
93395,93395,DB00393,DB01235,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
93525,93525,DB00484,DB00393,Brc1c(NC2=NCCN2)ccc2nccnc12,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
93526,93526,DB00975,DB00393,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
93527,93527,DB06267,DB00393,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
93528,93528,DB12010,DB00393,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
93530,93530,DB06237,DB00393,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
94165,94165,DB00416,DB00394,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94166,94166,DB00565,DB00394,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94167,94167,DB00728,DB00394,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94168,94168,DB00732,DB00394,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94169,94169,DB01135,DB00394,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94170,94170,DB01226,DB00394,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94171,94171,DB01336,DB00394,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94172,94172,DB01339,DB00394,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94173,94173,DB04834,DB00394,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
94174,94174,DB11156,DB00394,CN1CCCN=C1C=Cc1cccs1,CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
95695,95695,DB09042,DB00397,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(N)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
95851,95851,DB13946,DB00397,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(N)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
96756,96756,DB00399,DB09139,O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,O=P(O)(O)C(O)P(=O)(O)O.[Tc],132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
96757,96757,DB00695,DB00399,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
96758,96758,DB00887,DB00399,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
96759,96759,DB00903,DB00399,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
96760,96760,DB02925,DB00399,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
96993,96993,DB00401,DB01235,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
97105,97105,DB00484,DB00401,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
97106,97106,DB00975,DB00401,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
97107,97107,DB00862,DB00401,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
97109,97109,DB06267,DB00401,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
97110,97110,DB06237,DB00401,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
97111,97111,DB12010,DB00401,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
97722,97722,DB06711,DB00402,c1ccc2c(CC3=NCCN3)cccc2c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97723,97723,DB00404,DB00402,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97724,97724,DB00405,DB00402,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97725,97725,DB00408,DB00402,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97726,97726,DB00409,DB00402,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97727,97727,DB00416,DB00402,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97728,97728,DB00418,DB00402,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97729,97729,DB00420,DB00402,CN(C)CCCN1c2ccccc2Sc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97730,97730,DB00423,DB00402,COc1ccccc1OCC(O)COC(N)=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97731,97731,DB00427,DB00402,Cc1ccc(C(=CCN2CCCC2)c2ccccn2)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97732,97732,DB00433,DB00402,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97733,97733,DB00434,DB00402,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97734,97734,DB00450,DB00402,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97735,97735,DB00454,DB00402,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97736,97736,DB00458,DB00402,CN(C)CCCN1c2ccccc2CCc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97737,97737,DB00468,DB00402,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97738,97738,DB00470,DB00402,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97739,97739,DB00472,DB00402,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97740,97740,DB00474,DB00402,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97741,97741,DB00475,DB00402,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97742,97742,DB00476,DB00402,CNCCC(Oc1cccc2ccccc12)c1cccs1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97743,97743,DB00477,DB00402,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97744,97744,DB00483,DB00402,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-],CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97745,97745,DB00486,DB00402,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97746,97746,DB00494,DB00402,CCN(CC)C(=O)C(C#N)=Cc1cc(O)c(O)c([N+](=O)[O-])c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97747,97747,DB00497,DB00402,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97748,97748,DB00502,DB00402,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97749,97749,DB00508,DB00402,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97750,97750,DB00514,DB00402,COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97751,97751,DB00532,DB00402,CCC1(c2ccccc2)NC(=O)N(C)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97752,97752,DB00540,DB00402,CNCCC=C1c2ccccc2CCc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97753,97753,DB00543,DB00402,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97754,97754,DB00555,DB00402,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97755,97755,DB00564,DB00402,NC(=O)N1c2ccccc2C=Cc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97756,97756,DB00565,DB00402,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97757,97757,DB00574,DB00402,CCNC(C)Cc1cccc(C(F)(F)F)c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97758,97758,DB00579,DB00402,OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97759,97759,DB00588,DB00402,CCC(=O)OC1(C(=O)SCF)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97760,97760,DB00589,DB00402,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97761,97761,DB00593,DB00402,CCC1(C)CC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97762,97762,DB00599,DB00402,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97763,97763,DB00604,DB00402,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97764,97764,DB00611,DB00402,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97765,97765,DB00614,DB00402,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97766,97766,DB00617,DB00402,CCC1(C)OC(=O)N(C)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97767,97767,DB00623,DB00402,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97768,97768,DB00625,DB00402,O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97769,97769,DB00628,DB00402,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97770,97770,DB00633,DB00402,Cc1cccc(C(C)c2c[nH]cn2)c1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97771,97771,DB00645,DB00402,CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97772,97772,DB00647,DB00402,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97773,97773,DB00652,DB00402,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97774,97774,DB00656,DB00402,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97775,97775,DB00660,DB00402,Cc1cc(C)cc(OCC2CNC(=O)O2)c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97776,97776,DB00662,DB00402,COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97777,97777,DB00669,DB00402,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97778,97778,DB00679,DB00402,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97779,97779,DB00680,DB00402,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97780,97780,DB00683,DB00402,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97781,97781,DB00690,DB00402,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97782,97782,DB00696,DB00402,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)CC21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97783,97783,DB00697,DB00402,Clc1ccc2nsnc2c1NC1=NCCN1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97784,97784,DB00708,DB00402,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97785,97785,DB00714,DB00402,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97786,97786,DB00715,DB00402,Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97787,97787,DB00721,DB00402,CCN(CC)CCOC(=O)c1ccc(N)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97788,97788,DB00726,DB00402,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97789,97789,DB00728,DB00402,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97790,97790,DB00732,DB00402,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97791,97791,DB00734,DB00402,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97792,97792,DB00737,DB00402,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97793,97793,DB00740,DB00402,Nc1nc2ccc(OC(F)(F)F)cc2s1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97794,97794,DB00747,DB00402,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97795,97795,DB00748,DB00402,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97796,97796,DB00752,DB00402,NC1CC1c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97797,97797,DB00753,DB00402,FC(F)OC(Cl)C(F)(F)F,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97798,97798,DB00754,DB00402,CCN1C(=O)NC(c2ccccc2)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97799,97799,DB00757,DB00402,O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97800,97800,DB00771,DB00402,C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97801,97801,DB00776,DB00402,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97802,97802,DB00777,DB00402,CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97803,97803,DB00780,DB00402,NNCCc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97804,97804,DB00794,DB00402,CCC1(c2ccccc2)C(=O)NCNC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97805,97805,DB00801,DB00402,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97806,97806,DB00802,DB00402,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97807,97807,DB00805,DB00402,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97808,97808,DB00813,DB00402,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97809,97809,DB00818,DB00402,CC(C)c1cccc(C(C)C)c1O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97810,97810,DB00819,DB00402,CC(=O)Nc1nnc(S(N)(=O)=O)s1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97811,97811,DB00829,DB00402,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97812,97812,DB00831,DB00402,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97813,97813,DB00832,DB00402,CN1C(=O)CC(c2ccccc2)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97814,97814,DB00842,DB00402,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97815,97815,DB00843,DB00402,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97816,97816,DB00844,DB00402,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97817,97817,DB00849,DB00402,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97818,97818,DB00850,DB00402,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97819,97819,DB00854,DB00402,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97820,97820,DB00865,DB00402,CC(Cc1ccccc1)N(C)Cc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97821,97821,DB00875,DB00402,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97822,97822,DB00889,DB00402,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97823,97823,DB00897,DB00402,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97824,97824,DB00899,DB00402,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97825,97825,DB00904,DB00402,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97826,97826,DB00906,DB00402,Cc1ccsc1C(=CCCN1CCCC(C(=O)O)C1)c1sccc1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97827,97827,DB00909,DB00402,NS(=O)(=O)Cc1noc2ccccc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97828,97828,DB00918,DB00402,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97829,97829,DB00924,DB00402,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97830,97830,DB00933,DB00402,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97831,97831,DB00934,DB00402,CNCCCC12CCC(c3ccccc31)c1ccccc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97832,97832,DB00937,DB00402,CCN(CC)C(C)C(=O)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97833,97833,DB00941,DB00402,C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97834,97834,DB00949,DB00402,NC(=O)OCC(COC(N)=O)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97835,97835,DB00952,DB00402,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97836,97836,DB00953,DB00402,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97837,97837,DB00960,DB00402,CC(C)NCC(O)COc1cccc2[nH]ccc12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97838,97838,DB00962,DB00402,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97839,97839,DB00967,DB00402,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97840,97840,DB00969,DB00402,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97841,97841,DB00980,DB00402,CCC(=O)NCCC1CCc2ccc3c(c21)CCO3,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97842,97842,DB00985,DB00402,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97843,97843,DB00996,DB00402,NCC1(CC(=O)O)CCCCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97844,97844,DB00998,DB00402,CNC1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97845,97845,DB01018,DB00402,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97846,97846,DB01028,DB00402,COC(F)(F)C(Cl)Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97847,97847,DB01037,DB00402,C#CCN(C)C(C)Cc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97848,97848,DB01063,DB00402,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97849,97849,DB01065,DB00402,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97850,97850,DB01068,DB00402,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97851,97851,DB01069,DB00402,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97852,97852,DB01075,DB00402,CN(C)CCOC(c1ccccc1)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97853,97853,DB01080,DB00402,C=CC(N)CCC(=O)O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97854,97854,DB01081,DB00402,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97855,97855,DB01100,DB00402,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97856,97856,DB01104,DB00402,CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97857,97857,DB01105,DB00402,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97858,97858,DB01106,DB00402,CC1CN(C2CCC(C#N)(c3ccc(F)cc3)CC2)CCC1(C(=O)O)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97859,97859,DB01107,DB00402,CCC1(CC)C(=O)NCC(C)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97860,97860,DB01114,DB00402,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97861,97861,DB01121,DB00402,NC(=O)NC(=O)Cc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97862,97862,DB01135,DB00402,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97863,97863,DB01142,DB00402,CN(C)CCC=C1c2ccccc2COc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97864,97864,DB01149,DB00402,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97865,97865,DB01151,DB00402,CNCCCN1c2ccccc2CCc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97866,97866,DB01154,DB00402,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97867,97867,DB01156,DB00402,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97868,97868,DB01159,DB00402,FC(F)(F)C(Cl)Br,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97869,97869,DB01168,DB00402,CNNCc1ccc(C(=O)NC(C)C)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97870,97870,DB01171,DB00402,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97871,97871,DB01173,DB00402,Cc1ccccc1C(OCCN(C)C)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97872,97872,DB01174,DB00402,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97873,97873,DB01176,DB00402,CN1CCN(C(c2ccccc2)c2ccccc2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97874,97874,DB01178,DB00402,CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97875,97875,DB01186,DB00402,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97876,97876,DB01189,DB00402,FC(F)OC(F)C(F)(F)F,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97877,97877,DB01192,DB00402,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97878,97878,DB01198,DB00402,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97879,97879,DB01199,DB00402,COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3N(C)CC2)CC[N+]1(C)C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97880,97880,DB01200,DB00402,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97881,97881,DB01202,DB00402,CCC(C(N)=O)N1CCCC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97882,97882,DB01209,DB00402,CC12CCCCCC(Cc3ccc(O)cc31)C2N,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97883,97883,DB01215,DB00402,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97884,97884,DB01219,DB00402,O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97885,97885,DB01221,DB00402,CNC1(c2ccccc2Cl)CCCCC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97886,97886,DB01224,DB00402,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97887,97887,DB01226,DB00402,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97888,97888,DB01227,DB00402,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97889,97889,DB01235,DB00402,NC(Cc1ccc(O)c(O)c1)C(=O)O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97890,97890,DB01236,DB00402,FCOC(C(F)(F)F)C(F)(F)F,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97891,97891,DB01238,DB00402,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97892,97892,DB01239,DB00402,CN(C)CCC=C1c2ccccc2Sc2ccc(Cl)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97893,97893,DB01242,DB00402,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97894,97894,DB01245,DB00402,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97895,97895,DB01246,DB00402,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97896,97896,DB01247,DB00402,Cc1cc(C(=O)NNCc2ccccc2)no1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97897,97897,DB01253,DB00402,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97898,97898,DB01267,DB00402,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97899,97899,DB01320,DB00402,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97900,97900,DB01336,DB00402,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97901,97901,DB01337,DB00402,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1[N+]1(C)CCCCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97902,97902,DB01338,DB00402,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC(N3CC[N+](C)(C)CC3)C4OC(C)=O)C2(C)CC1N1CC[N+](C)(C)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97903,97903,DB01339,DB00402,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97904,97904,DB01351,DB00402,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97905,97905,DB01353,DB00402,CCCCC1(CC)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97906,97906,DB01359,DB00402,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97907,97907,DB01367,DB00402,C#CCNC1CCc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97908,97908,DB01392,DB00402,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97909,97909,DB01403,DB00402,COc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97910,97910,DB01437,DB00402,CCC1(c2ccccc2)CCC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97911,97911,DB01440,DB00402,O=C(O)CCCO,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97912,97912,DB01452,DB00402,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97913,97913,DB01495,DB00402,Cc1cc(=O)n(-c2ccccc2)n1C.OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97914,97914,DB01497,DB00402,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97915,97915,DB01501,DB00402,N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97916,97916,DB01535,DB00402,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97917,97917,DB01544,DB00402,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97918,97918,DB01551,DB00402,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97919,97919,DB01558,DB00402,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97920,97920,DB01559,DB00402,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97921,97921,DB01563,DB00402,OC(O)C(Cl)(Cl)Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97922,97922,DB01577,DB00402,CNC(C)Cc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97923,97923,DB01580,DB00402,C=CCOc1ccccc1OCC(O)CNC(C)C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97924,97924,DB01587,DB00402,CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97925,97925,DB01588,DB00402,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97926,97926,DB01589,DB00402,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97927,97927,DB01595,DB00402,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97928,97928,DB01608,DB00402,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97929,97929,DB01614,DB00402,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97930,97930,DB01616,DB00402,CCN(CCCc1ccccc1)CCCc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97931,97931,DB01618,DB00402,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97932,97932,DB01621,DB00402,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97933,97933,DB01623,DB00402,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97934,97934,DB01624,DB00402,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97935,97935,DB01626,DB00402,C#CCN(C)Cc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97936,97936,DB02959,DB00402,NC(Cc1c[nH]c2ccc(O)cc12)C(=O)O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97937,97937,DB04820,DB00402,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97938,97938,DB04821,DB00402,CN1Cc2c(N)cccc2C(c2ccccc2)C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97939,97939,DB04827,DB00402,CCOC(N)=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97940,97940,DB04832,DB00402,CN(C)CC=C(c1ccc(Br)cc1)c1cccnc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97941,97941,DB04834,DB00402,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97942,97942,DB04841,DB00402,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97943,97943,DB04842,DB00402,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97944,97944,DB04871,DB00402,CC1CNCCc2ccc(Cl)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97945,97945,DB04896,DB00402,CCN(CC)C(=O)C1(c2ccccc2)CC1CN,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97946,97946,DB04908,DB00402,O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97947,97947,DB04946,DB00402,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97948,97948,DB04953,DB00402,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97949,97949,DB05246,DB00402,CN1C(=O)CC(C)(c2ccccc2)C1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97950,97950,DB05271,DB00402,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97951,97951,DB05541,DB00402,CCCC1CC(=O)N(C(CC)C(N)=O)C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97952,97952,DB06016,DB00402,CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97953,97953,DB06077,DB00402,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97954,97954,DB06144,DB00402,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97955,97955,DB06148,DB00402,CN1CCN2c3ccccc3Cc3ccccc3C2C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97956,97956,DB06153,DB00402,CN1CCC(=C2c3ccccc3CCc3sccc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97957,97957,DB06201,DB00402,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97958,97958,DB06216,DB00402,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97959,97959,DB06218,DB00402,COCC(NC(C)=O)C(=O)NCc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97960,97960,DB06283,DB00402,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97961,97961,DB06288,DB00402,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97962,97962,DB06594,DB00402,COc1ccc2cccc(CCNC(C)=O)c2c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97963,97963,DB06654,DB00402,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97964,97964,DB06684,DB00402,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97965,97965,DB06690,DB00402,[N-]=[N+]=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97966,97966,DB06691,DB00402,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97967,97967,DB06700,DB00402,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97968,97968,DB06701,DB00402,COC(=O)C(c1ccccc1)C1CCCCN1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97969,97969,DB06716,DB00402,CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97970,97970,DB06753,DB00402,O=P(O)(O)OCC(Cl)(Cl)Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97971,97971,DB06770,DB00402,OCc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97972,97972,DB06797,DB00402,CCC(C)C(C)(COC(N)=O)COC(N)=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97973,97973,DB08329,DB00402,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97974,97974,DB08815,DB00402,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97975,97975,DB08872,DB00402,CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97976,97976,DB08883,DB00402,N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97977,97977,DB08910,DB00402,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97978,97978,DB09061,DB00402,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97979,97979,DB09068,DB00402,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97980,97980,DB09071,DB00402,CCC(=O)NCC1CC1c1cccc2c1CCO2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97981,97981,DB09117,DB00402,CC1OC(C)OC(C)O1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97982,97982,DB09118,DB00402,CC(C)(C)C(O)C=Cc1ccc2c(c1)OCO2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97983,97983,DB09119,DB00402,CC(=O)OC1Cc2ccccc2N(C(N)=O)c2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97984,97984,DB09128,DB00402,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97985,97985,DB09167,DB00402,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97986,97986,DB09185,DB00402,CCOc1ccccc1OCC1CNCCO1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97987,97987,DB09225,DB00402,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97988,97988,DB09241,DB00402,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97989,97989,DB11156,DB00402,CN1CCCN=C1C=Cc1cccs1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97990,97990,DB11371,DB00402,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3C(=O)CC12C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97991,97991,DB11376,DB00402,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97992,97992,DB11400,DB00402,COC1CC(OC2C(C)OC(OC3C(C)=CCC4CC(CC5(C=CC(C)C(C6CCCCC6)O5)O4)OC(=O)C4C=C(C)C(O)C5OCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97993,97993,DB11428,DB00402,Cc1cccc(C(C)c2cnc[nH]2)c1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97994,97994,DB11477,DB00402,Cc1cccc(C)c1NC1=NCCCS1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97995,97995,DB11540,DB00402,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97996,97996,DB11543,DB00402,Fc1cccc(Br)c1NC1=NCCN1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97997,97997,DB11549,DB00402,CCNC1(c2cccs2)CCCCC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97998,97998,DB11552,DB00402,CCOC(=O)c1cccc(N)c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
97999,97999,DB11555,DB00402,Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98000,98000,DB11556,DB00402,Cc1cccc(Cc2cnc[nH]2)c1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98001,98001,DB11609,DB00402,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98002,98002,DB11699,DB00402,CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98003,98003,DB11859,DB00402,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98004,98004,DB12401,DB00402,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98005,98005,DB12492,DB00402,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98006,98006,DB12537,DB00402,C1=Cc2ccccc2NN=C1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98007,98007,DB12710,DB00402,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98008,98008,DB12867,DB00402,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98009,98009,DB13114,DB00402,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98010,98010,DB13213,DB00402,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98011,98011,DB13219,DB00402,CN(C)CC(Oc1ccccc1)Oc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98012,98012,DB13221,DB00402,C=CCC(C(=O)NC(N)=O)C(C)C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98013,98013,DB13225,DB00402,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98014,98014,DB13246,DB00402,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98015,98015,DB13253,DB00402,C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98016,98016,DB13256,DB00402,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98017,98017,DB13273,DB00402,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98018,98018,DB13323,DB00402,ClC=C(Cl)Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98019,98019,DB13520,DB00402,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98020,98020,DB13872,DB00402,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98021,98021,DB14185,DB00402,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98022,98022,DB14509,DB00402,O=C([O-])[O-].[Li+].[Li+],CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98023,98023,DB14575,DB00402,NC(=O)N1c2ccccc2CC(O)c2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98024,98024,DB14754,DB00402,NC(=O)OCC(N)Cc1ccccc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98025,98025,DB00961,DB00402,Cc1cccc(C)c1NC(=O)C1CCCCN1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98026,98026,DB00490,DB00402,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98027,98027,DB11951,DB00402,Cc1ncc(OCC2(c3cccc(F)c3)CC2C(=O)Nc2ccc(F)cn2)c(C)n1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98028,98028,DB12404,DB00402,COC(=O)CCC1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98029,98029,DB00751,DB00402,NC1=NCC2c3ccccc3Cc3ccccc3N12,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98030,98030,DB00527,DB00402,CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98031,98031,DB01086,DB00402,CCOC(=O)c1ccc(N)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98032,98032,DB01161,DB00402,CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98033,98033,DB09009,DB00402,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98034,98034,DB09085,DB00402,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98035,98035,DB00750,DB00402,CCCNC(C)C(=O)Nc1ccccc1C,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98036,98036,DB00892,DB00402,CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98037,98037,DB09345,DB00402,CCCCOc1ccc(OCCCN2CCOCC2)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98754,98754,DB06711,DB00404,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98757,98757,DB00924,DB00404,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
98761,98761,DB00404,DB06283,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
99313,99313,DB00924,DB00405,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
99358,99358,DB00564,DB00408,NC(=O)N1c2ccccc2C=Cc2ccccc21,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
99412,99412,DB00408,DB01579,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99464,99464,DB00408,DB00865,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99470,99470,DB00408,DB00937,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99529,99529,DB00408,DB01577,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99807,99807,DB00408,DB00852,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99809,99809,DB00408,DB01255,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99810,99810,DB00408,DB01365,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99811,99811,DB00408,DB01576,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99812,99812,DB00408,DB09480,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99813,99813,DB00408,DB13624,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99817,99817,DB00924,DB00408,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
99820,99820,DB00502,DB00408,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
99821,99821,DB00408,DB06283,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
99916,99916,DB00409,DB00852,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99917,99917,DB00409,DB00865,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99918,99918,DB00409,DB00937,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99919,99919,DB00409,DB01255,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99920,99920,DB00409,DB01365,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99921,99921,DB00409,DB01576,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99922,99922,DB00409,DB01577,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99923,99923,DB00409,DB09480,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99924,99924,DB00409,DB13624,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
99925,99925,DB00409,DB01579,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
100348,100348,DB00924,DB00409,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
100352,100352,DB00502,DB00409,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
100353,100353,DB00409,DB06283,CCN1CCCC1CNC(=O)c1c(OC)ccc(Br)c1OC,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
100829,100829,DB00413,DB01235,CCCNC1CCc2nc(N)sc2C1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
101107,101107,DB00413,DB00800,CCCNC1CCc2nc(N)sc2C1,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
101108,101108,DB00413,DB09097,CCCNC1CCc2nc(N)sc2C1,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
101109,101109,DB00413,DB11273,CCCNC1CCc2nc(N)sc2C1,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
101110,101110,DB00413,DB12313,CCCNC1CCc2nc(N)sc2C1,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
102066,102066,DB00416,DB00443,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102068,102068,DB00416,DB00591,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102069,102069,DB00416,DB00620,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102070,102070,DB00416,DB00635,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102071,102071,DB00416,DB00687,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102072,102072,DB00416,DB00741,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102073,102073,DB00416,DB00860,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102074,102074,DB00416,DB00959,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102075,102075,DB00416,DB01108,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102076,102076,DB00416,DB01222,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102077,102077,DB00416,DB01234,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102078,102078,DB00416,DB01380,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102079,102079,DB00416,DB01410,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102080,102080,DB00416,DB08906,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102081,102081,DB00416,DB09091,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102082,102082,DB00416,DB09378,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102083,102083,DB00416,DB09383,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102084,102084,DB00416,DB11487,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102085,102085,DB00416,DB11529,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102086,102086,DB00416,DB11921,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102087,102087,DB00416,DB13867,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102088,102088,DB00416,DB14512,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102089,102089,DB00416,DB14539,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102090,102090,DB00416,DB14541,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102091,102091,DB00416,DB14545,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102092,102092,DB00416,DB14631,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102093,102093,DB00416,DB14644,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102094,102094,DB00416,DB14646,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102095,102095,DB00416,DB14669,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102096,102096,DB00416,DB01013,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102097,102097,DB00416,DB01047,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102098,102098,DB00416,DB14540,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102099,102099,DB00416,DB00547,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102100,102100,DB00416,DB08971,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102101,102101,DB00416,DB15566,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102102,102102,DB00416,DB09095,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102103,102103,DB00416,DB00663,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102104,102104,DB00416,DB14643,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102111,102111,DB00924,DB00416,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
102115,102115,DB00502,DB00416,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
102120,102120,DB00416,DB14649,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3.[I-].[I-],CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
102236,102236,DB00418,DB00436,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102237,102237,DB00418,DB00524,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102238,102238,DB00418,DB00562,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102239,102239,DB00418,DB00774,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102240,102240,DB00418,DB00808,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102241,102241,DB00418,DB00880,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102242,102242,DB00418,DB00999,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102243,102243,DB00418,DB01021,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102244,102244,DB00418,DB01324,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102245,102245,DB00418,DB01325,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102246,102246,DB00418,DB13532,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
102799,102799,DB06711,DB00418,c1ccc2c(CC3=NCCN3)cccc2c1,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
102829,102829,DB00924,DB00418,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
102837,102837,DB00502,DB00418,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
102841,102841,DB00418,DB06283,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
102908,102908,DB00420,DB00761,CN(C)CCCN1c2ccccc2Sc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
103644,103644,DB13946,DB00420,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCCN1c2ccccc2Sc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
103650,103650,DB00924,DB00420,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCCN1c2ccccc2Sc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
103670,103670,DB00420,DB06283,CN(C)CCCN1c2ccccc2Sc2ccccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
103730,103730,DB00421,DB01235,CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
103953,103953,DB00421,DB06283,CC(=O)SC1CC2=CC(=O)CCC2(C)C2CCC3(C)C(CCC34CCC(=O)O4)C12,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
104282,104282,DB00601,DB00422,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104283,104283,DB00614,DB00422,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104284,104284,DB00721,DB00422,CCN(CC)CCOC(=O)c1ccc(N)cc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104285,104285,DB00752,DB00422,NC1CC1c1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104286,104286,DB00780,DB00422,NNCCc1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104287,104287,DB00805,DB00422,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104288,104288,DB01037,DB00422,C#CCN(C)C(C)Cc1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104289,104289,DB01168,DB00422,CNNCc1ccc(C(=O)NC(C)C)cc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104290,104290,DB01171,DB00422,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104291,104291,DB01247,DB00422,Cc1cc(C(=O)NNCc2ccccc2)no1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104292,104292,DB01367,DB00422,C#CCNC1CCc2ccccc21,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104293,104293,DB01626,DB00422,C#CCN(C)Cc1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104294,104294,DB04820,DB00422,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104295,104295,DB06654,DB00422,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104296,104296,DB09241,DB00422,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104302,104302,DB00422,DB00753,COC(=O)C(c1ccccc1)C1CCCCN1,FC(F)OC(Cl)C(F)(F)F,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104303,104303,DB00422,DB01028,COC(=O)C(c1ccccc1)C1CCCCN1,COC(F)(F)C(Cl)Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104304,104304,DB00422,DB01159,COC(=O)C(c1ccccc1)C1CCCCN1,FC(F)(F)C(Cl)Br,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104305,104305,DB00422,DB01189,COC(=O)C(c1ccccc1)C1CCCCN1,FC(F)OC(F)C(F)(F)F,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104306,104306,DB00422,DB01236,COC(=O)C(c1ccccc1)C1CCCCN1,FCOC(C(F)(F)F)C(F)(F)F,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104307,104307,DB00422,DB06690,COC(=O)C(c1ccccc1)C1CCCCN1,[N-]=[N+]=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104308,104308,DB00422,DB13323,COC(=O)C(c1ccccc1)C1CCCCN1,ClC=C(Cl)Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104314,104314,DB13946,DB00422,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
104682,104682,DB00924,DB00423,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccccc1OCC(O)COC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
104685,104685,DB00502,DB00423,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccccc1OCC(O)COC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
104691,104691,DB00424,DB00761,CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
104761,104761,DB00424,DB00470,CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
104762,104762,DB00424,DB00486,CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
104763,104763,DB00424,DB06155,CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
104764,104764,DB00424,DB09061,CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
105137,105137,DB00424,DB14881,CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
105828,105828,DB06711,DB00425,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
106406,106406,DB00924,DB00427,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ccc(C(=CCN2CCCC2)c2ccccn2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
106881,106881,DB00433,DB00497,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106882,106882,DB00433,DB00611,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106883,106883,DB00433,DB00647,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106884,106884,DB00433,DB00652,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106885,106885,DB00433,DB00704,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106886,106886,DB00433,DB00708,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106887,106887,DB00433,DB00844,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106888,106888,DB00433,DB00854,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106889,106889,DB00433,DB00899,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106890,106890,DB00433,DB01081,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106891,106891,DB00433,DB01192,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106892,106892,DB00433,DB01209,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106893,106893,DB00433,DB01452,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106894,106894,DB00433,DB01497,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106895,106895,DB00433,DB01535,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106896,106896,DB00433,DB01551,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106897,106897,DB00433,DB09272,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106898,106898,DB00433,DB11609,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106899,106899,DB00433,DB12492,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106900,106900,DB00433,DB15465,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106901,106901,DB00433,DB09049,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
106955,106955,DB00433,DB00852,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106956,106956,DB00433,DB00865,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106957,106957,DB00433,DB00937,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106958,106958,DB00433,DB01255,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106959,106959,DB00433,DB01365,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106960,106960,DB00433,DB01576,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106961,106961,DB00433,DB01577,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106962,106962,DB00433,DB09480,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106963,106963,DB00433,DB13624,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
106964,106964,DB00433,DB01579,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
107252,107252,DB00433,DB00454,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
107256,107256,DB00433,DB00802,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
107257,107257,DB00433,DB00813,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
107272,107272,DB00433,DB01227,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
107409,107409,DB00924,DB00433,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
107437,107437,DB00433,DB06283,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
107518,107518,DB00434,DB00761,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
108054,108054,DB00924,DB00434,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
108068,108068,DB00435,DB01235,[N]=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108235,108235,DB00436,DB01235,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108336,108336,DB00484,DB00436,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
108337,108337,DB00862,DB00436,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
108338,108338,DB00975,DB00436,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
108339,108339,DB06237,DB00436,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
108340,108340,DB06267,DB00436,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
108341,108341,DB12010,DB00436,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
108397,108397,DB00898,DB00436,CCO,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108398,108398,DB00474,DB00436,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108399,108399,DB00599,DB00436,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108400,108400,DB00794,DB00436,CCC1(c2ccccc2)C(=O)NCNC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108401,108401,DB00849,DB00436,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108402,108402,DB01154,DB00436,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108403,108403,DB01174,DB00436,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108404,108404,DB01351,DB00436,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
108619,108619,DB00436,DB06283,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
110442,110442,DB00565,DB00443,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
110443,110443,DB00728,DB00443,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
110444,110444,DB00732,DB00443,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
110445,110445,DB01135,DB00443,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
110446,110446,DB01226,DB00443,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
110447,110447,DB01336,DB00443,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
110448,110448,DB01339,DB00443,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
110449,110449,DB04834,DB00443,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
110450,110450,DB11156,DB00443,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
113263,113263,DB13946,DB00450,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
113272,113272,DB00924,DB00450,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
113276,113276,DB00450,DB06283,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
113456,113456,DB01221,DB00451,CNC1(c2ccccc2Cl)CCCCC1=O,NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
113768,113768,DB00680,DB00454,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113769,113769,DB00831,DB00454,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113770,113770,DB01063,DB00454,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113771,113771,DB01608,DB00454,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113772,113772,DB01614,DB00454,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113773,113773,DB11540,DB00454,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113774,113774,DB12710,DB00454,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113775,113775,DB13213,DB00454,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113842,113842,DB01246,DB00454,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113860,113860,DB00623,DB00454,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113872,113872,DB00850,DB00454,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113876,113876,DB00933,DB00454,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113893,113893,DB01621,DB00454,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
113925,113925,DB00679,DB00454,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
114191,114191,DB00924,DB00454,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
114195,114195,DB00502,DB00454,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCOC(=O)C1(c2ccccc2)CCN(C)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
114537,114537,DB00457,DB01235,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
114595,114595,DB00484,DB00457,Brc1c(NC2=NCCN2)ccc2nccnc12,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
114845,114845,DB00458,DB01235,CN(C)CCCN1c2ccccc2CCc2ccccc21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
114894,114894,DB00458,DB00761,CN(C)CCCN1c2ccccc2CCc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
114908,114908,DB00488,DB00458,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CN(C)CCCN1c2ccccc2CCc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
114959,114959,DB00458,DB00610,CN(C)CCCN1c2ccccc2CCc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114960,114960,DB00458,DB00723,CN(C)CCCN1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114961,114961,DB00458,DB00841,CN(C)CCCN1c2ccccc2CCc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114962,114962,DB00458,DB00935,CN(C)CCCN1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114963,114963,DB00458,DB06262,CN(C)CCCN1c2ccccc2CCc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114964,114964,DB00458,DB06694,CN(C)CCCN1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114965,114965,DB00458,DB06706,CN(C)CCCN1c2ccccc2CCc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114966,114966,DB00458,DB06711,CN(C)CCCN1c2ccccc2CCc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114967,114967,DB00458,DB06764,CN(C)CCCN1c2ccccc2CCc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114968,114968,DB00458,DB01186,CN(C)CCCN1c2ccccc2CCc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114969,114969,DB00458,DB01253,CN(C)CCCN1c2ccccc2CCc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
114970,114970,DB00458,DB00668,CN(C)CCCN1c2ccccc2CCc2ccccc21,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
115682,115682,DB13946,DB00458,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCCN1c2ccccc2CCc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
115693,115693,DB00924,DB00458,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCCN1c2ccccc2CCc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
116394,116394,DB13946,DB00461,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc2cc(CCC(C)=O)ccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
116424,116424,DB00462,DB00761,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12.[Br-],[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
116504,116504,DB00462,DB00470,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12.[Br-],CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
116505,116505,DB00462,DB00486,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12.[Br-],CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
116506,116506,DB00462,DB06155,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12.[Br-],Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
116507,116507,DB00462,DB09061,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12.[Br-],C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
116845,116845,DB00462,DB14881,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12.[Br-],COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
117304,117304,DB13946,DB00465,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
118665,118665,DB00924,DB00468,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
119216,119216,DB13946,DB00469,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
119544,119544,DB00517,DB00470,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119545,119545,DB00670,DB00470,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119546,119546,DB00725,DB00470,C[N+]1(C)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2.[Br-],CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119547,119547,DB00782,DB00470,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119548,119548,DB00804,DB00470,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119549,119549,DB00810,DB00470,OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119550,119550,DB00940,DB00470,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119551,119551,DB00942,DB00470,OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119552,119552,DB00986,DB00470,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119553,119553,DB01036,DB00470,Cc1ccc(O)c(C(CCN(C(C)C)C(C)C)c2ccccc2)c1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119554,119554,DB01062,DB00470,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119555,119555,DB01148,DB00470,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119556,119556,DB01231,DB00470,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119557,119557,DB01409,DB00470,C[N+]1(C)C2CC(OC(=O)C(O)(c3cccs3)c3cccs3)CC1C1OC12,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119558,119558,DB01591,DB00470,O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119559,119559,DB01625,DB00470,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119560,119560,DB04843,DB00470,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119561,119561,DB06702,DB00470,CC(C)C(=O)Oc1ccc(CO)cc1C(CCN(C(C)C)C(C)C)c1ccccc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119562,119562,DB06787,DB00470,C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119563,119563,DB08801,DB00470,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119564,119564,DB08897,DB00470,O=C(OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119565,119565,DB09076,DB00470,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119566,119566,DB09089,DB00470,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119567,119567,DB09300,DB00470,CCCC[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119568,119568,DB11235,DB00470,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119569,119569,DB11315,DB00470,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119570,119570,DB12278,DB00470,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119571,119571,DB12554,DB00470,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119572,119572,DB13720,DB00470,C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119573,119573,DB00908,DB00470,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119574,119574,DB00496,DB00470,NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119613,119613,DB11855,DB00470,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
119767,119767,DB00924,DB00470,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
119774,119774,DB00502,DB00470,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
120405,120405,DB12161,DB00472,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
120592,120592,DB00924,DB00472,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
121090,121090,DB00474,DB00524,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121091,121091,DB00474,DB00562,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121092,121092,DB00474,DB00774,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121093,121093,DB00474,DB00808,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121094,121094,DB00474,DB00880,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121095,121095,DB00474,DB00999,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121096,121096,DB00474,DB01021,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121097,121097,DB00474,DB01324,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121098,121098,DB00474,DB01325,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121099,121099,DB00474,DB13532,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
121519,121519,DB06711,DB00474,c1ccc2c(CC3=NCCN3)cccc2c1,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
121549,121549,DB00924,DB00474,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
121552,121552,DB00502,DB00474,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
121553,121553,DB00474,DB06283,C=CCC1(C(C)C#CCC)C(=O)NC(=O)N(C)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
121907,121907,DB06711,DB00475,c1ccc2c(CC3=NCCN3)cccc2c1,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
121909,121909,DB00924,DB00475,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
121913,121913,DB00502,DB00475,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
121914,121914,DB00475,DB06283,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
122639,122639,DB00924,DB00476,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNCCC(Oc1cccc2ccccc12)c1cccs1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
122641,122641,DB00502,DB00476,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CNCCC(Oc1cccc2ccccc12)c1cccs1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
122656,122656,DB00477,DB01235,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
122701,122701,DB00477,DB00761,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
123463,123463,DB13946,DB00477,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
123469,123469,DB00924,DB00477,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
123489,123489,DB00477,DB06283,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
124518,124518,DB13946,DB00482,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
124606,124606,DB00483,DB00761,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-],[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
125046,125046,DB00924,DB00483,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
125050,125050,DB00502,DB00483,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
125054,125054,DB00484,DB00492,Brc1c(NC2=NCCN2)ccc2nccnc12,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125055,125055,DB00484,DB00519,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125056,125056,DB00484,DB00524,Brc1c(NC2=NCCN2)ccc2nccnc12,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125057,125057,DB00484,DB00528,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125058,125058,DB00484,DB00542,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125059,125059,DB00484,DB00559,Brc1c(NC2=NCCN2)ccc2nccnc12,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125060,125060,DB00484,DB00571,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)NCC(O)COc1cccc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125061,125061,DB00484,DB00584,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125062,125062,DB00484,DB00590,Brc1c(NC2=NCCN2)ccc2nccnc12,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125063,125063,DB00484,DB00598,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125064,125064,DB00484,DB00606,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125065,125065,DB00484,DB00612,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125066,125066,DB00484,DB00622,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125067,125067,DB00484,DB00629,Brc1c(NC2=NCCN2)ccc2nccnc12,NC(N)=NN=Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125068,125068,DB00484,DB00657,Brc1c(NC2=NCCN2)ccc2nccnc12,CNC1(C)C2CCC(C2)C1(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125069,125069,DB00484,DB00678,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125070,125070,DB00484,DB00691,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125071,125071,DB00484,DB00692,Brc1c(NC2=NCCN2)ccc2nccnc12,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125072,125072,DB00484,DB00700,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125073,125073,DB00484,DB00722,Brc1c(NC2=NCCN2)ccc2nccnc12,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125074,125074,DB00484,DB00727,Brc1c(NC2=NCCN2)ccc2nccnc12,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125075,125075,DB00484,DB00765,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(N)(Cc1ccc(O)cc1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125076,125076,DB00484,DB00774,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125077,125077,DB00484,DB00790,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125078,125078,DB00484,DB00796,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125079,125079,DB00484,DB00797,Brc1c(NC2=NCCN2)ccc2nccnc12,c1ccc(CC2=NCCN2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125080,125080,DB00484,DB00800,Brc1c(NC2=NCCN2)ccc2nccnc12,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125081,125081,DB00484,DB00808,Brc1c(NC2=NCCN2)ccc2nccnc12,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125082,125082,DB00484,DB00820,Brc1c(NC2=NCCN2)ccc2nccnc12,CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2ccc3c(c2)OCO3)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125083,125083,DB00484,DB00876,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125084,125084,DB00484,DB00880,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125085,125085,DB00484,DB00881,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125086,125086,DB00484,DB00925,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(COc1ccccc1)N(CCCl)Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125087,125087,DB00484,DB00960,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)NCC(O)COc1cccc2[nH]ccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125088,125088,DB00484,DB00966,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125089,125089,DB00484,DB00968,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125090,125090,DB00484,DB00999,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125091,125091,DB00484,DB01018,Brc1c(NC2=NCCN2)ccc2nccnc12,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125092,125092,DB00484,DB01021,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125093,125093,DB00484,DB01023,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125094,125094,DB00484,DB01029,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125095,125095,DB00484,DB01054,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125096,125096,DB00484,DB01089,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125097,125097,DB00484,DB01090,Brc1c(NC2=NCCN2)ccc2nccnc12,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125098,125098,DB00484,DB01116,Brc1c(NC2=NCCN2)ccc2nccnc12,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125099,125099,DB00484,DB01119,Brc1c(NC2=NCCN2)ccc2nccnc12,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125100,125100,DB00484,DB01136,Brc1c(NC2=NCCN2)ccc2nccnc12,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125101,125101,DB00484,DB01158,Brc1c(NC2=NCCN2)ccc2nccnc12,CC[N+](C)(C)Cc1ccccc1Br,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125102,125102,DB00484,DB01162,Brc1c(NC2=NCCN2)ccc2nccnc12,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125103,125103,DB00484,DB01170,Brc1c(NC2=NCCN2)ccc2nccnc12,NC(N)=NCCN1CCCCCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125104,125104,DB00484,DB01180,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125105,125105,DB00484,DB01193,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125106,125106,DB00484,DB01197,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(CS)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125107,125107,DB00484,DB01203,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125108,125108,DB00484,DB01240,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125109,125109,DB00484,DB01244,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125110,125110,DB00484,DB01275,Brc1c(NC2=NCCN2)ccc2nccnc12,NNc1nncc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125111,125111,DB00484,DB01297,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125112,125112,DB00484,DB01324,Brc1c(NC2=NCCN2)ccc2nccnc12,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125113,125113,DB00484,DB01340,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125114,125114,DB00484,DB01348,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125115,125115,DB00484,DB01359,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125116,125116,DB00484,DB01580,Brc1c(NC2=NCCN2)ccc2nccnc12,C=CCOc1ccccc1OCC(O)CNC(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125117,125117,DB00484,DB01626,Brc1c(NC2=NCCN2)ccc2nccnc12,C#CCN(C)Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125118,125118,DB00484,DB04840,Brc1c(NC2=NCCN2)ccc2nccnc12,N=C(N)N1CCc2ccccc2C1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125119,125119,DB00484,DB04846,Brc1c(NC2=NCCN2)ccc2nccnc12,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125120,125120,DB00484,DB04861,Brc1c(NC2=NCCN2)ccc2nccnc12,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125121,125121,DB00484,DB06268,Brc1c(NC2=NCCN2)ccc2nccnc12,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125122,125122,DB00484,DB06403,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(c1ccccc1)(c1ccccc1)C(Oc1nc(C)cc(C)n1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125123,125123,DB00484,DB06712,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125124,125124,DB00484,DB06762,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(NC(=Nc1ccncc1)NC#N)C(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125125,125125,DB00484,DB08931,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125126,125126,DB00484,DB08932,Brc1c(NC2=NCCN2)ccc2nccnc12,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125127,125127,DB00484,DB08950,Brc1c(NC2=NCCN2)ccc2nccnc12,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125128,125128,DB00484,DB09026,Brc1c(NC2=NCCN2)ccc2nccnc12,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125129,125129,DB00484,DB09220,Brc1c(NC2=NCCN2)ccc2nccnc12,O=C(NCCO[N+](=O)[O-])c1cccnc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125130,125130,DB00484,DB09238,Brc1c(NC2=NCCN2)ccc2nccnc12,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125131,125131,DB00484,DB09242,Brc1c(NC2=NCCN2)ccc2nccnc12,COc1nc(C)nc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125132,125132,DB00484,DB09477,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125133,125133,DB00484,DB11362,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125134,125134,DB00484,DB11738,Brc1c(NC2=NCCN2)ccc2nccnc12,C1COC(NC(C2CC2)C2CC2)=N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125135,125135,DB00484,DB12945,Brc1c(NC2=NCCN2)ccc2nccnc12,NNc1nnc(NN)c2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125136,125136,DB00484,DB13166,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125137,125137,DB00484,DB13211,Brc1c(NC2=NCCN2)ccc2nccnc12,N=C(N)NCC1COc2ccccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125138,125138,DB00484,DB13532,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125139,125139,DB00484,DB13801,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125140,125140,DB00484,DB00695,Brc1c(NC2=NCCN2)ccc2nccnc12,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125141,125141,DB00484,DB09237,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125142,125142,DB00484,DB00575,Brc1c(NC2=NCCN2)ccc2nccnc12,Clc1cccc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125143,125143,DB00484,DB04948,Brc1c(NC2=NCCN2)ccc2nccnc12,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125144,125144,DB00484,DB09236,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125145,125145,DB00484,DB08822,Brc1c(NC2=NCCN2)ccc2nccnc12,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
125452,125452,DB00924,DB00484,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Brc1c(NC2=NCCN2)ccc2nccnc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
125456,125456,DB00502,DB00484,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Brc1c(NC2=NCCN2)ccc2nccnc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
125650,125650,DB00486,DB01235,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
125957,125957,DB00496,DB00486,NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125958,125958,DB00517,DB00486,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125959,125959,DB00622,DB00486,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125960,125960,DB00670,DB00486,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125961,125961,DB00725,DB00486,C[N+]1(C)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2.[Br-],CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125962,125962,DB00782,DB00486,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125963,125963,DB00804,DB00486,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125964,125964,DB00810,DB00486,OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125965,125965,DB00940,DB00486,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125966,125966,DB00942,DB00486,OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125967,125967,DB00986,DB00486,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125968,125968,DB01036,DB00486,Cc1ccc(O)c(C(CCN(C(C)C)C(C)C)c2ccccc2)c1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125969,125969,DB01062,DB00486,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125970,125970,DB01148,DB00486,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125971,125971,DB01231,DB00486,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125972,125972,DB01409,DB00486,C[N+]1(C)C2CC(OC(=O)C(O)(c3cccs3)c3cccs3)CC1C1OC12,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125973,125973,DB01591,DB00486,O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125974,125974,DB01625,DB00486,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125975,125975,DB04843,DB00486,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125976,125976,DB06702,DB00486,CC(C)C(=O)Oc1ccc(CO)cc1C(CCN(C(C)C)C(C)C)c1ccccc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125977,125977,DB06787,DB00486,C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125978,125978,DB08801,DB00486,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125979,125979,DB08897,DB00486,O=C(OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125980,125980,DB09076,DB00486,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125981,125981,DB09089,DB00486,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125982,125982,DB09300,DB00486,CCCC[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125983,125983,DB11235,DB00486,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125984,125984,DB11315,DB00486,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125985,125985,DB11855,DB00486,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125986,125986,DB12278,DB00486,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125987,125987,DB12554,DB00486,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125988,125988,DB13720,DB00486,C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
125989,125989,DB00908,DB00486,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
126293,126293,DB00924,DB00486,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
126296,126296,DB00502,DB00486,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
126801,126801,DB00488,DB00540,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CNCCC=C1c2ccccc2CCc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126802,126802,DB00488,DB00543,CN(C)c1nc(N(C)C)nc(N(C)C)n1,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126803,126803,DB00488,DB00726,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126804,126804,DB00488,DB01142,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CN(C)CCC=C1c2ccccc2COc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126805,126805,DB00488,DB01151,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CNCCCN1c2ccccc2CCc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126806,126806,DB00488,DB01242,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126807,126807,DB00488,DB09167,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CN(C)CCC=C1c2ccccc2CSc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126808,126808,DB00488,DB13114,CN(C)c1nc(N(C)C)nc(N(C)C)n1,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126809,126809,DB00488,DB13225,CN(C)c1nc(N(C)C)nc(N(C)C)n1,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126810,126810,DB00488,DB13246,CN(C)c1nc(N(C)C)nc(N(C)C)n1,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
126840,126840,DB00489,DB01235,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
127210,127210,DB13967,DB00489,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
128122,128122,DB13946,DB00490,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
128128,128128,DB00924,DB00490,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
128133,128133,DB00502,DB00490,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
128351,128351,DB00492,DB01235,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
128498,128498,DB01592,DB00492,[Fe],CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
128502,128502,DB00862,DB00492,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
128503,128503,DB00975,DB00492,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
128504,128504,DB06237,DB00492,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
128505,128505,DB06267,DB00492,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
128506,128506,DB12010,DB00492,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
128634,128634,DB00695,DB00492,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
129149,129149,DB00924,DB00494,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CC)C(=O)C(C#N)=Cc1cc(O)c(O)c([N+](=O)[O-])c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
129152,129152,DB00502,DB00494,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CC)C(=O)C(C#N)=Cc1cc(O)c(O)c([N+](=O)[O-])c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
129585,129585,DB00496,DB00761,NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
129650,129650,DB00496,DB06155,NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
129651,129651,DB00496,DB09061,NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2ccc3c(c2)CCO3)C1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
130287,130287,DB00623,DB00497,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130288,130288,DB00680,DB00497,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130289,130289,DB00831,DB00497,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130290,130290,DB00850,DB00497,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130291,130291,DB00933,DB00497,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130292,130292,DB01063,DB00497,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130293,130293,DB01246,DB00497,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130294,130294,DB01608,DB00497,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130295,130295,DB01614,DB00497,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130296,130296,DB01621,DB00497,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130297,130297,DB11540,DB00497,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130298,130298,DB12710,DB00497,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130299,130299,DB13213,DB00497,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
130695,130695,DB00924,DB00497,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
130699,130699,DB00502,DB00497,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc2c3c1OC1C(=O)CCC4(O)C(C2)N(C)CCC314,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
131272,131272,DB00499,DB16019,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,O=C([O-])CCc1ccc(O)c(CN(CCN(CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)[O-])c1.[Ga+3],167,D064907,increase,0,#drug1 may increase effectiveness of #drug2 as a diagnostic agent.
131647,131647,DB13946,DB00500,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
131720,131720,DB01101,DB00501,CCCCCOC(=O)Nc1nc(=O)n(C2OC(C)C(O)C2O)cc1F,CNC(=NC#N)NCCSCc1nc[nH]c1C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
132161,132161,DB00608,DB00501,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,CNC(=NC#N)NCCSCc1nc[nH]c1C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
132310,132310,DB00924,DB00502,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132535,132535,DB00502,DB09117,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC1OC(C)OC(C)O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132536,132536,DB00502,DB08883,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132537,132537,DB00502,DB05271,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132538,132538,DB00502,DB06201,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132539,132539,DB00502,DB09072,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C([O-])CCCO.[Na+],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132540,132540,DB00502,DB06701,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COC(=O)C(c1ccccc1)C1CCCCN1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132541,132541,DB00502,DB04832,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)CC=C(c1ccc(Br)cc1)c1cccnc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132542,132542,DB00502,DB00589,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132543,132543,DB00502,DB01186,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132544,132544,DB00502,DB00777,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132545,132545,DB00502,DB00514,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132546,132546,DB00502,DB00579,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132547,132547,DB00502,DB00918,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132548,132548,DB00502,DB00952,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132549,132549,DB00502,DB01168,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CNNCc1ccc(C(=O)NC(C)C)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132550,132550,DB00502,DB01253,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132551,132551,DB00502,DB01367,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C#CCNC1CCc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132552,132552,DB00502,DB00565,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132553,132553,DB00502,DB00588,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)OC1(C(=O)SCF)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132554,132554,DB00502,DB00599,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132555,132555,DB00502,DB00611,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132556,132556,DB00502,DB00614,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132557,132557,DB00502,DB00617,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC1(C)OC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132558,132558,DB00502,DB00633,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cccc(C(C)c2c[nH]cn2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132559,132559,DB00502,DB00645,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132560,132560,DB00502,DB00660,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cc(C)cc(OCC2CNC(=O)O2)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132561,132561,DB00502,DB00662,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132562,132562,DB00502,DB00708,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132563,132563,DB00502,DB00721,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CC)CCOC(=O)c1ccc(N)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132564,132564,DB00502,DB00728,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132565,132565,DB00502,DB00732,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132566,132566,DB00502,DB00737,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132567,132567,DB00502,DB00740,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Nc1nc2ccc(OC(F)(F)F)cc2s1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132568,132568,DB00502,DB00754,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN1C(=O)NC(c2ccccc2)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132569,132569,DB00502,DB00771,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132570,132570,DB00502,DB00819,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)Nc1nnc(S(N)(=O)=O)s1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132571,132571,DB00502,DB00832,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C(=O)CC(c2ccccc2)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132572,132572,DB00502,DB00844,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132573,132573,DB00502,DB00849,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132574,132574,DB00502,DB00854,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132575,132575,DB00502,DB00899,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132576,132576,DB00502,DB00906,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1ccsc1C(=CCCN1CCCC(C(=O)O)C1)c1sccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132577,132577,DB00502,DB00941,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132578,132578,DB00502,DB00962,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132579,132579,DB00502,DB00980,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)NCCC1CCc2ccc3c(c21)CCO3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132580,132580,DB00502,DB01018,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132581,132581,DB00502,DB01063,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132582,132582,DB00502,DB01065,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132583,132583,DB00502,DB01068,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132584,132584,DB00502,DB01080,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CC(N)CCC(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132585,132585,DB00502,DB01081,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132586,132586,DB00502,DB01107,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC1(CC)C(=O)NCC(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132587,132587,DB00502,DB01121,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NC(=O)NC(=O)Cc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132588,132588,DB00502,DB01135,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132589,132589,DB00502,DB01154,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132590,132590,DB00502,DB01159,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,FC(F)(F)C(Cl)Br,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132591,132591,DB00502,DB01199,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3N(C)CC2)CC[N+]1(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132592,132592,DB00502,DB01209,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC12CCCCCC(Cc3ccc(O)cc31)C2N,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132593,132593,DB00502,DB01219,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132594,132594,DB00502,DB01221,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CNC1(c2ccccc2Cl)CCCCC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132595,132595,DB00502,DB01226,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132596,132596,DB00502,DB01245,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132597,132597,DB00502,DB01336,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132598,132598,DB00502,DB01337,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1[N+]1(C)CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132599,132599,DB00502,DB01338,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC(N3CC[N+](C)(C)CC3)C4OC(C)=O)C2(C)CC1N1CC[N+](C)(C)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132600,132600,DB00502,DB01339,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132601,132601,DB00502,DB01351,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132602,132602,DB00502,DB01353,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCC1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132603,132603,DB00502,DB01437,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC1(c2ccccc2)CCC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132604,132604,DB00502,DB01440,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(O)CCCO,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132605,132605,DB00502,DB01452,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132606,132606,DB00502,DB01495,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cc(=O)n(-c2ccccc2)n1C.OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132607,132607,DB00502,DB01497,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132608,132608,DB00502,DB01501,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132609,132609,DB00502,DB01535,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132610,132610,DB00502,DB01559,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132611,132611,DB00502,DB01563,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,OC(O)C(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132612,132612,DB00502,DB01589,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132613,132613,DB00502,DB01608,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132614,132614,DB00502,DB01616,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CCCc1ccccc1)CCCc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132615,132615,DB00502,DB01626,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C#CCN(C)Cc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132616,132616,DB00502,DB04821,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1Cc2c(N)cccc2C(c2ccccc2)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132617,132617,DB00502,DB04827,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCOC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132618,132618,DB00502,DB04834,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132619,132619,DB00502,DB05541,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCC1CC(=O)N(C(CC)C(N)=O)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132620,132620,DB00502,DB06218,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COCC(NC(C)=O)C(=O)NCc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132621,132621,DB00502,DB06690,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,[N-]=[N+]=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132622,132622,DB00502,DB06716,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132623,132623,DB00502,DB06753,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=P(O)(O)OCC(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132624,132624,DB00502,DB06770,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,OCc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132625,132625,DB00502,DB06797,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(C)C(C)(COC(N)=O)COC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132626,132626,DB00502,DB08329,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132627,132627,DB00502,DB08872,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132628,132628,DB00502,DB08910,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132629,132629,DB00502,DB09071,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)NCC1CC1c1cccc2c1CCO2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132630,132630,DB00502,DB09119,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)OC1Cc2ccccc2N(C(N)=O)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132631,132631,DB00502,DB09241,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132632,132632,DB00502,DB11156,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCCN=C1C=Cc1cccs1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132633,132633,DB00502,DB11371,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3C(=O)CC12C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132634,132634,DB00502,DB11400,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COC1CC(OC2C(C)OC(OC3C(C)=CCC4CC(CC5(C=CC(C)C(C6CCCCC6)O5)O4)OC(=O)C4C=C(C)C(O)C5OCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132635,132635,DB00502,DB11428,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cccc(C(C)c2cnc[nH]2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132636,132636,DB00502,DB11477,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cccc(C)c1NC1=NCCCS1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132637,132637,DB00502,DB11540,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132638,132638,DB00502,DB11543,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Fc1cccc(Br)c1NC1=NCCN1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132639,132639,DB00502,DB11549,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCNC1(c2cccs2)CCCCC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132640,132640,DB00502,DB11552,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCOC(=O)c1cccc(N)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132641,132641,DB00502,DB11556,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cccc(Cc2cnc[nH]2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132642,132642,DB00502,DB11609,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132643,132643,DB00502,DB11859,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132644,132644,DB00502,DB12492,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132645,132645,DB00502,DB12537,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C1=Cc2ccccc2NN=C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132646,132646,DB00502,DB13213,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132647,132647,DB00502,DB13219,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)CC(Oc1ccccc1)Oc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132648,132648,DB00502,DB13221,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CCC(C(=O)NC(N)=O)C(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132649,132649,DB00502,DB13253,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132650,132650,DB00502,DB13323,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,ClC=C(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132651,132651,DB00502,DB13872,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132652,132652,DB00502,DB14575,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NC(=O)N1c2ccccc2CC(O)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132653,132653,DB00502,DB14754,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NC(=O)OCC(N)Cc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132654,132654,DB00502,DB00508,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132655,132655,DB00502,DB00623,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132656,132656,DB00502,DB00628,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132657,132657,DB00502,DB00690,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132658,132658,DB00502,DB00715,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132659,132659,DB00502,DB00752,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NC1CC1c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132660,132660,DB00502,DB00780,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NNCCc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132661,132661,DB00502,DB00801,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132662,132662,DB00502,DB00805,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132663,132663,DB00502,DB00829,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132664,132664,DB00502,DB00831,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132665,132665,DB00502,DB00842,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132666,132666,DB00502,DB00850,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132667,132667,DB00502,DB00897,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132668,132668,DB00502,DB00996,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NCC1(CC(=O)O)CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132669,132669,DB00502,DB01037,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C#CCN(C)C(C)Cc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132670,132670,DB00502,DB01105,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132671,132671,DB00502,DB01149,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132672,132672,DB00502,DB01171,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132673,132673,DB00502,DB01178,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132674,132674,DB00502,DB01215,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132675,132675,DB00502,DB01247,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cc(C(=O)NNCc2ccccc2)no1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132676,132676,DB00502,DB01544,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132677,132677,DB00502,DB01558,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132678,132678,DB00502,DB01587,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132679,132679,DB00502,DB01588,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132680,132680,DB00502,DB01595,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132681,132681,DB00502,DB01614,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132682,132682,DB00502,DB01618,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132683,132683,DB00502,DB02959,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NC(Cc1c[nH]c2ccc(O)cc12)C(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132684,132684,DB00502,DB04820,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132685,132685,DB00502,DB04896,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CC)C(=O)C1(c2ccccc2)CC1CN,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132686,132686,DB00502,DB06016,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132688,132688,DB00502,DB06148,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCN2c3ccccc3Cc3ccccc3C2C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132689,132689,DB00502,DB06153,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCC(=C2c3ccccc3CCc3sccc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132690,132690,DB00502,DB06684,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132691,132691,DB00502,DB06700,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132692,132692,DB00502,DB08918,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CC)C(=O)C1(c2ccccc2)CC1CN,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132693,132693,DB00502,DB09068,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132694,132694,DB00502,DB09185,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCOc1ccccc1OCC1CNCCO1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132695,132695,DB00502,DB09225,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132696,132696,DB00502,DB11376,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132697,132697,DB00502,DB11555,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132698,132698,DB00502,DB12401,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132699,132699,DB00502,DB12710,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132700,132700,DB00502,DB12867,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132701,132701,DB00502,DB13256,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132702,132702,DB00502,DB14509,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C([O-])[O-].[Li+].[Li+],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132703,132703,DB00502,DB09061,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132704,132704,DB00502,DB13520,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132705,132705,DB00502,DB00953,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132706,132706,DB00502,DB00961,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1cccc(C)c1NC(=O)C1CCCCN1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132707,132707,DB00502,DB04871,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC1CNCCc2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132708,132708,DB00502,DB11699,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132709,132709,DB00502,DB01198,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132710,132710,DB00502,DB00969,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132711,132711,DB00502,DB00696,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132712,132712,DB00502,DB00802,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132713,132713,DB00502,DB01200,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132714,132714,DB00502,DB00960,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(C)NCC(O)COc1cccc2[nH]ccc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132715,132715,DB00502,DB01359,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132716,132716,DB00502,DB00574,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCNC(C)Cc1cccc(C(F)(F)F)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132717,132717,DB00502,DB00532,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC1(c2ccccc2)NC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132718,132718,DB00502,DB06654,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132719,132719,DB00502,DB00998,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CNC1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132720,132720,DB00502,DB04841,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132721,132721,DB00502,DB06594,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc2cccc(CCNC(C)=O)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132722,132722,DB00502,DB00776,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132723,132723,DB00502,DB01320,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132724,132724,DB00502,DB00647,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132725,132725,DB00502,DB01028,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COC(F)(F)C(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132726,132726,DB00502,DB01192,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132727,132727,DB00502,DB01551,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132728,132728,DB00502,DB01621,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132729,132729,DB00502,DB09118,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(C)(C)C(O)C=Cc1ccc2c(c1)OCO2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132730,132730,DB00502,DB00794,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC1(c2ccccc2)C(=O)NCNC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132731,132731,DB00502,DB11951,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1ncc(OCC2(c3cccc(F)c3)CC2C(=O)Nc2ccc(F)cn2)c(C)n1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132732,132732,DB00502,DB01174,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132733,132733,DB00502,DB00747,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132734,132734,DB00502,DB00652,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132735,132735,DB00502,DB00669,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132736,132736,DB00502,DB01202,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCC(C(N)=O)N1CCCC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132737,132737,DB00502,DB01392,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132738,132738,DB00502,DB00856,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,OCC(O)COc1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132739,132739,DB00502,DB13259,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132740,132740,DB00502,DB13583,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,Cc1ccccc1OCC(O)CO,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132741,132741,DB00502,DB06283,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132742,132742,DB00502,DB00527,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132743,132743,DB00502,DB01086,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCOC(=O)c1ccc(N)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132744,132744,DB00502,DB01161,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132745,132745,DB00502,DB09009,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132746,132746,DB00502,DB11148,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCOC(=O)c1ccc(N)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132747,132747,DB00502,DB09085,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132748,132748,DB00502,DB00750,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCNC(C)C(=O)Nc1ccccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132749,132749,DB00502,DB00892,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132750,132750,DB00502,DB09345,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCOc1ccc(OCCCN2CCOCC2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132751,132751,DB00502,DB00807,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132752,132752,DB00502,DB11304,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,OCCOc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132753,132753,DB00502,DB01104,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132754,132754,DB00502,DB00843,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
132881,132881,DB00502,DB01002,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
133159,133159,DB00531,DB00503,O=P1(N(CCCl)CCCl)NCCCO1,CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
133182,133182,DB00615,DB00503,COC1C=COC2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O,CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
133942,133942,DB16165,DB00503,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
133976,133976,DB00508,DB00761,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
134173,134173,DB00508,DB00852,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
134176,134176,DB00508,DB01255,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
134177,134177,DB00508,DB01365,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
134178,134178,DB00508,DB01576,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
134180,134180,DB00508,DB09480,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
134181,134181,DB00508,DB13624,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
134182,134182,DB00508,DB01579,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
134403,134403,DB00924,DB00508,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
134430,134430,DB00508,DB06283,CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
134641,134641,DB00755,DB00513,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,NCCCCCC(=O)O,60,D013927,increase,1,the risk or severity of thrombosis can be increased when #drug1 is combined with #drug2.
135265,135265,DB00924,DB00514,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2c(c1)C13CCCCC1C(C2)N(C)CC3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
135549,135549,DB00517,DB00761,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
135626,135626,DB00517,DB06155,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
135627,135627,DB00517,DB09061,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
135952,135952,DB00517,DB14881,CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-],COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
136395,136395,DB00519,DB01235,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
136574,136574,DB01592,DB00519,[Fe],CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
136578,136578,DB00862,DB00519,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136579,136579,DB00975,DB00519,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136580,136580,DB06237,DB00519,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136581,136581,DB06267,DB00519,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136582,136582,DB12010,DB00519,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136685,136685,DB00695,DB00519,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
136786,136786,DB00524,DB01235,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
136941,136941,DB00862,DB00524,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136942,136942,DB00975,DB00524,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136943,136943,DB06237,DB00524,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136944,136944,DB06267,DB00524,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136945,136945,DB12010,DB00524,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
136995,136995,DB00898,DB00524,CCO,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
136999,136999,DB00599,DB00524,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
137000,137000,DB00794,DB00524,CCC1(c2ccccc2)C(=O)NCNC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
137001,137001,DB00849,DB00524,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
137002,137002,DB01154,DB00524,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
137003,137003,DB01174,DB00524,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
137004,137004,DB01351,DB00524,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
137100,137100,DB00524,DB06283,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
137844,137844,DB00924,DB00527,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
137848,137848,DB00528,DB01235,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
137956,137956,DB00641,DB00528,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
137982,137982,DB00975,DB00528,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
137983,137983,DB06267,DB00528,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
137984,137984,DB12010,DB00528,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
137986,137986,DB00862,DB00528,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
137987,137987,DB06237,DB00528,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
139478,139478,DB00531,DB00701,O=P1(N(CCCl)CCCl)NCCCO1,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
139479,139479,DB00531,DB00932,O=P1(N(CCCl)CCCl)NCCCO1,CCCC1(CCc2ccccc2)CC(O)=C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
139480,139480,DB00531,DB01072,O=P1(N(CCCl)CCCl)NCCCO1,COC(=O)NC(C(=O)NC(Cc1ccccc1)C(O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
139481,139481,DB00531,DB01232,O=P1(N(CCCl)CCCl)NCCCO1,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
139482,139482,DB00531,DB01319,O=P1(N(CCCl)CCCl)NCCCO1,CC(C)CN(CC(OP(=O)(O)O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
139483,139483,DB00531,DB01601,O=P1(N(CCCl)CCCl)NCCCO1,Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
139484,139484,DB00531,DB11586,O=P1(N(CCCl)CCCl)NCCCO1,C=CC1CC1(NC(=O)C1CC(Oc2ncc(OC)c3ccc(Cl)cc23)CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
140740,140740,DB00924,DB00532,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(c2ccccc2)NC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
140748,140748,DB00532,DB06283,CCC1(c2ccccc2)NC(=O)N(C)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
141277,141277,DB13946,DB00533,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
142583,142583,DB00540,DB00761,CNCCC=C1c2ccccc2CCc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
142650,142650,DB00540,DB00610,CNCCC=C1c2ccccc2CCc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142651,142651,DB00540,DB00723,CNCCC=C1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142652,142652,DB00540,DB00841,CNCCC=C1c2ccccc2CCc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142653,142653,DB00540,DB00935,CNCCC=C1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142654,142654,DB00540,DB06262,CNCCC=C1c2ccccc2CCc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142655,142655,DB00540,DB06694,CNCCC=C1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142656,142656,DB00540,DB06706,CNCCC=C1c2ccccc2CCc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142657,142657,DB00540,DB06711,CNCCC=C1c2ccccc2CCc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142658,142658,DB00540,DB06764,CNCCC=C1c2ccccc2CCc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142659,142659,DB00540,DB01253,CNCCC=C1c2ccccc2CCc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
142660,142660,DB00540,DB01186,CNCCC=C1c2ccccc2CCc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
143338,143338,DB13946,DB00540,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNCCC=C1c2ccccc2CCc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
143345,143345,DB00924,DB00540,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNCCC=C1c2ccccc2CCc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
143992,143992,DB00542,DB01235,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
144169,144169,DB01592,DB00542,[Fe],CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
144172,144172,DB00862,DB00542,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
144173,144173,DB00975,DB00542,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
144174,144174,DB06237,DB00542,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
144175,144175,DB06267,DB00542,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
144176,144176,DB12010,DB00542,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
144303,144303,DB00695,DB00542,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
144355,144355,DB00543,DB00761,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
144428,144428,DB00543,DB00610,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144429,144429,DB00543,DB00668,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144430,144430,DB00543,DB00723,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144431,144431,DB00543,DB00841,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144432,144432,DB00543,DB00935,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144433,144433,DB00543,DB01253,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144434,144434,DB00543,DB06262,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144435,144435,DB00543,DB06694,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144436,144436,DB00543,DB06706,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144437,144437,DB00543,DB06711,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144438,144438,DB00543,DB06764,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144439,144439,DB00543,DB01186,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
144973,144973,DB13946,DB00543,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
144979,144979,DB00924,DB00543,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
144999,144999,DB00543,DB06283,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
145910,145910,DB00565,DB00547,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
145911,145911,DB00728,DB00547,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
145912,145912,DB00732,DB00547,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
145913,145913,DB01135,DB00547,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
145914,145914,DB01226,DB00547,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
145915,145915,DB01336,DB00547,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
145916,145916,DB01339,DB00547,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
145917,145917,DB04834,DB00547,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
145918,145918,DB11156,DB00547,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
147254,147254,DB13946,DB00554,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
147287,147287,DB00555,DB00761,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
147829,147829,DB00924,DB00555,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
147841,147841,DB00555,DB06283,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
148461,148461,DB06711,DB00557,c1ccc2c(CC3=NCCN3)cccc2c1,OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
148924,148924,DB06267,DB00559,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
148925,148925,DB12010,DB00559,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
148927,148927,DB00862,DB00559,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
149626,149626,DB00601,DB00561,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149627,149627,DB00614,DB00561,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149628,149628,DB00721,DB00561,CCN(CC)CCOC(=O)c1ccc(N)cc1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149629,149629,DB00752,DB00561,NC1CC1c1ccccc1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149630,149630,DB00780,DB00561,NNCCc1ccccc1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149631,149631,DB00805,DB00561,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149632,149632,DB01037,DB00561,C#CCN(C)C(C)Cc1ccccc1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149633,149633,DB01168,DB00561,CNNCc1ccc(C(=O)NC(C)C)cc1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149634,149634,DB01171,DB00561,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149635,149635,DB01247,DB00561,Cc1cc(C(=O)NNCc2ccccc2)no1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149636,149636,DB01367,DB00561,C#CCNC1CCc2ccccc21,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149637,149637,DB01626,DB00561,C#CCN(C)Cc1ccccc1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149638,149638,DB04820,DB00561,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149639,149639,DB06654,DB00561,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149640,149640,DB09241,DB00561,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149643,149643,DB13946,DB00561,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
149710,149710,DB00898,DB00562,CCO,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
149711,149711,DB00599,DB00562,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
149712,149712,DB00794,DB00562,CCC1(c2ccccc2)C(=O)NCNC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
149713,149713,DB00849,DB00562,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
149714,149714,DB01154,DB00562,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
149715,149715,DB01174,DB00562,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
149716,149716,DB01351,DB00562,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
149857,149857,DB00562,DB06283,NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
150474,150474,DB00564,DB01224,NC(=O)N1c2ccccc2C=Cc2ccccc21,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
150931,150931,DB00924,DB00564,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2C=Cc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
150946,150946,DB00564,DB06283,NC(=O)N1c2ccccc2C=Cc2ccccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
151562,151562,DB00565,DB00591,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151563,151563,DB00565,DB00620,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151564,151564,DB00565,DB00635,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151565,151565,DB00565,DB00687,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151566,151566,DB00565,DB00741,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151567,151567,DB00565,DB00860,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151568,151568,DB00565,DB00959,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151569,151569,DB00565,DB01108,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151570,151570,DB00565,DB01222,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151571,151571,DB00565,DB01234,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151572,151572,DB00565,DB01380,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151573,151573,DB00565,DB01410,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151574,151574,DB00565,DB08906,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151575,151575,DB00565,DB09091,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151576,151576,DB00565,DB09378,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151577,151577,DB00565,DB09383,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151578,151578,DB00565,DB11487,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151579,151579,DB00565,DB11529,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151580,151580,DB00565,DB11921,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151581,151581,DB00565,DB13867,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151582,151582,DB00565,DB14512,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151583,151583,DB00565,DB14539,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151584,151584,DB00565,DB14541,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151585,151585,DB00565,DB14545,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151586,151586,DB00565,DB14631,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151587,151587,DB00565,DB14644,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151588,151588,DB00565,DB14646,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151589,151589,DB00565,DB14669,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151590,151590,DB00565,DB01013,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151591,151591,DB00565,DB01047,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151592,151592,DB00565,DB14540,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151593,151593,DB00565,DB08971,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151594,151594,DB00565,DB15566,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151595,151595,DB00565,DB09095,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151596,151596,DB00565,DB00663,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151597,151597,DB00565,DB14643,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
151604,151604,DB00924,DB00565,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
151611,151611,DB00565,DB14649,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
153187,153187,DB00571,DB01235,CC(C)NCC(O)COc1cccc2ccccc12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
153316,153316,DB06267,DB00571,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)NCC(O)COc1cccc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
153317,153317,DB12010,DB00571,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)NCC(O)COc1cccc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
153319,153319,DB06237,DB00571,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(C)NCC(O)COc1cccc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
153476,153476,DB13967,DB00571,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)NCC(O)COc1cccc2ccccc12,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
153540,153540,DB00862,DB00571,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(C)NCC(O)COc1cccc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
154312,154312,DB13946,DB00572,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
154622,154622,DB13946,DB00573,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(=O)O)c1cccc(Oc2ccccc2)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
155058,155058,DB00924,DB00574,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCNC(C)Cc1cccc(C(F)(F)F)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
155135,155135,DB06237,DB00575,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,Clc1cccc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
155136,155136,DB00975,DB00575,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,Clc1cccc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
155197,155197,DB00601,DB00575,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,Clc1cccc(Cl)c1NC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
155478,155478,DB13946,DB00575,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Clc1cccc(Cl)c1NC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
156501,156501,DB00924,DB00579,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
156911,156911,DB13946,DB00580,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
157084,157084,DB00701,DB00582,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
157085,157085,DB01319,DB00582,CC(C)CN(CC(OP(=O)(O)O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
157705,157705,DB16165,DB00582,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(c1ncncc1F)C(O)(Cn1cncn1)c1ccc(F)cc1F,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
157728,157728,DB00584,DB01235,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
157897,157897,DB01592,DB00584,[Fe],CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
157899,157899,DB00975,DB00584,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
157900,157900,DB06267,DB00584,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
157901,157901,DB12010,DB00584,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
157903,157903,DB06237,DB00584,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
157904,157904,DB00862,DB00584,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
158047,158047,DB00695,DB00584,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
158666,158666,DB13946,DB00586,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
159405,159405,DB00924,DB00588,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)OC1(C(=O)SCF)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
159636,159636,DB00589,DB06262,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
159639,159639,DB00589,DB00714,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159640,159640,DB00589,DB00800,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159641,159641,DB00589,DB01186,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159642,159642,DB00589,DB01200,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159643,159643,DB00589,DB01238,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159644,159644,DB00589,DB09097,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159645,159645,DB00589,DB09128,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159646,159646,DB00589,DB11273,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159647,159647,DB00589,DB12313,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
159648,159648,DB00589,DB13520,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
160085,160085,DB13946,DB00589,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
160086,160086,DB00924,DB00589,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CC)C(=O)NC1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
160146,160146,DB00590,DB01235,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
160964,160964,DB00728,DB00591,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
160965,160965,DB00732,DB00591,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
160966,160966,DB01135,DB00591,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
160967,160967,DB01226,DB00591,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
160968,160968,DB01336,DB00591,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
160969,160969,DB01339,DB00591,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
160970,160970,DB04834,DB00591,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
160971,160971,DB11156,DB00591,CN1CCCN=C1C=Cc1cccs1,CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
161899,161899,DB00924,DB00593,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(C)CC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
161916,161916,DB00593,DB06283,CCC1(C)CC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
161969,161969,DB00594,DB01235,N=C(N)NC(=O)c1nc(Cl)c(N)nc1N,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162122,162122,DB00594,DB06283,N=C(N)NC(=O)c1nc(Cl)c(N)nc1N,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
162246,162246,DB00598,DB01235,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162294,162294,DB09042,DB00598,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
162579,162579,DB13967,DB00598,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
162782,162782,DB00599,DB01235,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162878,162878,DB00599,DB00774,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162879,162879,DB00599,DB00808,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162880,162880,DB00599,DB00880,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162881,162881,DB00599,DB00999,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162882,162882,DB00599,DB01021,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162883,162883,DB00599,DB01324,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162884,162884,DB00599,DB01325,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
162885,162885,DB00599,DB13532,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
163288,163288,DB06711,DB00599,c1ccc2c(CC3=NCCN3)cccc2c1,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
163334,163334,DB00924,DB00599,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
163347,163347,DB00599,DB06283,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
163578,163578,DB00601,DB06707,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
163707,163707,DB00601,DB01579,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
163731,163731,DB00601,DB01200,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
163732,163732,DB00601,DB06262,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
163733,163733,DB00601,DB06694,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
163751,163751,DB13946,DB00601,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(=O)NCC1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
164815,164815,DB12161,DB00604,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
165042,165042,DB00924,DB00604,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
165390,165390,DB13946,DB00605,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc(S(C)=O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
165490,165490,DB00862,DB00606,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
165491,165491,DB00975,DB00606,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
165492,165492,DB06237,DB00606,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
165493,165493,DB06267,DB00606,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
165494,165494,DB12010,DB00606,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
165666,165666,DB00606,DB06283,NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
166647,166647,DB09042,DB00610,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166654,166654,DB00726,DB00610,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
166655,166655,DB01142,DB00610,CN(C)CCC=C1c2ccccc2COc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
166656,166656,DB01151,DB00610,CNCCCN1c2ccccc2CCc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
166657,166657,DB01242,DB00610,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
166658,166658,DB09167,DB00610,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
166659,166659,DB13114,DB00610,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
166660,166660,DB13225,DB00610,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
166661,166661,DB13246,DB00610,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CC(N)C(O)c1cccc(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
166700,166700,DB00614,DB00610,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166701,166701,DB00721,DB00610,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166702,166702,DB00752,DB00610,NC1CC1c1ccccc1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166703,166703,DB00780,DB00610,NNCCc1ccccc1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166704,166704,DB00805,DB00610,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166705,166705,DB01037,DB00610,C#CCN(C)C(C)Cc1ccccc1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166706,166706,DB01168,DB00610,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166707,166707,DB01171,DB00610,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166708,166708,DB01247,DB00610,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166709,166709,DB01367,DB00610,C#CCNC1CCc2ccccc21,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166710,166710,DB01626,DB00610,C#CCN(C)Cc1ccccc1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166711,166711,DB04820,DB00610,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166712,166712,DB06654,DB00610,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166713,166713,DB09241,DB00610,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166770,166770,DB13946,DB00610,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(N)C(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
166868,166868,DB00623,DB00611,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166869,166869,DB00679,DB00611,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166870,166870,DB00680,DB00611,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166871,166871,DB00831,DB00611,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166872,166872,DB00850,DB00611,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166873,166873,DB00933,DB00611,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166874,166874,DB01063,DB00611,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166875,166875,DB01246,DB00611,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166876,166876,DB01608,DB00611,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166877,166877,DB01614,DB00611,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166878,166878,DB01621,DB00611,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166879,166879,DB11540,DB00611,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166880,166880,DB12710,DB00611,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
166881,166881,DB13213,DB00611,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
167075,167075,DB00924,DB00611,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Oc1ccc2c(c1)C13CCCCC1(O)C(C2)N(CC1CCC1)CC3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
167078,167078,DB00612,DB01235,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
167210,167210,DB06267,DB00612,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
167211,167211,DB12010,DB00612,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
167335,167335,DB13967,DB00612,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
168048,168048,DB00614,DB06707,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168052,168052,DB00614,DB06701,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168133,168133,DB00614,DB00668,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168225,168225,DB00614,DB00852,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168226,168226,DB00614,DB00865,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168227,168227,DB00614,DB01255,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168228,168228,DB00614,DB01365,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168229,168229,DB00614,DB01576,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168230,168230,DB00614,DB01577,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168231,168231,DB00614,DB09480,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168232,168232,DB00614,DB13624,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168233,168233,DB00614,DB01579,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168424,168424,DB00614,DB00723,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168425,168425,DB00614,DB00841,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168426,168426,DB00614,DB01186,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168427,168427,DB00614,DB01200,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168428,168428,DB00614,DB01253,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168429,168429,DB00614,DB06262,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168430,168430,DB00614,DB06694,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168431,168431,DB00614,DB06711,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168498,168498,DB13946,DB00614,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
168526,168526,DB00615,DB01601,COC1C=COC2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O,Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
168529,168529,DB00615,DB01232,COC1C=COC2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
168531,168531,DB00615,DB00932,COC1C=COC2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C4=O,CCCC1(CCc2ccccc2)CC(O)=C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
169335,169335,DB00924,DB00617,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(C)OC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
169341,169341,DB00617,DB06283,CCC1(C)OC(=O)N(C)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
170324,170324,DB00728,DB00620,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
170325,170325,DB00732,DB00620,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
170326,170326,DB01135,DB00620,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
170327,170327,DB01226,DB00620,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
170328,170328,DB01336,DB00620,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
170329,170329,DB01339,DB00620,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
170330,170330,DB04834,DB00620,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
170331,170331,DB11156,DB00620,CN1CCCN=C1C=Cc1cccs1,CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
170799,170799,DB00622,DB01235,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
170827,170827,DB00622,DB00761,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
170910,170910,DB00622,DB06155,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc([N+](=O)[O-])c1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
171683,171683,DB00623,DB00647,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171684,171684,DB00623,DB00652,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171685,171685,DB00623,DB00704,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171686,171686,DB00623,DB00708,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171687,171687,DB00623,DB00802,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171688,171688,DB00623,DB00813,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171689,171689,DB00623,DB00844,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171690,171690,DB00623,DB00854,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171691,171691,DB00623,DB00899,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171692,171692,DB00623,DB01081,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171693,171693,DB00623,DB01192,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171694,171694,DB00623,DB01209,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171695,171695,DB00623,DB01227,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171696,171696,DB00623,DB01452,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171697,171697,DB00623,DB01497,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171698,171698,DB00623,DB01535,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171699,171699,DB00623,DB01551,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171700,171700,DB00623,DB09272,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171701,171701,DB00623,DB11609,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171702,171702,DB00623,DB12492,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171703,171703,DB00623,DB15465,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171704,171704,DB00623,DB09049,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
171759,171759,DB00623,DB00852,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171760,171760,DB00623,DB00865,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171761,171761,DB00623,DB00937,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171762,171762,DB00623,DB01255,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171763,171763,DB00623,DB01365,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171764,171764,DB00623,DB01576,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171765,171765,DB00623,DB01577,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171766,171766,DB00623,DB09480,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171767,171767,DB00623,DB13624,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
171768,171768,DB00623,DB01579,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
172037,172037,DB00924,DB00623,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
172058,172058,DB00623,DB06283,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
172914,172914,DB00924,DB00625,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
173303,173303,DB16165,DB00625,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
174016,174016,DB06711,DB00628,c1ccc2c(CC3=NCCN3)cccc2c1,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
174043,174043,DB00924,DB00628,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
174048,174048,DB00628,DB06283,O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
174255,174255,DB00862,DB00629,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NC(N)=NN=Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
174256,174256,DB00975,DB00629,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NC(N)=NN=Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
174257,174257,DB06237,DB00629,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NC(N)=NN=Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
174258,174258,DB06267,DB00629,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NC(N)=NN=Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
174259,174259,DB12010,DB00629,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NC(N)=NN=Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
174456,174456,DB13946,DB00629,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,NC(N)=NN=Cc1c(Cl)cccc1Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
174580,174580,DB00630,DB09139,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,O=P(O)(O)C(O)P(=O)(O)O.[Tc],132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
174581,174581,DB00695,DB00630,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
174582,174582,DB00887,DB00630,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
174583,174583,DB00903,DB00630,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
174584,174584,DB02925,DB00630,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
174790,174790,DB00631,DB01235,Nc1nc(Cl)nc2c1ncn2C1OC(CO)C(O)C1F,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
174963,174963,DB00633,DB01235,Cc1cccc(C(C)c2c[nH]cn2)c1C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
175525,175525,DB06711,DB00633,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1cccc(C(C)c2c[nH]cn2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
175526,175526,DB13946,DB00633,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cccc(C(C)c2c[nH]cn2)c1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
175528,175528,DB00924,DB00633,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cccc(C(C)c2c[nH]cn2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
175532,175532,DB00633,DB06283,Cc1cccc(C(C)c2c[nH]cn2)c1C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
175750,175750,DB00728,DB00635,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
175751,175751,DB00732,DB00635,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
175752,175752,DB01135,DB00635,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
175753,175753,DB01226,DB00635,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
175754,175754,DB01336,DB00635,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
175755,175755,DB04834,DB00635,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
175756,175756,DB11156,DB00635,CN1CCCN=C1C=Cc1cccs1,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
175757,175757,DB01339,DB00635,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
178082,178082,DB00924,DB00645,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
178213,178213,DB00680,DB00647,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178214,178214,DB00831,DB00647,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178215,178215,DB00850,DB00647,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178216,178216,DB00933,DB00647,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178217,178217,DB01063,DB00647,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178218,178218,DB01246,DB00647,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178219,178219,DB01608,DB00647,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178220,178220,DB01614,DB00647,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178221,178221,DB01621,DB00647,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178222,178222,DB11540,DB00647,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178223,178223,DB12710,DB00647,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178224,178224,DB13213,DB00647,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
178582,178582,DB00924,DB00647,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)OC(Cc1ccccc1)(c1ccccc1)C(C)CN(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
179236,179236,DB00651,DB04854,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
179401,179401,DB00679,DB00652,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179402,179402,DB00680,DB00652,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179403,179403,DB00831,DB00652,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179404,179404,DB00850,DB00652,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179405,179405,DB00933,DB00652,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179406,179406,DB01063,DB00652,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179407,179407,DB01246,DB00652,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179408,179408,DB01608,DB00652,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179409,179409,DB01614,DB00652,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179410,179410,DB01621,DB00652,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179411,179411,DB11540,DB00652,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179412,179412,DB12710,DB00652,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179413,179413,DB13213,DB00652,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
179602,179602,DB00924,DB00652,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
180090,180090,DB00898,DB00656,CCO,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
180277,180277,DB06711,DB00656,c1ccc2c(CC3=NCCN3)cccc2c1,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
180278,180278,DB13946,DB00656,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
180535,180535,DB00657,DB01235,CNC1(C)C2CCC(C2)C1(C)C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
180740,180740,DB00862,DB00657,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CNC1(C)C2CCC(C2)C1(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
180741,180741,DB00975,DB00657,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CNC1(C)C2CCC(C2)C1(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
180742,180742,DB06237,DB00657,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CNC1(C)C2CCC(C2)C1(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
180743,180743,DB06267,DB00657,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CNC1(C)C2CCC(C2)C1(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
180744,180744,DB12010,DB00657,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CNC1(C)C2CCC(C2)C1(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
180900,180900,DB00657,DB14881,CNC1(C)C2CCC(C2)C1(C)C,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
181221,181221,DB00924,DB00660,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cc(C)cc(OCC2CNC(=O)O2)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
181224,181224,DB00661,DB01235,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
181764,181764,DB00776,DB00661,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,152,D044967&D008660,decrease&decrease,2,the serum concentration of the active metabolites of #drug1 can be decreased when #drug1 is used in combination with #drug2.
182255,182255,DB00924,DB00662,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
182373,182373,DB00728,DB00663,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
182374,182374,DB00732,DB00663,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
182375,182375,DB01135,DB00663,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
182376,182376,DB01226,DB00663,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
182377,182377,DB01336,DB00663,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
182378,182378,DB01339,DB00663,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
182379,182379,DB04834,DB00663,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
182380,182380,DB11156,DB00663,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
182683,182683,DB00665,DB16019,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,O=C([O-])CCc1ccc(O)c(CN(CCN(CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)[O-])c1.[Ga+3],167,D064907,increase,0,#drug1 may increase effectiveness of #drug2 as a diagnostic agent.
182864,182864,DB09042,DB00668,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182869,182869,DB01151,DB00668,CNCCCN1c2ccccc2CCc2ccccc21,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
182870,182870,DB09167,DB00668,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
182871,182871,DB13114,DB00668,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
182872,182872,DB13225,DB00668,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
182873,182873,DB13246,DB00668,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
182874,182874,DB01142,DB00668,CN(C)CCC=C1c2ccccc2COc2ccccc21,CNCC(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
182885,182885,DB00721,DB00668,CCN(CC)CCOC(=O)c1ccc(N)cc1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182886,182886,DB00752,DB00668,NC1CC1c1ccccc1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182887,182887,DB00780,DB00668,NNCCc1ccccc1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182888,182888,DB00805,DB00668,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182889,182889,DB01037,DB00668,C#CCN(C)C(C)Cc1ccccc1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182890,182890,DB01168,DB00668,CNNCc1ccc(C(=O)NC(C)C)cc1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182891,182891,DB01171,DB00668,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182892,182892,DB01247,DB00668,Cc1cc(C(=O)NNCc2ccccc2)no1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182893,182893,DB01367,DB00668,C#CCNC1CCc2ccccc21,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182894,182894,DB01626,DB00668,C#CCN(C)Cc1ccccc1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182895,182895,DB04820,DB00668,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182896,182896,DB06654,DB00668,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
182897,182897,DB09241,DB00668,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
183197,183197,DB13946,DB00668,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
183304,183304,DB00669,DB06262,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
183676,183676,DB13946,DB00669,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
183677,183677,DB00924,DB00669,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
183687,183687,DB00670,DB00761,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
183755,183755,DB00670,DB06155,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
183756,183756,DB00670,DB09061,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
184049,184049,DB00670,DB14881,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
185959,185959,DB00678,DB01235,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
186086,186086,DB06267,DB00678,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
186088,186088,DB06237,DB00678,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
186474,186474,DB00695,DB00678,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
186528,186528,DB00679,DB01235,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
186659,186659,DB00679,DB00704,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186660,186660,DB00679,DB00708,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186661,186661,DB00679,DB00802,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186662,186662,DB00679,DB00813,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186663,186663,DB00679,DB00844,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186664,186664,DB00679,DB00854,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186665,186665,DB00679,DB00899,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186666,186666,DB00679,DB01081,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186667,186667,DB00679,DB01209,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186668,186668,DB00679,DB01452,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186669,186669,DB00679,DB01497,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186670,186670,DB00679,DB01535,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186671,186671,DB00679,DB09272,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186672,186672,DB00679,DB11609,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186673,186673,DB00679,DB12492,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186674,186674,DB00679,DB15465,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
186675,186675,DB00679,DB09049,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187107,187107,DB12161,DB00679,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
187175,187175,DB13946,DB00679,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
187181,187181,DB00924,DB00679,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
187198,187198,DB00679,DB06283,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
187242,187242,DB00680,DB00704,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187243,187243,DB00680,DB00708,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187244,187244,DB00680,DB00802,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187245,187245,DB00680,DB00813,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187246,187246,DB00680,DB00844,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187247,187247,DB00680,DB00854,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187248,187248,DB00680,DB00899,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187249,187249,DB00680,DB01081,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187250,187250,DB00680,DB01192,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187251,187251,DB00680,DB01209,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187252,187252,DB00680,DB01227,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187253,187253,DB00680,DB01452,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187254,187254,DB00680,DB01497,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187255,187255,DB00680,DB01535,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187256,187256,DB00680,DB01551,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187257,187257,DB00680,DB09272,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187258,187258,DB00680,DB11609,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187259,187259,DB00680,DB12492,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187260,187260,DB00680,DB15465,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187261,187261,DB00680,DB09049,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
187319,187319,DB00680,DB00852,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187320,187320,DB00680,DB00865,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187321,187321,DB00680,DB00937,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187322,187322,DB00680,DB01255,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187323,187323,DB00680,DB01365,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187324,187324,DB00680,DB01576,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187325,187325,DB00680,DB01577,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187326,187326,DB00680,DB09480,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187327,187327,DB00680,DB13624,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187328,187328,DB00680,DB01579,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
187635,187635,DB00924,DB00680,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
187659,187659,DB00680,DB06283,CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
187664,187664,DB00681,DB01235,CC1C=CC=CC=CC=CC=CC=CC=CC(OC2OC(C)C(O)C(N)C2O)CC2OC(O)(CC(O)CC(O)C(O)CCC(O)CC(O)CC(=O)OC(C)C(C)C1O)CC(O)C2C(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
188408,188408,DB00682,DB06701,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
189017,189017,DB06711,DB00683,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
189020,189020,DB00924,DB00683,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
189028,189028,DB00683,DB06283,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
189697,189697,DB00728,DB00687,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
189698,189698,DB00732,DB00687,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
189699,189699,DB01135,DB00687,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
189700,189700,DB01226,DB00687,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
189701,189701,DB01336,DB00687,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
189702,189702,DB01339,DB00687,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
189703,189703,DB04834,DB00687,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
189704,189704,DB11156,DB00687,CN1CCCN=C1C=Cc1cccs1,CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C12F,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
190654,190654,DB06711,DB00690,c1ccc2c(CC3=NCCN3)cccc2c1,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
190655,190655,DB00924,DB00690,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
190660,190660,DB00690,DB06283,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
190716,190716,DB00691,DB01235,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
190853,190853,DB01592,DB00691,[Fe],CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
190856,190856,DB00975,DB00691,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
190857,190857,DB06237,DB00691,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
190858,190858,DB06267,DB00691,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
190859,190859,DB12010,DB00691,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
191126,191126,DB00695,DB00691,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191131,191131,DB00692,DB01235,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
191323,191323,DB13946,DB00692,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
191594,191594,DB00695,DB01235,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
191721,191721,DB00975,DB00695,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
191722,191722,DB00862,DB00695,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
191723,191723,DB06237,DB00695,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
191724,191724,DB06267,DB00695,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
191817,191817,DB00695,DB00710,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
191818,191818,DB00695,DB00720,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,O=P(O)(O)C(Cl)(Cl)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
191819,191819,DB00695,DB00884,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
191820,191820,DB00695,DB01077,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
191821,191821,DB00695,DB01133,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
191873,191873,DB00695,DB00722,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191874,191874,DB00695,DB00790,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191875,191875,DB00695,DB00881,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191876,191876,DB00695,DB01180,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191877,191877,DB00695,DB01197,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CC(CS)C(=O)N1CCCC1C(=O)O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191878,191878,DB00695,DB01340,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191879,191879,DB00695,DB01348,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191880,191880,DB00695,DB09477,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191881,191881,DB00695,DB13166,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191882,191882,DB00695,DB08822,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191883,191883,DB00695,DB00796,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191884,191884,DB00695,DB00876,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191885,191885,DB00695,DB00966,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191886,191886,DB00695,DB01029,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,72,D051437&D007022,increase&increase,1,the risk or severity of renal failure and hypotension can be increased when #drug1 is combined with #drug2.
191888,191888,DB00695,DB06283,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
191986,191986,DB00696,DB06262,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)CC21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
192296,192296,DB13946,DB00696,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
192298,192298,DB00924,DB00696,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
192678,192678,DB16165,DB00696,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)CC21,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
192727,192727,DB00697,DB01235,Clc1ccc2nsnc2c1NC1=NCCN1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
193330,193330,DB00924,DB00697,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Clc1ccc2nsnc2c1NC1=NCCN1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
193336,193336,DB00697,DB06283,Clc1ccc2nsnc2c1NC1=NCCN1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
193754,193754,DB13946,DB00699,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COC12CC(COC(=O)c3cncc(Br)c3)CN(C)C1Cc1cn(C)c3cccc2c13,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
193787,193787,DB00700,DB01235,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
193920,193920,DB00975,DB00700,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
193921,193921,DB00862,DB00700,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
193922,193922,DB06267,DB00700,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
193923,193923,DB06237,DB00700,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
193924,193924,DB12010,DB00700,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
194110,194110,DB00700,DB06283,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
194177,194177,DB00701,DB06414,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
194725,194725,DB16165,DB00701,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
194744,194744,DB00703,DB01235,CC(=O)N=c1sc(S(N)(=O)=O)nn1C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
194903,194903,DB00703,DB06283,CC(=O)N=c1sc(S(N)(=O)=O)nn1C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
195012,195012,DB00831,DB00704,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195013,195013,DB00850,DB00704,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195014,195014,DB00933,DB00704,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195015,195015,DB01063,DB00704,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195016,195016,DB01246,DB00704,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195017,195017,DB01608,DB00704,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195018,195018,DB01614,DB00704,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195019,195019,DB01621,DB00704,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195020,195020,DB11540,DB00704,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195021,195021,DB12710,DB00704,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195022,195022,DB13213,DB00704,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,O=C1CCC2(O)C3Cc4ccc(O)c5c4C2(CCN3CC2CC2)C1O5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
195657,195657,DB16165,DB00705,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
195674,195674,DB00706,DB01235,CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
195976,195976,DB00708,DB01235,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
196230,196230,DB00831,DB00708,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196231,196231,DB00850,DB00708,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196232,196232,DB00933,DB00708,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196233,196233,DB01063,DB00708,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196234,196234,DB01246,DB00708,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196235,196235,DB01608,DB00708,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196236,196236,DB01614,DB00708,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196237,196237,DB01621,DB00708,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196238,196238,DB11540,DB00708,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196239,196239,DB12710,DB00708,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196240,196240,DB13213,DB00708,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
196457,196457,DB13946,DB00708,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
196458,196458,DB00924,DB00708,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
196769,196769,DB00710,DB09139,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,O=P(O)(O)C(O)P(=O)(O)O.[Tc],132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
196771,196771,DB00887,DB00710,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
196772,196772,DB00903,DB00710,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
196773,196773,DB02925,DB00710,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
197413,197413,DB13946,DB00712,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
197451,197451,DB00714,DB01235,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
197467,197467,DB00714,DB00800,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
197468,197468,DB00714,DB01186,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
197469,197469,DB00714,DB01200,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
197470,197470,DB00714,DB01238,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
197471,197471,DB00714,DB09097,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
197472,197472,DB00714,DB09128,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
197473,197473,DB00714,DB11273,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
197474,197474,DB00714,DB12313,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
197475,197475,DB00714,DB13520,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
198086,198086,DB00924,DB00714,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCc2cccc3c2C1Cc1ccc(O)c(O)c1-3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
198128,198128,DB00715,DB00761,Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
198526,198526,DB12161,DB00715,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
198729,198729,DB00924,DB00715,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Fc1ccc(C2CCNCC2COc2ccc3c(c2)OCO3)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
199555,199555,DB00720,DB09139,O=P(O)(O)C(Cl)(Cl)P(=O)(O)O,O=P(O)(O)C(O)P(=O)(O)O.[Tc],132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
199556,199556,DB00887,DB00720,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,O=P(O)(O)C(Cl)(Cl)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
199557,199557,DB00903,DB00720,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,O=P(O)(O)C(Cl)(Cl)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
199558,199558,DB02925,DB00720,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,O=P(O)(O)C(Cl)(Cl)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
199656,199656,DB00721,DB06707,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199660,199660,DB00721,DB06701,CCN(CC)CCOC(=O)c1ccc(N)cc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199830,199830,DB00721,DB00852,CCN(CC)CCOC(=O)c1ccc(N)cc1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199831,199831,DB00721,DB00865,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199832,199832,DB00721,DB01255,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199833,199833,DB00721,DB01365,CCN(CC)CCOC(=O)c1ccc(N)cc1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199834,199834,DB00721,DB01576,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199835,199835,DB00721,DB01577,CCN(CC)CCOC(=O)c1ccc(N)cc1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199836,199836,DB00721,DB09480,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199837,199837,DB00721,DB13624,CCN(CC)CCOC(=O)c1ccc(N)cc1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199838,199838,DB00721,DB01579,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199990,199990,DB00721,DB00723,CCN(CC)CCOC(=O)c1ccc(N)cc1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199991,199991,DB00721,DB00841,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199992,199992,DB00721,DB01186,CCN(CC)CCOC(=O)c1ccc(N)cc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199993,199993,DB00721,DB01200,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199994,199994,DB00721,DB01253,CCN(CC)CCOC(=O)c1ccc(N)cc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199995,199995,DB00721,DB06262,CCN(CC)CCOC(=O)c1ccc(N)cc1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199996,199996,DB00721,DB06694,CCN(CC)CCOC(=O)c1ccc(N)cc1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
199997,199997,DB00721,DB06711,CCN(CC)CCOC(=O)c1ccc(N)cc1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200073,200073,DB00722,DB01235,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
200203,200203,DB01592,DB00722,[Fe],NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
200206,200206,DB00862,DB00722,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
200207,200207,DB00975,DB00722,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
200208,200208,DB06237,DB00722,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
200209,200209,DB06267,DB00722,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
200210,200210,DB12010,DB00722,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
200472,200472,DB09042,DB00723,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200478,200478,DB00726,DB00723,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
200479,200479,DB01142,DB00723,CN(C)CCC=C1c2ccccc2COc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
200480,200480,DB01151,DB00723,CNCCCN1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
200481,200481,DB01242,DB00723,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
200482,200482,DB09167,DB00723,CN(C)CCC=C1c2ccccc2CSc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
200483,200483,DB13114,DB00723,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
200484,200484,DB13225,DB00723,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
200485,200485,DB13246,DB00723,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,COc1ccc(OC)c(C(O)C(C)N)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
200521,200521,DB00752,DB00723,NC1CC1c1ccccc1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200522,200522,DB00780,DB00723,NNCCc1ccccc1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200523,200523,DB00805,DB00723,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200524,200524,DB01037,DB00723,C#CCN(C)C(C)Cc1ccccc1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200525,200525,DB01168,DB00723,CNNCc1ccc(C(=O)NC(C)C)cc1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200526,200526,DB01171,DB00723,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200527,200527,DB01247,DB00723,Cc1cc(C(=O)NNCc2ccccc2)no1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200528,200528,DB01367,DB00723,C#CCNC1CCc2ccccc21,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200529,200529,DB01626,DB00723,C#CCN(C)Cc1ccccc1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200530,200530,DB04820,DB00723,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200531,200531,DB06654,DB00723,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200532,200532,DB09241,DB00723,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200585,200585,DB13946,DB00723,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc(OC)c(C(O)C(C)N)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
200597,200597,DB00725,DB00761,C[N+]1(C)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2.[Br-],[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
200661,200661,DB00725,DB06155,C[N+]1(C)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2.[Br-],Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
200662,200662,DB00725,DB09061,C[N+]1(C)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2.[Br-],C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
200945,200945,DB00725,DB14881,C[N+]1(C)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2.[Br-],COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
201019,201019,DB00726,DB00841,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201020,201020,DB00726,DB00935,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201021,201021,DB00726,DB06262,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201022,201022,DB00726,DB06694,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201023,201023,DB00726,DB06706,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201024,201024,DB00726,DB06711,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201025,201025,DB00726,DB06764,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201026,201026,DB00726,DB01253,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201027,201027,DB00726,DB01186,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
201666,201666,DB13946,DB00726,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
201672,201672,DB00924,DB00726,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
201761,201761,DB00727,DB01235,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
202017,202017,DB00728,DB00761,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
202320,202320,DB00728,DB00741,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202321,202321,DB00728,DB00860,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202322,202322,DB00728,DB00959,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202323,202323,DB00728,DB01108,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202324,202324,DB00728,DB01222,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202325,202325,DB00728,DB01234,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202326,202326,DB00728,DB01380,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202327,202327,DB00728,DB01410,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202328,202328,DB00728,DB08906,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202329,202329,DB00728,DB09091,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202330,202330,DB00728,DB09378,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202331,202331,DB00728,DB09383,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202332,202332,DB00728,DB11487,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202333,202333,DB00728,DB11529,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202334,202334,DB00728,DB11921,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202335,202335,DB00728,DB13867,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202336,202336,DB00728,DB14512,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202337,202337,DB00728,DB14539,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202338,202338,DB00728,DB14541,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202339,202339,DB00728,DB14545,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202340,202340,DB00728,DB14631,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202341,202341,DB00728,DB14644,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202342,202342,DB00728,DB14646,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202343,202343,DB00728,DB14669,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202344,202344,DB00728,DB01013,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202345,202345,DB00728,DB01047,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202346,202346,DB00728,DB14540,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202347,202347,DB00728,DB08971,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202348,202348,DB00728,DB15566,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202349,202349,DB00728,DB09095,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202350,202350,DB00728,DB14643,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
202429,202429,DB00924,DB00728,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
202436,202436,DB00728,DB14649,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203299,203299,DB00732,DB00741,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203300,203300,DB00732,DB00860,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203301,203301,DB00732,DB00959,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203302,203302,DB00732,DB01108,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203303,203303,DB00732,DB01222,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203304,203304,DB00732,DB01234,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203305,203305,DB00732,DB01380,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203306,203306,DB00732,DB01410,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203307,203307,DB00732,DB08906,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203308,203308,DB00732,DB09091,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203309,203309,DB00732,DB09378,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203310,203310,DB00732,DB09383,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203311,203311,DB00732,DB11487,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203312,203312,DB00732,DB11529,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203313,203313,DB00732,DB11921,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203314,203314,DB00732,DB13867,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203315,203315,DB00732,DB14512,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203316,203316,DB00732,DB14539,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203317,203317,DB00732,DB14541,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203318,203318,DB00732,DB14545,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203319,203319,DB00732,DB14631,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203320,203320,DB00732,DB14644,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203321,203321,DB00732,DB14646,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203322,203322,DB00732,DB14669,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203323,203323,DB00732,DB01013,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203324,203324,DB00732,DB01047,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203325,203325,DB00732,DB14540,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203326,203326,DB00732,DB08971,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203327,203327,DB00732,DB15566,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203328,203328,DB00732,DB09095,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203329,203329,DB00732,DB14643,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203335,203335,DB00924,DB00732,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
203342,203342,DB00732,DB14649,COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1.O=S(=O)([O-])c1ccccc1,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
203995,203995,DB13946,DB00734,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
203999,203999,DB00924,DB00734,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
204005,204005,DB00734,DB06283,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
204580,204580,DB00924,DB00737,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
205500,205500,DB00924,DB00740,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Nc1nc2ccc(OC(F)(F)F)cc2s1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
205506,205506,DB00740,DB06283,Nc1nc2ccc(OC(F)(F)F)cc2s1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
205629,205629,DB01135,DB00741,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
205630,205630,DB01226,DB00741,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
205631,205631,DB01336,DB00741,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
205632,205632,DB01339,DB00741,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
205633,205633,DB04834,DB00741,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
205634,205634,DB11156,DB00741,CN1CCCN=C1C=Cc1cccs1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
205991,205991,DB00742,DB01235,OCC(O)C(O)C(O)C(O)CO,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
206380,206380,DB00742,DB06283,OCC(O)C(O)C(O)C(O)CO,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
207269,207269,DB00747,DB00761,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
207597,207597,DB06711,DB00747,c1ccc2c(CC3=NCCN3)cccc2c1,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
207598,207598,DB00924,DB00747,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
207603,207603,DB00747,DB06283,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
208084,208084,DB00924,DB00748,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
208461,208461,DB13946,DB00749,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
208750,208750,DB00924,DB00750,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCNC(C)C(=O)Nc1ccccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
209234,209234,DB00924,DB00751,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC1=NCC2c3ccccc3Cc3ccccc3N12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
209369,209369,DB00752,DB06707,NC1CC1c1ccccc1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209371,209371,DB00752,DB06701,NC1CC1c1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209499,209499,DB00752,DB00852,NC1CC1c1ccccc1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209500,209500,DB00752,DB00865,NC1CC1c1ccccc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209501,209501,DB00752,DB01255,NC1CC1c1ccccc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209502,209502,DB00752,DB01365,NC1CC1c1ccccc1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209503,209503,DB00752,DB01576,NC1CC1c1ccccc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209504,209504,DB00752,DB01577,NC1CC1c1ccccc1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209505,209505,DB00752,DB09480,NC1CC1c1ccccc1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209506,209506,DB00752,DB13624,NC1CC1c1ccccc1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209507,209507,DB00752,DB01579,NC1CC1c1ccccc1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209695,209695,DB00752,DB00841,NC1CC1c1ccccc1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209696,209696,DB00752,DB01186,NC1CC1c1ccccc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209697,209697,DB00752,DB01253,NC1CC1c1ccccc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209698,209698,DB00752,DB06262,NC1CC1c1ccccc1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209699,209699,DB00752,DB06694,NC1CC1c1ccccc1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209700,209700,DB00752,DB01200,NC1CC1c1ccccc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209863,209863,DB06711,DB00752,c1ccc2c(CC3=NCCN3)cccc2c1,NC1CC1c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
209864,209864,DB13946,DB00752,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,NC1CC1c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
209888,209888,DB00753,DB01235,FC(F)OC(Cl)C(F)(F)F,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
210510,210510,DB13946,DB00753,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,FC(F)OC(Cl)C(F)(F)F,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
210515,210515,DB00924,DB00753,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,FC(F)OC(Cl)C(F)(F)F,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
210527,210527,DB16629,DB00753,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,FC(F)OC(Cl)C(F)(F)F,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
210834,210834,DB00924,DB00754,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN1C(=O)NC(c2ccccc2)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
210843,210843,DB00754,DB06283,CCN1C(=O)NC(c2ccccc2)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
210927,210927,DB00755,DB01235,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
210934,210934,DB00755,DB11091,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,OO,60,D013927,increase,1,the risk or severity of thrombosis can be increased when #drug1 is combined with #drug2.
211811,211811,DB00924,DB00757,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
212465,212465,DB00771,DB00761,C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212466,212466,DB00777,DB00761,CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212467,212467,DB00810,DB00761,OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212468,212468,DB00835,DB00761,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212469,212469,DB00875,DB00761,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212470,212470,DB00907,DB00761,COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1N2C,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212471,212471,DB00908,DB00761,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212472,212472,DB00934,DB00761,CNCCCC12CCC(c3ccccc31)c1ccccc12,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212473,212473,DB00942,DB00761,OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212474,212474,DB01036,DB00761,Cc1ccc(O)c(C(CCN(C(C)C)C(C)C)c2ccccc2)c1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212475,212475,DB01062,DB00761,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212476,212476,DB01069,DB00761,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212477,212477,DB01075,DB00761,CN(C)CCOC(c1ccccc1)c1ccccc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212478,212478,DB01135,DB00761,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212479,212479,DB01142,DB00761,CN(C)CCC=C1c2ccccc2COc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212480,212480,DB01148,DB00761,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212481,212481,DB01151,DB00761,CNCCCN1c2ccccc2CCc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212482,212482,DB01173,DB00761,Cc1ccccc1C(OCCN(C)C)c1ccccc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212483,212483,DB01175,DB00761,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212484,212484,DB01224,DB00761,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212485,212485,DB01226,DB00761,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212486,212486,DB01231,DB00761,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212487,212487,DB01238,DB00761,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212488,212488,DB01239,DB00761,CN(C)CCC=C1c2ccccc2Sc2ccc(Cl)cc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212489,212489,DB01336,DB00761,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212490,212490,DB01337,DB00761,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1[N+]1(C)CCCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212491,212491,DB01338,DB00761,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC(N3CC[N+](C)(C)CC3)C4OC(C)=O)C2(C)CC1N1CC[N+](C)(C)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212492,212492,DB01403,DB00761,COc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212493,212493,DB01409,DB00761,C[N+]1(C)C2CC(OC(=O)C(O)(c3cccs3)c3cccs3)CC1C1OC12,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212494,212494,DB01591,DB00761,O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212495,212495,DB04834,DB00761,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212496,212496,DB06153,DB00761,CN1CCC(=C2c3ccccc3CCc3sccc32)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212497,212497,DB06702,DB00761,CC(C)C(=O)Oc1ccc(CO)cc1C(CCN(C(C)C)C(C)C)c1ccccc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212498,212498,DB08801,DB00761,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212499,212499,DB08897,DB00761,O=C(OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212500,212500,DB09076,DB00761,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212501,212501,DB09167,DB00761,CN(C)CCC=C1c2ccccc2CSc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212502,212502,DB09300,DB00761,CCCC[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212503,212503,DB11235,DB00761,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212504,212504,DB11855,DB00761,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212505,212505,DB12278,DB00761,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212507,212507,DB00804,DB00761,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212508,212508,DB09089,DB00761,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212509,212509,DB12554,DB00761,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212510,212510,DB00782,DB00761,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212511,212511,DB00940,DB00761,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212512,212512,DB01625,DB00761,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212513,212513,DB04843,DB00761,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212514,212514,DB06787,DB00761,C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212515,212515,DB11315,DB00761,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
212516,212516,DB13720,DB00761,C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1,[Cl-].[K+],106,D013276,increase,1,the risk or severity of gastrointestinal ulceration can be increased when #drug1 is combined with #drug2.
213495,213495,DB16165,DB00763,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,Cn1cc[nH]c1=S,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
213873,213873,DB00862,DB00765,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(N)(Cc1ccc(O)cc1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
213874,213874,DB00975,DB00765,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(N)(Cc1ccc(O)cc1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
213875,213875,DB06237,DB00765,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(N)(Cc1ccc(O)cc1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
213876,213876,DB06267,DB00765,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(N)(Cc1ccc(O)cc1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
213877,213877,DB12010,DB00765,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(N)(Cc1ccc(O)cc1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
214390,214390,DB00924,DB00771,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
214906,214906,DB00774,DB01235,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
214989,214989,DB00862,DB00774,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
214990,214990,DB00975,DB00774,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
214991,214991,DB06237,DB00774,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
214992,214992,DB06267,DB00774,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
214993,214993,DB12010,DB00774,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
215033,215033,DB00898,DB00774,CCO,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
215034,215034,DB00794,DB00774,CCC1(c2ccccc2)C(=O)NCNC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
215035,215035,DB00849,DB00774,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
215036,215036,DB01154,DB00774,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
215037,215037,DB01174,DB00774,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
215038,215038,DB01351,DB00774,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
215188,215188,DB00774,DB06283,NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
215683,215683,DB00924,DB00776,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
215697,215697,DB00776,DB06283,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
216117,216117,DB06711,DB00777,c1ccc2c(CC3=NCCN3)cccc2c1,CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
216118,216118,DB13946,DB00777,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216119,216119,DB00924,DB00777,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
216122,216122,DB00777,DB06283,CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
216803,216803,DB00780,DB06707,NNCCc1ccccc1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216807,216807,DB00780,DB06701,NNCCc1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216956,216956,DB00780,DB00852,NNCCc1ccccc1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216957,216957,DB00780,DB00865,NNCCc1ccccc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216958,216958,DB00780,DB01255,NNCCc1ccccc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216959,216959,DB00780,DB01365,NNCCc1ccccc1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216960,216960,DB00780,DB01576,NNCCc1ccccc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216961,216961,DB00780,DB01577,NNCCc1ccccc1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216962,216962,DB00780,DB09480,NNCCc1ccccc1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216963,216963,DB00780,DB13624,NNCCc1ccccc1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
216964,216964,DB00780,DB01579,NNCCc1ccccc1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217079,217079,DB00780,DB00841,NNCCc1ccccc1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217080,217080,DB00780,DB01186,NNCCc1ccccc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217081,217081,DB00780,DB01253,NNCCc1ccccc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217082,217082,DB00780,DB06262,NNCCc1ccccc1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217083,217083,DB00780,DB06694,NNCCc1ccccc1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217084,217084,DB00780,DB06711,NNCCc1ccccc1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217085,217085,DB00780,DB01200,NNCCc1ccccc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217234,217234,DB13946,DB00780,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,NNCCc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
217310,217310,DB00782,DB06155,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
217311,217311,DB00782,DB09061,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
217571,217571,DB00782,DB14881,CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
218439,218439,DB13946,DB00784,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cccc(Nc2ccccc2C(=O)O)c1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
219113,219113,DB13946,DB00788,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc2cc(C(C)C(=O)O)ccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
219132,219132,DB00790,DB01235,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
219269,219269,DB01592,DB00790,[Fe],CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
219272,219272,DB00862,DB00790,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
219273,219273,DB06237,DB00790,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
219274,219274,DB06267,DB00790,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
219275,219275,DB12010,DB00790,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
219276,219276,DB00975,DB00790,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
219581,219581,DB00794,DB00880,CCC1(c2ccccc2)C(=O)NCNC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
219582,219582,DB00794,DB00999,CCC1(c2ccccc2)C(=O)NCNC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
219583,219583,DB00794,DB01021,CCC1(c2ccccc2)C(=O)NCNC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
219584,219584,DB00794,DB01324,CCC1(c2ccccc2)C(=O)NCNC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
219585,219585,DB00794,DB01325,CCC1(c2ccccc2)C(=O)NCNC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
219586,219586,DB00794,DB13532,CCC1(c2ccccc2)C(=O)NCNC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
219886,219886,DB06711,DB00794,c1ccc2c(CC3=NCCN3)cccc2c1,CCC1(c2ccccc2)C(=O)NCNC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
219887,219887,DB00794,DB06701,CCC1(c2ccccc2)C(=O)NCNC1=O,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
219912,219912,DB00924,DB00794,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(c2ccccc2)C(=O)NCNC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
219925,219925,DB00794,DB06283,CCC1(c2ccccc2)C(=O)NCNC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
220587,220587,DB13946,DB00795,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
220612,220612,DB00796,DB01235,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
220746,220746,DB00862,DB00796,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
220747,220747,DB00975,DB00796,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
220748,220748,DB06237,DB00796,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
220749,220749,DB06267,DB00796,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
220750,220750,DB12010,DB00796,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
220972,220972,DB00797,DB01235,c1ccc(CC2=NCCN2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
221151,221151,DB13946,DB00797,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,c1ccc(CC2=NCCN2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
221361,221361,DB00800,DB01235,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
221441,221441,DB00800,DB01186,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221442,221442,DB00800,DB01200,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221443,221443,DB00800,DB01238,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221444,221444,DB00800,DB05271,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221445,221445,DB00800,DB09097,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221446,221446,DB00800,DB09128,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221447,221447,DB00800,DB11273,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221448,221448,DB00800,DB12313,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221449,221449,DB00800,DB13520,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
221491,221491,DB00862,DB00800,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
221492,221492,DB00975,DB00800,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
221493,221493,DB06237,DB00800,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
221494,221494,DB06267,DB00800,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
221495,221495,DB12010,DB00800,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
221837,221837,DB06711,DB00801,c1ccc2c(CC3=NCCN3)cccc2c1,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
221838,221838,DB00924,DB00801,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
222086,222086,DB00831,DB00802,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222087,222087,DB00933,DB00802,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222088,222088,DB01063,DB00802,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222089,222089,DB01608,DB00802,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222090,222090,DB01614,DB00802,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222091,222091,DB11540,DB00802,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222092,222092,DB12710,DB00802,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222093,222093,DB13213,DB00802,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222185,222185,DB00850,DB00802,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222188,222188,DB01246,DB00802,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222206,222206,DB01621,DB00802,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
222373,222373,DB13946,DB00802,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
222374,222374,DB00924,DB00802,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
222520,222520,DB00804,DB06155,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
222521,222521,DB00804,DB09061,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
222778,222778,DB00804,DB14881,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
222864,222864,DB00805,DB06707,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
222868,222868,DB00805,DB06701,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223020,223020,DB00805,DB00852,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223021,223021,DB00805,DB00865,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223022,223022,DB00805,DB01255,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223023,223023,DB00805,DB01365,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223024,223024,DB00805,DB01576,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223025,223025,DB00805,DB01577,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223026,223026,DB00805,DB09480,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223027,223027,DB00805,DB13624,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223028,223028,DB00805,DB01579,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223166,223166,DB00805,DB00841,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223167,223167,DB00805,DB01186,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223168,223168,DB00805,DB01200,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223169,223169,DB00805,DB01253,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223170,223170,DB00805,DB06262,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223171,223171,DB00805,DB06694,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223172,223172,DB00805,DB06711,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223311,223311,DB13946,DB00805,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
223419,223419,DB00806,DB04854,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
223587,223587,DB00924,DB00807,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
223591,223591,DB00808,DB01235,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
223656,223656,DB00975,DB00808,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
223657,223657,DB06267,DB00808,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
223658,223658,DB12010,DB00808,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
223659,223659,DB06237,DB00808,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
223689,223689,DB00898,DB00808,CCO,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
223693,223693,DB00849,DB00808,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
223694,223694,DB01154,DB00808,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
223695,223695,DB01351,DB00808,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
223922,223922,DB00808,DB06283,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
224041,224041,DB00809,DB14881,CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
224081,224081,DB00810,DB06155,OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
224082,224082,DB00810,DB09061,OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
224392,224392,DB00810,DB14881,OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
224395,224395,DB00993,DB00811,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12,NC(=O)c1ncn(C2OC(CO)C(O)C2O)n1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
224829,224829,DB13946,DB00812,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
225155,225155,DB00831,DB00813,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225156,225156,DB00933,DB00813,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225157,225157,DB01063,DB00813,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225158,225158,DB01608,DB00813,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225159,225159,DB01614,DB00813,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225160,225160,DB11540,DB00813,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225161,225161,DB12710,DB00813,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225162,225162,DB13213,DB00813,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225237,225237,DB00850,DB00813,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225239,225239,DB01246,DB00813,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225251,225251,DB01621,DB00813,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
225389,225389,DB00924,DB00813,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
225745,225745,DB13946,DB00814,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
225937,225937,DB09042,DB00816,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(C)NCC(O)c1cc(O)cc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
226049,226049,DB13946,DB00816,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)NCC(O)c1cc(O)cc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
226345,226345,DB00818,DB01235,CC(C)c1cccc(C(C)C)c1O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
227078,227078,DB00818,DB01364,CC(C)c1cccc(C(C)C)c1O,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
227087,227087,DB06711,DB00818,c1ccc2c(CC3=NCCN3)cccc2c1,CC(C)c1cccc(C(C)C)c1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
227088,227088,DB13946,DB00818,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)c1cccc(C(C)C)c1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
227094,227094,DB00924,DB00818,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(C)c1cccc(C(C)C)c1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
227105,227105,DB00818,DB06283,CC(C)c1cccc(C(C)C)c1O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
227546,227546,DB00924,DB00819,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)Nc1nnc(S(N)(=O)=O)s1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
227553,227553,DB00819,DB06283,CC(=O)Nc1nnc(S(N)(=O)=O)s1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
228160,228160,DB13946,DB00821,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
229673,229673,DB06711,DB00829,c1ccc2c(CC3=NCCN3)cccc2c1,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
229700,229700,DB00924,DB00829,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
229708,229708,DB00829,DB06283,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
229945,229945,DB09042,DB00830,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC1NCCOC1c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
230021,230021,DB13946,DB00830,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC1NCCOC1c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
230146,230146,DB00831,DB00844,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230147,230147,DB00831,DB00854,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230148,230148,DB00831,DB00899,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230149,230149,DB00831,DB01081,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230150,230150,DB00831,DB01192,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230151,230151,DB00831,DB01209,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230152,230152,DB00831,DB01227,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230153,230153,DB00831,DB01452,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230154,230154,DB00831,DB01497,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230155,230155,DB00831,DB01535,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230156,230156,DB00831,DB01551,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230157,230157,DB00831,DB09272,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230158,230158,DB00831,DB11609,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230159,230159,DB00831,DB12492,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230160,230160,DB00831,DB15465,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230161,230161,DB00831,DB09049,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
230483,230483,DB13946,DB00831,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
230484,230484,DB00924,DB00831,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
230498,230498,DB00831,DB06283,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
230785,230785,DB00924,DB00832,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)CC(c2ccccc2)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
230788,230788,DB00832,DB06283,CN1C(=O)CC(c2ccccc2)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
231708,231708,DB00924,DB00835,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
232340,232340,DB16165,DB00836,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
232726,232726,DB09042,DB00841,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232731,232731,DB01142,DB00841,CN(C)CCC=C1c2ccccc2COc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
232732,232732,DB01151,DB00841,CNCCCN1c2ccccc2CCc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
232733,232733,DB01242,DB00841,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
232734,232734,DB09167,DB00841,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
232735,232735,DB13114,DB00841,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
232736,232736,DB13225,DB00841,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
232737,232737,DB13246,DB00841,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
232766,232766,DB01037,DB00841,C#CCN(C)C(C)Cc1ccccc1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232767,232767,DB01168,DB00841,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232768,232768,DB01171,DB00841,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232769,232769,DB01247,DB00841,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232770,232770,DB01367,DB00841,C#CCNC1CCc2ccccc21,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232771,232771,DB01626,DB00841,C#CCN(C)Cc1ccccc1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232772,232772,DB04820,DB00841,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232773,232773,DB06654,DB00841,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232774,232774,DB09241,DB00841,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
232881,232881,DB13946,DB00841,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
233154,233154,DB06711,DB00842,c1ccc2c(CC3=NCCN3)cccc2c1,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
233155,233155,DB00924,DB00842,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
233158,233158,DB00842,DB06283,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
233540,233540,DB00924,DB00843,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
233673,233673,DB00850,DB00844,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233674,233674,DB00933,DB00844,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233675,233675,DB01063,DB00844,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233676,233676,DB01246,DB00844,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233677,233677,DB01608,DB00844,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233678,233678,DB01614,DB00844,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233679,233679,DB01621,DB00844,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233680,233680,DB11540,DB00844,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233681,233681,DB12710,DB00844,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233682,233682,DB13213,DB00844,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
233841,233841,DB00924,DB00844,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Oc1ccc2c3c1OC1C(O)CCC4(O)C(C2)N(CC2CCC2)CCC314,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
234327,234327,DB00849,DB00880,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
234328,234328,DB00849,DB00999,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
234329,234329,DB00849,DB01021,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
234330,234330,DB00849,DB01324,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
234331,234331,DB00849,DB01325,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
234332,234332,DB00849,DB13532,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
234749,234749,DB06711,DB00849,c1ccc2c(CC3=NCCN3)cccc2c1,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
234772,234772,DB00924,DB00849,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
234784,234784,DB00849,DB06283,CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
234836,234836,DB00850,DB00854,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234837,234837,DB00850,DB00899,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234838,234838,DB00850,DB01081,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234839,234839,DB00850,DB01192,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234840,234840,DB00850,DB01209,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234841,234841,DB00850,DB01452,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234842,234842,DB00850,DB01497,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234843,234843,DB00850,DB01535,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234844,234844,DB00850,DB01551,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234845,234845,DB00850,DB09272,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234846,234846,DB00850,DB11609,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234847,234847,DB00850,DB12492,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234848,234848,DB00850,DB15465,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234849,234849,DB00850,DB09049,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
234884,234884,DB00850,DB00852,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
234885,234885,DB00850,DB00865,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
234886,234886,DB00850,DB00937,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
234887,234887,DB00850,DB01255,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
234888,234888,DB00850,DB01365,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
234889,234889,DB00850,DB01576,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
234890,234890,DB00850,DB09480,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
234891,234891,DB00850,DB13624,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
234892,234892,DB00850,DB01579,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235016,235016,DB00850,DB01227,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235092,235092,DB00850,DB01577,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235208,235208,DB00924,DB00850,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
235223,235223,DB00850,DB06283,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
235563,235563,DB09042,DB00852,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235632,235632,DB00933,DB00852,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235633,235633,DB01063,DB00852,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235634,235634,DB01618,DB00852,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235635,235635,DB01621,DB00852,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235636,235636,DB01623,DB00852,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235637,235637,DB06077,DB00852,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235638,235638,DB06288,DB00852,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235639,235639,DB11376,DB00852,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235640,235640,DB11540,DB00852,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235641,235641,DB12401,DB00852,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235642,235642,DB12710,DB00852,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235643,235643,DB12867,DB00852,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235644,235644,DB13213,DB00852,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235645,235645,DB13256,DB00852,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235646,235646,DB13273,DB00852,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235659,235659,DB01168,DB00852,CNNCc1ccc(C(=O)NC(C)C)cc1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235660,235660,DB01171,DB00852,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235661,235661,DB01247,DB00852,Cc1cc(C(=O)NNCc2ccccc2)no1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235662,235662,DB01367,DB00852,C#CCNC1CCc2ccccc21,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235663,235663,DB01626,DB00852,C#CCN(C)Cc1ccccc1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235664,235664,DB04820,DB00852,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235665,235665,DB06654,DB00852,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235695,235695,DB04842,DB00852,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235697,235697,DB06144,DB00852,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235699,235699,DB09225,DB00852,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CNC(C)C(O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
235732,235732,DB13946,DB00852,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
235925,235925,DB00933,DB00854,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235926,235926,DB01063,DB00854,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235927,235927,DB01246,DB00854,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235928,235928,DB01608,DB00854,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235929,235929,DB01614,DB00854,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235930,235930,DB01621,DB00854,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235931,235931,DB11540,DB00854,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235932,235932,DB12710,DB00854,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
235933,235933,DB13213,DB00854,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
236093,236093,DB00924,DB00854,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCC23CCCCC2C1Cc1ccc(O)cc13,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
236096,236096,DB00924,DB00856,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OCC(O)COc1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
236854,236854,DB01135,DB00860,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
236855,236855,DB01226,DB00860,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
236856,236856,DB01336,DB00860,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
236857,236857,DB01339,DB00860,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
236858,236858,DB04834,DB00860,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
236859,236859,DB11156,DB00860,CN1CCCN=C1C=Cc1cccs1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
237170,237170,DB00861,DB01009,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
237171,237171,DB00861,DB09214,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
237346,237346,DB13946,DB00861,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
237495,237495,DB00862,DB00876,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237496,237496,DB00862,DB00880,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237497,237497,DB00862,DB00881,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237498,237498,DB00862,DB00960,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(C)NCC(O)COc1cccc2[nH]ccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237499,237499,DB00862,DB00966,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237500,237500,DB00862,DB00968,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237501,237501,DB00862,DB01021,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237502,237502,DB00862,DB01089,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237503,237503,DB00862,DB01090,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237504,237504,DB00862,DB01116,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237505,237505,DB00862,DB01119,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237506,237506,DB00862,DB01180,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237507,237507,DB00862,DB01197,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(CS)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237508,237508,DB00862,DB01203,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237509,237509,DB00862,DB01240,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237510,237510,DB00862,DB01297,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237511,237511,DB00862,DB01324,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237512,237512,DB00862,DB01340,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237513,237513,DB00862,DB01348,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237514,237514,DB00862,DB01359,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237515,237515,DB00862,DB01626,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,C#CCN(C)Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237516,237516,DB00862,DB04840,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,N=C(N)N1CCc2ccccc2C1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237517,237517,DB00862,DB09242,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COc1nc(C)nc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237518,237518,DB00862,DB09477,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237519,237519,DB00862,DB11738,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,C1COC(NC(C2CC2)C2CC2)=N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237520,237520,DB00862,DB12945,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NNc1nnc(NN)c2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237521,237521,DB00862,DB13166,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237522,237522,DB00862,DB13211,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,N=C(N)NCC1COc2ccccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237523,237523,DB00862,DB13532,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237524,237524,DB00862,DB13801,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237525,237525,DB00862,DB01018,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237526,237526,DB00862,DB01170,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,NC(N)=NCCN1CCCCCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237527,237527,DB00862,DB04861,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237528,237528,DB00862,DB06762,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CC(NC(=Nc1ccncc1)NC#N)C(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237529,237529,DB00862,DB08932,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237530,237530,DB00862,DB09026,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237531,237531,DB00862,DB08822,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237532,237532,DB00862,DB01193,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237533,237533,DB00862,DB01580,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,C=CCOc1ccccc1OCC(O)CNC(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
237778,237778,DB00862,DB09237,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
238864,238864,DB09042,DB00865,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
238965,238965,DB00933,DB00865,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238966,238966,DB01063,DB00865,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238967,238967,DB01618,DB00865,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238968,238968,DB01621,DB00865,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238969,238969,DB01623,DB00865,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238970,238970,DB06077,DB00865,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238971,238971,DB06288,DB00865,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238972,238972,DB11376,DB00865,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238973,238973,DB11540,DB00865,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238974,238974,DB12401,DB00865,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238975,238975,DB12710,DB00865,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238976,238976,DB12867,DB00865,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238977,238977,DB13213,DB00865,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238978,238978,DB13256,DB00865,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238979,238979,DB13273,DB00865,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
238992,238992,DB01168,DB00865,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
238993,238993,DB01171,DB00865,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
238994,238994,DB01247,DB00865,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
238995,238995,DB01367,DB00865,C#CCNC1CCc2ccccc21,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
238996,238996,DB01626,DB00865,C#CCN(C)Cc1ccccc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
238997,238997,DB04820,DB00865,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
238998,238998,DB06654,DB00865,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
239066,239066,DB04842,DB00865,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
239071,239071,DB06144,DB00865,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
239089,239089,DB09225,DB00865,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CC(Cc1ccccc1)N(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
239183,239183,DB13946,DB00865,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(Cc1ccccc1)N(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
239184,239184,DB00924,DB00865,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(Cc1ccccc1)N(C)Cc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
239365,239365,DB09042,DB00867,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
239471,239471,DB13946,DB00867,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
239582,239582,DB00869,DB06283,CCNC1CC(C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
239704,239704,DB09042,DB00871,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
239973,239973,DB13946,DB00871,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
239982,239982,DB00872,DB01235,Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
240181,240181,DB00872,DB06283,Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
240564,240564,DB16165,DB00872,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
240939,240939,DB13946,DB00875,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
240942,240942,DB00924,DB00875,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
240944,240944,DB00875,DB06283,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
241052,241052,DB00876,DB01235,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
241178,241178,DB00975,DB00876,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
241179,241179,DB06237,DB00876,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
241180,241180,DB06267,DB00876,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
241181,241181,DB12010,DB00876,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
241359,241359,DB00877,DB01026,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
241360,241360,DB00877,DB01167,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
241729,241729,DB00880,DB01235,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
241804,241804,DB00975,DB00880,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
241805,241805,DB06237,DB00880,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
241806,241806,DB06267,DB00880,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
241807,241807,DB12010,DB00880,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
241844,241844,DB00898,DB00880,CCO,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
241845,241845,DB01154,DB00880,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
241846,241846,DB01174,DB00880,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
241847,241847,DB01351,DB00880,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
241988,241988,DB00880,DB06283,NS(=O)(=O)c1cc2c(cc1Cl)NC=NS2(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
241992,241992,DB00881,DB01235,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
242124,242124,DB01592,DB00881,[Fe],CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
242126,242126,DB00975,DB00881,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
242127,242127,DB06237,DB00881,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
242128,242128,DB06267,DB00881,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
242129,242129,DB12010,DB00881,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
242369,242369,DB00883,DB01235,O=[N+]([O-])OC1COC2C(O[N+](=O)[O-])COC12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
242570,242570,DB00884,DB09139,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,O=P(O)(O)C(O)P(=O)(O)O.[Tc],132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
242571,242571,DB00887,DB00884,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
242572,242572,DB00903,DB00884,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
242573,242573,DB02925,DB00884,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
242650,242650,DB00887,DB01235,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
242795,242795,DB00887,DB01077,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,CC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
242796,242796,DB00887,DB01133,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
242835,242835,DB00887,DB06283,CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
243306,243306,DB00924,DB00889,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
243743,243743,DB00924,DB00892,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
244187,244187,DB06711,DB00897,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
244188,244188,DB00924,DB00897,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
244194,244194,DB00897,DB06283,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
244471,244471,DB00898,DB00999,CCO,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
244472,244472,DB00898,DB01021,CCO,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
244473,244473,DB00898,DB01324,CCO,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
244474,244474,DB00898,DB01325,CCO,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
244475,244475,DB00898,DB13532,CCO,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
244528,244528,DB00898,DB13783,CCO,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
244784,244784,DB06711,DB00898,c1ccc2c(CC3=NCCN3)cccc2c1,CCO,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
244873,244873,DB00899,DB01235,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
245082,245082,DB00933,DB00899,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245083,245083,DB01063,DB00899,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245084,245084,DB01246,DB00899,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245085,245085,DB01608,DB00899,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245086,245086,DB01614,DB00899,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245087,245087,DB01621,DB00899,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245088,245088,DB11540,DB00899,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245089,245089,DB12710,DB00899,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245090,245090,DB13213,DB00899,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
245285,245285,DB06711,DB00899,c1ccc2c(CC3=NCCN3)cccc2c1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
245286,245286,DB13946,DB00899,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
245287,245287,DB00924,DB00899,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
245288,245288,DB00899,DB06283,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
245364,245364,DB00903,DB01235,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
245523,245523,DB00903,DB01077,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,CC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
245524,245524,DB00903,DB01133,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
245546,245546,DB00903,DB06283,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
246088,246088,DB06711,DB00904,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
246092,246092,DB00924,DB00904,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
246483,246483,DB00924,DB00906,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ccsc1C(=CCCN1CCCC(C(=O)O)C1)c1sccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
246488,246488,DB00906,DB06283,Cc1ccsc1C(=CCCN1CCCC(C(=O)O)C1)c1sccc1C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
246946,246946,DB00907,DB09061,COC(=O)C1C(OC(=O)c2ccccc2)CC2CCC1N2C,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
247079,247079,DB00908,DB06155,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
247080,247080,DB00908,DB09061,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
247263,247263,DB12161,DB00908,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
247457,247457,DB13946,DB00908,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
248076,248076,DB00924,DB00909,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NS(=O)(=O)Cc1noc2ccccc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
248091,248091,DB00909,DB06283,NS(=O)(=O)Cc1noc2ccccc12,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
249050,249050,DB01101,DB00916,CCCCCOC(=O)Nc1nc(=O)n(C2OC(C)C(O)C2O)cc1F,Cc1ncc([N+](=O)[O-])n1CCO,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
249546,249546,DB00918,DB06262,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
249962,249962,DB13946,DB00918,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
249963,249963,DB00924,DB00918,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
250588,250588,DB00922,DB01235,CC1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
251021,251021,DB00924,DB01403,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251022,251022,DB00924,DB01173,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ccccc1C(OCCN(C)C)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251023,251023,DB00924,DB09117,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC1OC(C)OC(C)O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251024,251024,DB00924,DB08883,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251025,251025,DB00924,DB05271,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251026,251026,DB00924,DB06201,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251027,251027,DB00924,DB09072,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C([O-])CCCO.[Na+],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251028,251028,DB00924,DB06701,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COC(=O)C(c1ccccc1)C1CCCCN1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251029,251029,DB00924,DB14509,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C([O-])[O-].[Li+].[Li+],50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251030,251030,DB00924,DB01392,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251031,251031,DB00924,DB11428,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cccc(C(C)c2cnc[nH]2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251032,251032,DB00924,DB11477,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cccc(C)c1NC1=NCCCS1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251033,251033,DB00924,DB11543,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Fc1cccc(Br)c1NC1=NCCN1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251034,251034,DB00924,DB11556,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cccc(Cc2cnc[nH]2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251035,251035,DB00924,DB01063,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251036,251036,DB00924,DB01239,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCC=C1c2ccccc2Sc2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251037,251037,DB00924,DB01608,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251038,251038,DB00924,DB01614,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251039,251039,DB00924,DB01618,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251040,251040,DB00924,DB06077,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251041,251041,DB00924,DB06288,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251042,251042,DB00924,DB11376,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251043,251043,DB00924,DB11540,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251044,251044,DB00924,DB12401,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251045,251045,DB00924,DB12710,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251046,251046,DB00924,DB12867,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251047,251047,DB00924,DB13213,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251048,251048,DB00924,DB13256,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251049,251049,DB00924,DB13273,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251050,251050,DB00924,DB00941,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251051,251051,DB00924,DB00952,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251052,251052,DB00924,DB00953,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251053,251053,DB00924,DB00985,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2nc(Cl)[nH]c2n(C)c1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251054,251054,DB00924,DB01080,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CC(N)CCC(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251055,251055,DB00924,DB01107,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(CC)C(=O)NCC(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251056,251056,DB00924,DB01121,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(=O)NC(=O)Cc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251057,251057,DB00924,DB01135,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251058,251058,DB00924,DB01176,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(C(c2ccccc2)c2ccccc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251059,251059,DB00924,DB01178,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251060,251060,DB00924,DB01189,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,FC(F)OC(F)C(F)(F)F,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251061,251061,DB00924,DB01199,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1cc2c3cc1Oc1cc(ccc1O)CC1c4c(cc(OC)c(O)c4Oc4ccc(cc4)CC3N(C)CC2)CC[N+]1(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251062,251062,DB00924,DB01226,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251063,251063,DB00924,DB01235,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(Cc1ccc(O)c(O)c1)C(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251064,251064,DB00924,DB01245,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251065,251065,DB00924,DB01336,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251066,251066,DB00924,DB01337,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1[N+]1(C)CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251067,251067,DB00924,DB01338,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC(N3CC[N+](C)(C)CC3)C4OC(C)=O)C2(C)CC1N1CC[N+](C)(C)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251068,251068,DB00924,DB01339,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251069,251069,DB00924,DB01353,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCC1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251070,251070,DB00924,DB01440,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(O)CCCO,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251071,251071,DB00924,DB01452,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251072,251072,DB00924,DB01495,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cc(=O)n(-c2ccccc2)n1C.OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251073,251073,DB00924,DB01501,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251074,251074,DB00924,DB01563,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OC(O)C(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251075,251075,DB00924,DB01616,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CCCc1ccccc1)CCCc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251076,251076,DB00924,DB02959,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(Cc1c[nH]c2ccc(O)cc12)C(=O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251077,251077,DB00924,DB04821,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1Cc2c(N)cccc2C(c2ccccc2)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251078,251078,DB00924,DB04827,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251079,251079,DB00924,DB04834,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251080,251080,DB00924,DB04953,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251081,251081,DB00924,DB05246,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)CC(C)(c2ccccc2)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251082,251082,DB00924,DB06153,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCC(=C2c3ccccc3CCc3sccc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251083,251083,DB00924,DB06690,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,[N-]=[N+]=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251084,251084,DB00924,DB06716,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251085,251085,DB00924,DB06753,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=P(O)(O)OCC(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251086,251086,DB00924,DB06797,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(C)C(C)(COC(N)=O)COC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251087,251087,DB00924,DB08329,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251088,251088,DB00924,DB08872,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251089,251089,DB00924,DB11156,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCCN=C1C=Cc1cccs1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251090,251090,DB00924,DB11371,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3C(=O)CC12C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251091,251091,DB00924,DB11549,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCNC1(c2cccs2)CCCCC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251092,251092,DB00924,DB11552,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOC(=O)c1cccc(N)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251093,251093,DB00924,DB11555,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251094,251094,DB00924,DB11699,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251095,251095,DB00924,DB11859,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251096,251096,DB00924,DB13114,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251097,251097,DB00924,DB13219,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CC(Oc1ccccc1)Oc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251098,251098,DB00924,DB13221,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCC(C(=O)NC(N)=O)C(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251099,251099,DB00924,DB13225,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251100,251100,DB00924,DB13246,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251101,251101,DB00924,DB13253,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251102,251102,DB00924,DB13323,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,ClC=C(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251103,251103,DB00924,DB13520,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251104,251104,DB00924,DB13872,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251105,251105,DB00924,DB01174,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251106,251106,DB00924,DB00949,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(=O)OCC(COC(N)=O)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251107,251107,DB00924,DB09119,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(=O)OC1Cc2ccccc2N(C(N)=O)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251108,251108,DB00924,DB14575,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(=O)N1c2ccccc2CC(O)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251109,251109,DB00924,DB09185,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOc1ccccc1OCC1CNCCO1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251110,251110,DB00924,DB01544,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251111,251111,DB00924,DB09061,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251112,251112,DB00924,DB00937,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CC)C(C)C(=O)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251113,251113,DB00924,DB01577,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNC(C)Cc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251114,251114,DB00924,DB01081,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251115,251115,DB00924,DB01209,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC12CCCCCC(Cc3ccc(O)cc31)C2N,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251116,251116,DB00924,DB01497,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251117,251117,DB00924,DB01535,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251118,251118,DB00924,DB11609,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251119,251119,DB00924,DB12492,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251120,251120,DB00924,DB14754,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NC(=O)OCC(N)Cc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251121,251121,DB00924,DB01221,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNC1(c2ccccc2Cl)CCCCC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251122,251122,DB00924,DB01351,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251123,251123,DB00924,DB01320,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251124,251124,DB00924,DB04832,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CC=C(c1ccc(Br)cc1)c1cccnc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251125,251125,DB00924,DB09118,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(C)(C)C(O)C=Cc1ccc2c(c1)OCO2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251126,251126,DB00924,DB06691,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251127,251127,DB00924,DB11400,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COC1CC(OC2C(C)OC(OC3C(C)=CCC4CC(CC5(C=CC(C)C(C6CCCCC6)O5)O4)OC(=O)C4C=C(C)C(O)C5OCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251128,251128,DB00924,DB01100,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251129,251129,DB00924,DB01142,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCC=C1c2ccccc2COc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251130,251130,DB00924,DB01200,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251131,251131,DB00924,DB01224,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251132,251132,DB00924,DB01227,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251133,251133,DB00924,DB01242,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251134,251134,DB00924,DB08815,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251135,251135,DB00924,DB00962,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251136,251136,DB00924,DB00969,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251137,251137,DB00924,DB00980,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)NCCC1CCc2ccc3c(c21)CCO3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251138,251138,DB00924,DB00996,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,NCC1(CC(=O)O)CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251139,251139,DB00924,DB01018,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251140,251140,DB00924,DB01028,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COC(F)(F)C(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251141,251141,DB00924,DB01068,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251142,251142,DB00924,DB01104,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251143,251143,DB00924,DB01105,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251144,251144,DB00924,DB01114,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251145,251145,DB00924,DB01149,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251146,251146,DB00924,DB01151,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNCCCN1c2ccccc2CCc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251147,251147,DB00924,DB01154,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251148,251148,DB00924,DB01159,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,FC(F)(F)C(Cl)Br,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251149,251149,DB00924,DB01175,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251150,251150,DB00924,DB01186,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251151,251151,DB00924,DB01192,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251152,251152,DB00924,DB01198,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251153,251153,DB00924,DB01202,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(C(N)=O)N1CCCC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251154,251154,DB00924,DB01215,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251155,251155,DB00924,DB01236,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,FCOC(C(F)(F)F)C(F)(F)F,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251156,251156,DB00924,DB01238,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251157,251157,DB00924,DB01253,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251158,251158,DB00924,DB01267,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251159,251159,DB00924,DB01551,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251160,251160,DB00924,DB01559,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251161,251161,DB00924,DB01587,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251162,251162,DB00924,DB01588,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251163,251163,DB00924,DB01589,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251164,251164,DB00924,DB01595,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251165,251165,DB00924,DB01621,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251166,251166,DB00924,DB01624,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(Cl)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251167,251167,DB00924,DB04841,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251168,251168,DB00924,DB04842,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251169,251169,DB00924,DB04871,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC1CNCCc2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251170,251170,DB00924,DB04896,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CC)C(=O)C1(c2ccccc2)CC1CN,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251171,251171,DB00924,DB04908,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251172,251172,DB00924,DB04946,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251173,251173,DB00924,DB05541,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCC1CC(=O)N(C(CC)C(N)=O)C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251174,251174,DB00924,DB06016,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251175,251175,DB00924,DB06144,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251176,251176,DB00924,DB06148,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN2c3ccccc3Cc3ccccc3C2C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251177,251177,DB00924,DB06216,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251178,251178,DB00924,DB06218,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COCC(NC(C)=O)C(=O)NCc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251179,251179,DB00924,DB06282,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251180,251180,DB00924,DB06283,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251181,251181,DB00924,DB06684,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251182,251182,DB00924,DB06700,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251183,251183,DB00924,DB08910,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251184,251184,DB00924,DB08918,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CC)C(=O)C1(c2ccccc2)CC1CN,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251185,251185,DB00924,DB09068,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251186,251186,DB00924,DB09071,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC(=O)NCC1CC1c1cccc2c1CCO2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251187,251187,DB00924,DB09128,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251188,251188,DB00924,DB09225,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251189,251189,DB00924,DB12537,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C1=Cc2ccccc2NN=C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251190,251190,DB00924,DB14185,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251191,251191,DB00924,DB01437,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCC1(c2ccccc2)CCC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251192,251192,DB00924,DB00998,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNC1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251193,251193,DB00924,DB01065,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251194,251194,DB00924,DB06594,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COc1ccc2cccc(CCNC(C)=O)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251195,251195,DB00924,DB09167,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCC=C1c2ccccc2CSc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251196,251196,DB00924,DB00934,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CNCCCC12CCC(c3ccccc31)c1ccccc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251197,251197,DB00924,DB01558,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251198,251198,DB00924,DB01623,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251199,251199,DB00924,DB06770,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OCc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251200,251200,DB00924,DB00960,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(C)NCC(O)COc1cccc2[nH]ccc12,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251201,251201,DB00924,DB01359,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251202,251202,DB00924,DB01580,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,C=CCOc1ccccc1OCC(O)CNC(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251203,251203,DB00924,DB01069,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251204,251204,DB00924,DB01075,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN(C)CCOC(c1ccccc1)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251205,251205,DB00924,DB00933,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251206,251206,DB00924,DB00967,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251207,251207,DB00924,DB01219,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251208,251208,DB00924,DB01246,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251209,251209,DB00924,DB01106,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CC1CN(C2CCC(C#N)(c3ccc(F)cc3)CC2)CCC1(C(=O)O)c1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251210,251210,DB00924,DB13259,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251211,251211,DB00924,DB13583,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ccccc1OCC(O)CO,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251212,251212,DB00924,DB01002,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251213,251213,DB00924,DB11951,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1ncc(OCC2(c3cccc(F)c3)CC2C(=O)Nc2ccc(F)cn2)c(C)n1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251214,251214,DB00924,DB12404,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,COC(=O)CCC1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251215,251215,DB00924,DB01086,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCOC(=O)c1ccc(N)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251216,251216,DB00924,DB01161,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCN(CC)CCOC(=O)c1ccc(N)cc1Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251217,251217,DB00924,DB09009,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251218,251218,DB00924,DB11148,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCOC(=O)c1ccc(N)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251219,251219,DB00924,DB00961,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,Cc1cccc(C)c1NC(=O)C1CCCCN1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251220,251220,DB00924,DB09085,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251221,251221,DB00924,DB09345,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,CCCCOc1ccc(OCCCN2CCOCC2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251222,251222,DB00924,DB11304,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21,OCCOc1ccccc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
251272,251272,DB00925,DB01235,CC(COc1ccccc1)N(CCCl)Cc1ccccc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
251435,251435,DB13946,DB00925,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(COc1ccccc1)N(CCCl)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
252325,252325,DB16165,DB00932,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCCC1(CCc2ccccc2)CC(O)=C(C(CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
252383,252383,DB00933,DB01081,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252384,252384,DB00933,DB01192,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252385,252385,DB00933,DB01209,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252386,252386,DB00933,DB01227,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252387,252387,DB00933,DB01452,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252388,252388,DB00933,DB01497,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252389,252389,DB00933,DB01535,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252390,252390,DB00933,DB01551,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252391,252391,DB00933,DB09272,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252392,252392,DB00933,DB11609,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252393,252393,DB00933,DB12492,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252394,252394,DB00933,DB15465,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252395,252395,DB00933,DB09049,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
252435,252435,DB00933,DB00937,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
252436,252436,DB00933,DB01255,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
252437,252437,DB00933,DB01365,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
252438,252438,DB00933,DB01576,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
252439,252439,DB00933,DB01577,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
252440,252440,DB00933,DB09480,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
252441,252441,DB00933,DB13624,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
252442,252442,DB00933,DB01579,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
252783,252783,DB00933,DB06283,CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
253364,253364,DB09042,DB00935,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
253369,253369,DB01142,DB00935,CN(C)CCC=C1c2ccccc2COc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
253370,253370,DB01151,DB00935,CNCCCN1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
253371,253371,DB01242,DB00935,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
253372,253372,DB09167,DB00935,CN(C)CCC=C1c2ccccc2CSc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
253373,253373,DB13114,DB00935,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
253374,253374,DB13225,DB00935,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
253375,253375,DB13246,DB00935,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
253439,253439,DB13946,DB00935,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
253562,253562,DB00936,DB01009,O=C(O)c1ccccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
253563,253563,DB00936,DB09214,O=C(O)c1ccccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
253624,253624,DB00936,DB01294,O=C(O)c1ccccc1O,O=C1O[Bi](O)Oc2ccccc21,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
253625,253625,DB00936,DB06807,O=C(O)c1ccccc1O,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
253626,253626,DB00936,DB09543,O=C(O)c1ccccc1O,COC(=O)c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
253627,253627,DB00936,DB14006,O=C(O)c1ccccc1O,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
253808,253808,DB13946,DB00936,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)c1ccccc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
253949,253949,DB09042,DB00937,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CCN(CC)C(C)C(=O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
254048,254048,DB01063,DB00937,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254049,254049,DB01618,DB00937,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254050,254050,DB01621,DB00937,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254051,254051,DB01623,DB00937,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254052,254052,DB06077,DB00937,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254053,254053,DB06288,DB00937,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254054,254054,DB11376,DB00937,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254055,254055,DB11540,DB00937,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254056,254056,DB12401,DB00937,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254057,254057,DB12710,DB00937,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254058,254058,DB12867,DB00937,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254059,254059,DB13213,DB00937,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254060,254060,DB13256,DB00937,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254061,254061,DB13273,DB00937,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254137,254137,DB04842,DB00937,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254143,254143,DB06144,DB00937,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254162,254162,DB09225,DB00937,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CCN(CC)C(C)C(=O)c1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
254211,254211,DB13946,DB00937,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCN(CC)C(C)C(=O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
254641,254641,DB13946,DB00938,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
254917,254917,DB13946,DB00939,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
254985,254985,DB00940,DB06155,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
254986,254986,DB00940,DB09061,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
255212,255212,DB00940,DB14881,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
255532,255532,DB00942,DB06155,OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
255533,255533,DB00942,DB09061,OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
255764,255764,DB00942,DB14881,OC(CCN1CCCCC1)(c1ccccc1)C1CCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
255920,255920,DB00945,DB01009,CC(=O)Oc1ccccc1C(=O)O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
255921,255921,DB00945,DB09214,CC(=O)Oc1ccccc1C(=O)O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
256102,256102,DB13946,DB00945,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(=O)Oc1ccccc1C(=O)O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
256539,256539,DB00946,DB06701,CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
257138,257138,DB00949,DB06283,NC(=O)OCC(COC(N)=O)c1ccccc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
257962,257962,DB00952,DB06262,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
258190,258190,DB13946,DB00952,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
258274,258274,DB00953,DB06262,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
258552,258552,DB13946,DB00953,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
259670,259670,DB01135,DB00959,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
259671,259671,DB01226,DB00959,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
259672,259672,DB01336,DB00959,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
259673,259673,DB01339,DB00959,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
259674,259674,DB04834,DB00959,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
259675,259675,DB11156,DB00959,CN1CCCN=C1C=Cc1cccs1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
259879,259879,DB00960,DB01235,CC(C)NCC(O)COc1cccc2[nH]ccc12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
259989,259989,DB06237,DB00960,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(C)NCC(O)COc1cccc2[nH]ccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
259990,259990,DB06267,DB00960,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)NCC(O)COc1cccc2[nH]ccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
259991,259991,DB12010,DB00960,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)NCC(O)COc1cccc2[nH]ccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
260267,260267,DB13967,DB00960,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)NCC(O)COc1cccc2[nH]ccc12,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
260874,260874,DB06711,DB00962,c1ccc2c(CC3=NCCN3)cccc2c1,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
260900,260900,DB00962,DB06283,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
261012,261012,DB00966,DB01235,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
261128,261128,DB06237,DB00966,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
261129,261129,DB06267,DB00966,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
261130,261130,DB12010,DB00966,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
261591,261591,DB00968,DB01235,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
261684,261684,DB00975,DB00968,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
261685,261685,DB06237,DB00968,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
261686,261686,DB06267,DB00968,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
261687,261687,DB12010,DB00968,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(N)(Cc1ccc(O)c(O)c1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263054,263054,DB00975,DB01235,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
263086,263086,DB00975,DB00999,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263087,263087,DB00975,DB01018,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263088,263088,DB00975,DB01021,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263089,263089,DB00975,DB01029,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263090,263090,DB00975,DB01089,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263091,263091,DB00975,DB01090,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263092,263092,DB00975,DB01116,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263093,263093,DB00975,DB01119,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263094,263094,DB00975,DB01158,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC[N+](C)(C)Cc1ccccc1Br,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263095,263095,DB00975,DB01170,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NC(N)=NCCN1CCCCCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263096,263096,DB00975,DB01180,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263097,263097,DB00975,DB01197,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(CS)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263098,263098,DB00975,DB01244,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263099,263099,DB00975,DB01275,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NNc1nncc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263100,263100,DB00975,DB01324,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263101,263101,DB00975,DB01340,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263102,263102,DB00975,DB01348,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263103,263103,DB00975,DB04840,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,N=C(N)N1CCc2ccccc2C1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263104,263104,DB00975,DB04948,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263105,263105,DB00975,DB06268,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263106,263106,DB00975,DB06403,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COC(c1ccccc1)(c1ccccc1)C(Oc1nc(C)cc(C)n1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263107,263107,DB00975,DB06712,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263108,263108,DB00975,DB06762,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(NC(=Nc1ccncc1)NC#N)C(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263109,263109,DB00975,DB08932,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263110,263110,DB00975,DB09026,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263111,263111,DB00975,DB09238,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263112,263112,DB00975,DB09242,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,COc1nc(C)nc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263113,263113,DB00975,DB09477,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263114,263114,DB00975,DB11362,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263115,263115,DB00975,DB11738,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,C1COC(NC(C2CC2)C2CC2)=N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263116,263116,DB00975,DB12945,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NNc1nnc(NN)c2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263117,263117,DB00975,DB13166,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263118,263118,DB00975,DB13211,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,N=C(N)NCC1COc2ccccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263119,263119,DB00975,DB13532,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263120,263120,DB00975,DB13801,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263121,263121,DB00975,DB09237,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263171,263171,DB00975,DB08822,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
263689,263689,DB16165,DB00976,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCC1OC(=O)C(C)C(=O)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)OC12C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
264427,264427,DB00979,DB14881,CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
264788,264788,DB06711,DB00980,c1ccc2c(CC3=NCCN3)cccc2c1,CCC(=O)NCCC1CCc2ccc3c(c21)CCO3,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
264795,264795,DB00980,DB06283,CCC(=O)NCCC1CCc2ccc3c(c21)CCO3,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
265305,265305,DB13946,DB00983,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
265840,265840,DB00986,DB06155,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
265841,265841,DB00986,DB09061,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
266041,266041,DB00986,DB14881,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
266271,266271,DB09042,DB00988,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
266430,266430,DB13946,DB00988,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,NCCc1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
266765,266765,DB13946,DB00991,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
267221,267221,DB00996,DB06283,NCC1(CC(=O)O)CCCCC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
267703,267703,DB00998,DB06262,CNC1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
267984,267984,DB13946,DB00998,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNC1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
267991,267991,DB00999,DB01235,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
268055,268055,DB06237,DB00999,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
268056,268056,DB06267,DB00999,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
268057,268057,DB12010,DB00999,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
268075,268075,DB01154,DB00999,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
268076,268076,DB01174,DB00999,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
268077,268077,DB01351,DB00999,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
268352,268352,DB00999,DB06283,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
268684,268684,DB13946,DB01001,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
269499,269499,DB01014,DB01009,O=C(O)CCNC(=O)c1ccc(N=Nc2ccc(O)c(C(=O)O)c2)cc1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
269500,269500,DB01250,DB01009,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
269501,269501,DB01294,DB01009,O=C1O[Bi](O)Oc2ccccc21,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
269502,269502,DB06807,DB01009,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
269503,269503,DB09543,DB01009,COC(=O)c1ccccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
269504,269504,DB14006,DB01009,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
269680,269680,DB13946,DB01009,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
269973,269973,DB12161,DB01012,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,CC(NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
270231,270231,DB01135,DB01013,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
270232,270232,DB01226,DB01013,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
270233,270233,DB01336,DB01013,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
270234,270234,DB01339,DB01013,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
270235,270235,DB04834,DB01013,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
270236,270236,DB11156,DB01013,CN1CCCN=C1C=Cc1cccs1,CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
270548,270548,DB01014,DB09214,O=C(O)CCNC(=O)c1ccc(N=Nc2ccc(O)c(C(=O)O)c2)cc1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
270688,270688,DB13946,DB01014,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)CCNC(=O)c1ccc(N=Nc2ccc(O)c(C(=O)O)c2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
271674,271674,DB01018,DB01235,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
271757,271757,DB06267,DB01018,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
271758,271758,DB12010,DB01018,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
271759,271759,DB06237,DB01018,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
271992,271992,DB13946,DB01018,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
272080,272080,DB01020,DB01235,O=[N+]([O-])OC1COC2C(O)COC12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
272263,272263,DB06237,DB01021,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
272264,272264,DB06267,DB01021,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
272265,272265,DB12010,DB01021,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
272295,272295,DB01154,DB01021,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
272296,272296,DB01174,DB01021,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
272297,272297,DB01351,DB01021,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
272426,272426,DB01021,DB06283,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
272430,272430,DB01023,DB01235,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
272500,272500,DB06267,DB01023,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
272501,272501,DB12010,DB01023,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
273090,273090,DB06287,DB01026,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(OC(=O)C(C)(CO)CO)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
273568,273568,DB16165,DB01026,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
274075,274075,DB13946,DB01028,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COC(F)(F)C(Cl)Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
274091,274091,DB16629,DB01028,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,COC(F)(F)C(Cl)Cl,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
274096,274096,DB01029,DB01235,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
274202,274202,DB06267,DB01029,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
274203,274203,DB12010,DB01029,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
274204,274204,DB06237,DB01029,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
274465,274465,DB01029,DB01115,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
274731,274731,DB06819,DB01032,O=C(O)CCCc1ccccc1,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
274732,274732,DB08909,DB01032,O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
274733,274733,DB03793,DB01032,O=C(O)c1ccccc1,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
275395,275395,DB01036,DB06155,Cc1ccc(O)c(C(CCN(C(C)C)C(C)C)c2ccccc2)c1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
275396,275396,DB01036,DB09061,Cc1ccc(O)c(C(CCN(C(C)C)C(C)C)c2ccccc2)c1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
275791,275791,DB01036,DB14881,Cc1ccc(O)c(C(CCN(C(C)C)C(C)C)c2ccccc2)c1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
275892,275892,DB01037,DB06707,C#CCN(C)C(C)Cc1ccccc1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
275894,275894,DB01037,DB06701,C#CCN(C)C(C)Cc1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
276121,276121,DB01037,DB01186,C#CCN(C)C(C)Cc1ccccc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
276122,276122,DB01037,DB01253,C#CCN(C)C(C)Cc1ccccc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
276123,276123,DB01037,DB06262,C#CCN(C)C(C)Cc1ccccc1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
276124,276124,DB01037,DB06694,C#CCN(C)C(C)Cc1ccccc1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
276125,276125,DB01037,DB06711,C#CCN(C)C(C)Cc1ccccc1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
276126,276126,DB01037,DB01200,C#CCN(C)C(C)Cc1ccccc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
276193,276193,DB01037,DB01235,C#CCN(C)C(C)Cc1ccccc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,155,D007024,increase,1,the risk or severity of orthostatic hypotension can be increased when #drug1 is combined with #drug2.
276343,276343,DB13946,DB01037,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C#CCN(C)C(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
278285,278285,DB01135,DB01047,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
278286,278286,DB01226,DB01047,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
278287,278287,DB01336,DB01047,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
278288,278288,DB01339,DB01047,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
278289,278289,DB04834,DB01047,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
278290,278290,DB11156,DB01047,CN1CCCN=C1C=Cc1cccs1,CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
278800,278800,DB01050,DB06605,CC(C)Cc1ccc(C(C)C(=O)O)cc1,COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
278857,278857,DB13946,DB01050,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)Cc1ccc(C(C)C(=O)O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
278911,278911,DB01051,DB06701,COC1C(OC(N)=O)C(O)C(Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
278938,278938,DB01054,DB01235,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
279018,279018,DB06267,DB01054,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
279019,279019,DB12010,DB01054,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
279020,279020,DB06237,DB01054,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
280015,280015,DB01062,DB06155,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
280016,280016,DB01062,DB09061,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
280415,280415,DB01062,DB14881,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
280490,280490,DB01063,DB01081,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280491,280491,DB01063,DB01192,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280492,280492,DB01063,DB01209,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280493,280493,DB01063,DB01227,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280494,280494,DB01063,DB01452,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280495,280495,DB01063,DB01497,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280496,280496,DB01063,DB01535,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280497,280497,DB01063,DB01551,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280498,280498,DB01063,DB09272,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280499,280499,DB01063,DB11609,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280500,280500,DB01063,DB12492,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280501,280501,DB01063,DB15465,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280502,280502,DB01063,DB09049,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
280546,280546,DB01063,DB01255,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
280547,280547,DB01063,DB01365,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
280548,280548,DB01063,DB01576,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
280549,280549,DB01063,DB01577,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
280550,280550,DB01063,DB09480,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
280551,280551,DB01063,DB13624,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
280552,280552,DB01063,DB01579,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
280715,280715,DB01063,DB06283,CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
280816,280816,DB09042,DB01064,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(C)NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
280906,280906,DB13946,DB01064,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)NCC(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
281177,281177,DB06711,DB01065,c1ccc2c(CC3=NCCN3)cccc2c1,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
281779,281779,DB01068,DB06283,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
282264,282264,DB01069,DB06283,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
282852,282852,DB16165,DB01072,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,COC(=O)NC(C(=O)NC(Cc1ccccc1)C(O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
283722,283722,DB01075,DB06283,CN(C)CCOC(c1ccccc1)c1ccccc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
284058,284058,DB01077,DB09139,CC(O)(P(=O)(O)O)P(=O)(O)O,O=P(O)(O)C(O)P(=O)(O)O.[Tc],132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
284059,284059,DB02925,DB01077,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,CC(O)(P(=O)(O)O)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
284735,284735,DB01080,DB06283,C=CC(N)CCC(=O)O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
284805,284805,DB01246,DB01081,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
284806,284806,DB01608,DB01081,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
284807,284807,DB01614,DB01081,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
284808,284808,DB01621,DB01081,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
284809,284809,DB11540,DB01081,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
284810,284810,DB12710,DB01081,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
284811,284811,DB13213,DB01081,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
286029,286029,DB01088,DB01235,CC#CCC(C)C(O)C=CC1C(O)CC2CC(=CCCCC(=O)O)CC21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
286288,286288,DB06237,DB01089,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
286289,286289,DB06267,DB01089,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
286290,286290,DB12010,DB01089,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(=O)C1C2CC3c4[nH]c5ccccc5c4CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
286477,286477,DB06237,DB01090,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
286478,286478,DB06267,DB01090,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
286479,286479,DB12010,DB01090,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
286574,286574,DB01090,DB14881,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
288433,288433,DB01100,DB06283,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
288847,288847,DB13946,DB01102,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Oc1ccc(CCCCNCC(O)c2ccc(O)c(O)c2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
289936,289936,DB06711,DB01107,c1ccc2c(CC3=NCCN3)cccc2c1,CCC1(CC)C(=O)NCC(C)C1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
289939,289939,DB01107,DB06283,CCC1(CC)C(=O)NCC(C)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
290069,290069,DB01135,DB01108,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
290070,290070,DB01226,DB01108,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
290071,290071,DB01336,DB01108,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
290072,290072,DB01339,DB01108,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
290073,290073,DB04834,DB01108,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
290074,290074,DB11156,DB01108,CN1CCCN=C1C=Cc1cccs1,CC12CCC3C(CCC45OC4C(O)=C(C#N)CC35C)C1CCC2O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
291400,291400,DB01115,DB01235,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
292025,292025,DB06237,DB01116,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
292026,292026,DB06267,DB01116,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
292027,292027,DB12010,DB01116,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
292118,292118,DB01116,DB14881,O=C1N(Cc2ccccc2)C2C[S+]3CCCC3C2N1Cc1ccccc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
292250,292250,DB01118,DB01235,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
292819,292819,DB16165,DB01118,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
292841,292841,DB01119,DB01235,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
292971,292971,DB06237,DB01119,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
292972,292972,DB06267,DB01119,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
292973,292973,DB12010,DB01119,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC1=NS(=O)(=O)c2cc(Cl)ccc2N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
293449,293449,DB01121,DB06283,NC(=O)NC(=O)Cc1ccccc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
293975,293975,DB13946,DB01126,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC12C=CC(=O)NC1CCC1C2CCC2(C)C(C(=O)Nc3cc(C(F)(F)F)ccc3C(F)(F)F)CCC12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
294010,294010,DB16165,DB01127,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
294217,294217,DB01128,DB16019,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,O=C([O-])CCc1ccc(O)c(CN(CCN(CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)[O-])c1.[Ga+3],167,D064907,increase,0,#drug1 may increase effectiveness of #drug2 as a diagnostic agent.
294830,294830,DB01133,DB09139,O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,O=P(O)(O)C(O)P(=O)(O)O.[Tc],132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
294831,294831,DB02925,DB01133,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O,132,D006996,increase,1,the risk or severity of hypocalcemia can be increased when #drug1 is combined with #drug2.
295123,295123,DB01135,DB01222,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295124,295124,DB01135,DB01234,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295125,295125,DB01135,DB01380,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295126,295126,DB01135,DB01410,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295127,295127,DB01135,DB08906,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295128,295128,DB01135,DB09091,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295129,295129,DB01135,DB09378,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295130,295130,DB01135,DB09383,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295131,295131,DB01135,DB11487,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295132,295132,DB01135,DB11529,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295133,295133,DB01135,DB11921,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295134,295134,DB01135,DB13867,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295135,295135,DB01135,DB14512,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295136,295136,DB01135,DB14539,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295137,295137,DB01135,DB14541,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295138,295138,DB01135,DB14545,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295139,295139,DB01135,DB14631,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295140,295140,DB01135,DB14644,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295141,295141,DB01135,DB14646,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295142,295142,DB01135,DB14669,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295143,295143,DB01135,DB14540,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295144,295144,DB01135,DB08971,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295145,295145,DB01135,DB15566,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295146,295146,DB01135,DB09095,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295147,295147,DB01135,DB14643,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295160,295160,DB01135,DB14649,COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
295161,295161,DB01136,DB01235,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
295372,295372,DB13967,DB01136,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
296166,296166,DB01142,DB06262,CN(C)CCC=C1c2ccccc2COc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
296167,296167,DB01142,DB06694,CN(C)CCC=C1c2ccccc2COc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
296168,296168,DB01142,DB06706,CN(C)CCC=C1c2ccccc2COc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
296169,296169,DB01142,DB06764,CN(C)CCC=C1c2ccccc2COc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
296170,296170,DB01142,DB01253,CN(C)CCC=C1c2ccccc2COc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
296171,296171,DB01142,DB01186,CN(C)CCC=C1c2ccccc2COc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
296535,296535,DB06711,DB01142,c1ccc2c(CC3=NCCN3)cccc2c1,CN(C)CCC=C1c2ccccc2COc2ccccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
296536,296536,DB13946,DB01142,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCC=C1c2ccccc2COc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
296556,296556,DB01142,DB06283,CN(C)CCC=C1c2ccccc2COc2ccccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
296626,296626,DB01143,DB01235,NCCCNCCSP(=O)(O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
296705,296705,DB01144,DB01235,NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
296809,296809,DB01144,DB06283,NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
296868,296868,DB01148,DB06155,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
296869,296869,DB01148,DB09061,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
297057,297057,DB01148,DB14881,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
297321,297321,DB13946,DB01149,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
297633,297633,DB16165,DB01149,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
297787,297787,DB01151,DB01253,CNCCCN1c2ccccc2CCc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
297788,297788,DB01151,DB06262,CNCCCN1c2ccccc2CCc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
297789,297789,DB01151,DB06694,CNCCCN1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
297790,297790,DB01151,DB06706,CNCCCN1c2ccccc2CCc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
297791,297791,DB01151,DB06711,CNCCCN1c2ccccc2CCc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
297792,297792,DB01151,DB06764,CNCCCN1c2ccccc2CCc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
297793,297793,DB01151,DB01186,CNCCCN1c2ccccc2CCc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
297794,297794,DB01151,DB01200,CNCCCN1c2ccccc2CCc2ccccc21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
298186,298186,DB13946,DB01151,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNCCCN1c2ccccc2CCc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
298382,298382,DB01154,DB01324,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
298383,298383,DB01154,DB01325,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
298384,298384,DB01154,DB13532,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
298731,298731,DB06711,DB01154,c1ccc2c(CC3=NCCN3)cccc2c1,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
298758,298758,DB01154,DB06283,C=CCC1(C(C)CCC)C(=O)NC(=S)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
299217,299217,DB12161,DB01156,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
299334,299334,DB01158,DB01235,CC[N+](C)(C)Cc1ccccc1Br,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
299396,299396,DB06237,DB01158,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC[N+](C)(C)Cc1ccccc1Br,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
299397,299397,DB06267,DB01158,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC[N+](C)(C)Cc1ccccc1Br,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
299398,299398,DB12010,DB01158,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC[N+](C)(C)Cc1ccccc1Br,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
299566,299566,DB01159,DB01235,FC(F)(F)C(Cl)Br,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
299966,299966,DB13946,DB01159,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,FC(F)(F)C(Cl)Br,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
299977,299977,DB16629,DB01159,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,FC(F)(F)C(Cl)Br,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
300194,300194,DB01162,DB01235,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
300860,300860,DB06287,DB01167,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(OC(=O)C(C)(CO)CO)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
301244,301244,DB16165,DB01167,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
301343,301343,DB01168,DB06707,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301345,301345,DB01168,DB06701,CNNCc1ccc(C(=O)NC(C)C)cc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301442,301442,DB01168,DB01255,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301443,301443,DB01168,DB01365,CNNCc1ccc(C(=O)NC(C)C)cc1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301444,301444,DB01168,DB01576,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301445,301445,DB01168,DB01577,CNNCc1ccc(C(=O)NC(C)C)cc1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301446,301446,DB01168,DB09480,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301447,301447,DB01168,DB13624,CNNCc1ccc(C(=O)NC(C)C)cc1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301448,301448,DB01168,DB01579,CNNCc1ccc(C(=O)NC(C)C)cc1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301554,301554,DB01168,DB01186,CNNCc1ccc(C(=O)NC(C)C)cc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301555,301555,DB01168,DB01200,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301556,301556,DB01168,DB01253,CNNCc1ccc(C(=O)NC(C)C)cc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301557,301557,DB01168,DB06262,CNNCc1ccc(C(=O)NC(C)C)cc1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301558,301558,DB01168,DB06694,CNNCc1ccc(C(=O)NC(C)C)cc1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301559,301559,DB01168,DB06711,CNNCc1ccc(C(=O)NC(C)C)cc1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
301675,301675,DB01169,DB01235,O=[As]O[As]=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
301995,301995,DB06267,DB01170,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NC(N)=NCCN1CCCCCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
301996,301996,DB12010,DB01170,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NC(N)=NCCN1CCCCCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
301997,301997,DB06237,DB01170,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NC(N)=NCCN1CCCCCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
302120,302120,DB01171,DB06707,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302122,302122,DB01171,DB06701,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302207,302207,DB01171,DB01255,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302208,302208,DB01171,DB01365,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302209,302209,DB01171,DB01576,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302210,302210,DB01171,DB01577,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302211,302211,DB01171,DB09480,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302212,302212,DB01171,DB13624,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302213,302213,DB01171,DB01579,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302309,302309,DB01171,DB01186,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302310,302310,DB01171,DB01200,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302311,302311,DB01171,DB01253,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302312,302312,DB01171,DB06262,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302313,302313,DB01171,DB06694,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302314,302314,DB01171,DB06711,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302450,302450,DB13946,DB01171,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
302749,302749,DB12161,DB01173,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,Cc1ccccc1C(OCCN(C)C)c1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
303012,303012,DB01174,DB01324,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
303013,303013,DB01174,DB01325,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
303014,303014,DB01174,DB13532,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
303253,303253,DB06711,DB01174,c1ccc2c(CC3=NCCN3)cccc2c1,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
303254,303254,DB01174,DB06701,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
303290,303290,DB01174,DB06283,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
304532,304532,DB06711,DB01178,c1ccc2c(CC3=NCCN3)cccc2c1,CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
304637,304637,DB01592,DB01180,[Fe],COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
304639,304639,DB06237,DB01180,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
304640,304640,DB06267,DB01180,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
304641,304641,DB12010,DB01180,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
304682,304682,DB13946,DB01180,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COC(=O)C1C2CC3c4[nH]c5cc(OC)ccc5c4CCN3CC2CC(OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)C1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
305283,305283,DB12161,DB01182,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
305284,305284,DB13967,DB01182,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
305388,305388,DB13946,DB01182,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
305767,305767,DB16165,DB01183,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,C=CCN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
306209,306209,DB01186,DB01200,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
306210,306210,DB01186,DB09097,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
306211,306211,DB01186,DB09128,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
306212,306212,DB01186,DB11273,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
306213,306213,DB01186,DB12313,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
306214,306214,DB01186,DB13520,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
306215,306215,DB01186,DB01238,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
306226,306226,DB13114,DB01186,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
306227,306227,DB13225,DB01186,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
306228,306228,DB13246,DB01186,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
306229,306229,DB01242,DB01186,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
306230,306230,DB09167,DB01186,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
306382,306382,DB01247,DB01186,Cc1cc(C(=O)NNCc2ccccc2)no1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
306383,306383,DB01367,DB01186,C#CCNC1CCc2ccccc21,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
306384,306384,DB01626,DB01186,C#CCN(C)Cc1ccccc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
306385,306385,DB04820,DB01186,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
306386,306386,DB06654,DB01186,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
306411,306411,DB13946,DB01186,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCN1CC(CSC)CC2c3cccc4[nH]cc(c34)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
306428,306428,DB01189,DB01235,FC(F)OC(F)C(F)(F)F,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
306800,306800,DB13946,DB01189,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,FC(F)OC(F)C(F)(F)F,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
306810,306810,DB16629,DB01189,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,FC(F)OC(F)C(F)(F)F,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
307229,307229,DB01246,DB01192,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
307230,307230,DB01608,DB01192,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
307231,307231,DB01614,DB01192,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
307232,307232,DB01621,DB01192,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
307233,307233,DB11540,DB01192,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
307234,307234,DB12710,DB01192,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
307235,307235,DB13213,DB01192,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CN1CCC23c4c5ccc(O)c4OC2C(=O)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
307453,307453,DB01193,DB01235,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
307477,307477,DB09042,DB01193,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
307535,307535,DB06237,DB01193,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
307536,307536,DB06267,DB01193,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
307537,307537,DB12010,DB01193,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
307614,307614,DB13967,DB01193,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
307694,307694,DB01194,DB06283,CCNC1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
308064,308064,DB01197,DB01235,CC(CS)C(=O)N1CCCC1C(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
308163,308163,DB01592,DB01197,[Fe],CC(CS)C(=O)N1CCCC1C(=O)O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
308165,308165,DB06237,DB01197,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(CS)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
308166,308166,DB06267,DB01197,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(CS)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
308167,308167,DB12010,DB01197,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(CS)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
308463,308463,DB06711,DB01198,c1ccc2c(CC3=NCCN3)cccc2c1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
308467,308467,DB01198,DB06283,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
308734,308734,DB01200,DB01235,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
308807,308807,DB01200,DB09097,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
308808,308808,DB01200,DB11273,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
308809,308809,DB01200,DB12313,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
308810,308810,DB01200,DB13520,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
308823,308823,DB09167,DB01200,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
308824,308824,DB13114,DB01200,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
308825,308825,DB13225,DB01200,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
308826,308826,DB13246,DB01200,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
308827,308827,DB01242,DB01200,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
309006,309006,DB01247,DB01200,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
309007,309007,DB01367,DB01200,C#CCNC1CCc2ccccc21,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
309008,309008,DB01626,DB01200,C#CCN(C)Cc1ccccc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
309009,309009,DB04820,DB01200,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
309010,309010,DB06654,DB01200,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
309011,309011,DB09241,DB01200,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
309060,309060,DB13946,DB01200,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5cccc6[nH]c(Br)c(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
309688,309688,DB01202,DB06283,CCC(C(N)=O)N1CCCC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
309691,309691,DB01203,DB01235,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
309765,309765,DB06237,DB01203,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
309766,309766,DB06267,DB01203,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
309767,309767,DB12010,DB01203,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
309855,309855,DB13967,DB01203,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
310285,310285,DB01246,DB01209,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
310286,310286,DB01608,DB01209,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
310287,310287,DB01614,DB01209,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
310288,310288,DB01621,DB01209,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
310289,310289,DB11540,DB01209,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
310290,310290,DB12710,DB01209,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
310291,310291,DB13213,DB01209,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC12CCCCCC(Cc3ccc(O)cc31)C2N,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
310831,310831,DB16165,DB01211,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
311136,311136,DB06711,DB01215,c1ccc2c(CC3=NCCN3)cccc2c1,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
311161,311161,DB01215,DB06283,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
311428,311428,DB13946,DB01216,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
311700,311700,DB12161,DB01218,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
312580,312580,DB01226,DB01222,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
312581,312581,DB01336,DB01222,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
312582,312582,DB01339,DB01222,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
312583,312583,DB04834,DB01222,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
312584,312584,DB11156,DB01222,CN1CCCN=C1C=Cc1cccs1,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
312787,312787,DB01223,DB04854,Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
313039,313039,DB01224,DB01235,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
313394,313394,DB13946,DB01224,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
313435,313435,DB01224,DB06283,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
313651,313651,DB01226,DB01234,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313652,313652,DB01226,DB01380,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313653,313653,DB01226,DB01410,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313654,313654,DB01226,DB08906,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313655,313655,DB01226,DB09091,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313656,313656,DB01226,DB09378,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313657,313657,DB01226,DB09383,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313658,313658,DB01226,DB11487,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313659,313659,DB01226,DB11529,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313660,313660,DB01226,DB11921,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313661,313661,DB01226,DB13867,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313662,313662,DB01226,DB14512,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313663,313663,DB01226,DB14539,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313664,313664,DB01226,DB14541,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313665,313665,DB01226,DB14545,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313666,313666,DB01226,DB14631,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313667,313667,DB01226,DB14644,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313668,313668,DB01226,DB14646,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313669,313669,DB01226,DB14669,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313670,313670,DB01226,DB14540,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313671,313671,DB01226,DB08971,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313672,313672,DB01226,DB15566,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313673,313673,DB01226,DB09095,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313674,313674,DB01226,DB14643,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313718,313718,DB01226,DB14649,COc1cc2c(cc1OC)C(Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CCC=CCCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3C1Cc1cc(OC)c(OC)c(OC)c1)CC2,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
313775,313775,DB01608,DB01227,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
313776,313776,DB01614,DB01227,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
313777,313777,DB11540,DB01227,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
313778,313778,DB12710,DB01227,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
313779,313779,DB13213,DB01227,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
313835,313835,DB01246,DB01227,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
313908,313908,DB01621,DB01227,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCC(OC(C)=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
314305,314305,DB01229,DB01235,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
314715,314715,DB01231,DB06155,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
314716,314716,DB01231,DB09061,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
314886,314886,DB01231,DB14881,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
315298,315298,DB16165,DB01232,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
315669,315669,DB01336,DB01234,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
315670,315670,DB01339,DB01234,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
315671,315671,DB04834,DB01234,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
315672,315672,DB11156,DB01234,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
315933,315933,DB01236,DB01235,FCOC(C(F)(F)F)C(F)(F)F,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315934,315934,DB01240,DB01235,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315935,315935,DB01242,DB01235,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315936,315936,DB01244,DB01235,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315937,315937,DB01275,DB01235,NNc1nncc2ccccc12,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315938,315938,DB01282,DB01235,CCC(C)C1NC(=O)C(Cc2ccc(OC)cc2)NC(=O)CCCSCC(C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315939,315939,DB01340,DB01235,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315940,315940,DB01359,DB01235,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315941,315941,DB01367,DB01235,C#CCNC1CCc2ccccc21,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315942,315942,DB01580,DB01235,C=CCOc1ccccc1OCC(O)CNC(C)C,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315943,315943,DB01612,DB01235,CCCCCON=O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315944,315944,DB04861,DB01235,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315945,315945,DB04920,DB01235,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315946,315946,DB05271,DB01235,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315947,315947,DB06292,DB01235,CCOc1ccc(Cc2cc(C3OC(CO)C(O)C(O)C3O)ccc2Cl)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315948,315948,DB06712,DB01235,COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315949,315949,DB08822,DB01235,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315950,315950,DB08907,DB01235,Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315951,315951,DB08931,DB01235,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315952,315952,DB08941,DB01235,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315953,315953,DB08950,DB01235,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315954,315954,DB09026,DB01235,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315955,315955,DB09038,DB01235,OCC1OC(c2ccc(Cl)c(Cc3ccc(OC4CCOC4)cc3)c2)C(O)C(O)C1O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315956,315956,DB09112,DB01235,O=NO,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315957,315957,DB09242,DB01235,COc1nc(C)nc(Cl)c1NC1=NCCN1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315958,315958,DB09292,DB01235,CCOC(=O)C(C)CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315959,315959,DB09477,DB01235,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315960,315960,DB11632,DB01235,Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(-c2cc(O)c(O)c([N+](=O)[O-])c2)n1,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
315961,315961,DB15456,DB01235,COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N,NC(Cc1ccc(O)c(O)c1)C(=O)O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
316499,316499,DB13946,DB01236,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,FCOC(C(F)(F)F)C(F)(F)F,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
316511,316511,DB16629,DB01236,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,FCOC(C(F)(F)F)C(F)(F)F,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
316609,316609,DB01238,DB06262,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
316611,316611,DB01238,DB11273,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
316612,316612,DB01238,DB12313,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
316613,316613,DB01238,DB13520,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
316941,316941,DB13946,DB01238,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
316976,316976,DB01238,DB06283,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
317290,317290,DB01239,DB06283,CN(C)CCC=C1c2ccccc2Sc2ccc(Cl)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
317380,317380,DB06237,DB01240,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
317381,317381,DB06267,DB01240,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
317382,317382,DB12010,DB01240,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
317701,317701,DB01242,DB06262,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
317702,317702,DB01242,DB06694,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
317703,317703,DB01242,DB06706,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
317704,317704,DB01242,DB06711,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
317705,317705,DB01242,DB06764,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
317706,317706,DB01242,DB01253,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
318104,318104,DB13946,DB01242,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
318260,318260,DB06267,DB01244,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
318261,318261,DB12010,DB01244,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
318262,318262,DB06237,DB01244,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
318711,318711,DB01246,DB01452,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318712,318712,DB01246,DB01497,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318713,318713,DB01246,DB01535,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318714,318714,DB01246,DB01551,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318715,318715,DB01246,DB09272,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318716,318716,DB01246,DB11609,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318717,318717,DB01246,DB12492,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318718,318718,DB01246,DB15465,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318719,318719,DB01246,DB09049,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
318953,318953,DB01246,DB06283,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
319015,319015,DB01247,DB06707,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319017,319017,DB01247,DB06701,Cc1cc(C(=O)NNCc2ccccc2)no1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319091,319091,DB01247,DB01255,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319092,319092,DB01247,DB01365,Cc1cc(C(=O)NNCc2ccccc2)no1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319093,319093,DB01247,DB01576,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319094,319094,DB01247,DB01577,Cc1cc(C(=O)NNCc2ccccc2)no1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319095,319095,DB01247,DB09480,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319096,319096,DB01247,DB13624,Cc1cc(C(=O)NNCc2ccccc2)no1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319097,319097,DB01247,DB01579,Cc1cc(C(=O)NNCc2ccccc2)no1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319175,319175,DB01247,DB01253,Cc1cc(C(=O)NNCc2ccccc2)no1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319176,319176,DB01247,DB06262,Cc1cc(C(=O)NNCc2ccccc2)no1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319177,319177,DB01247,DB06694,Cc1cc(C(=O)NNCc2ccccc2)no1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319178,319178,DB01247,DB06711,Cc1cc(C(=O)NNCc2ccccc2)no1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319238,319238,DB13946,DB01247,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cc(C(=O)NNCc2ccccc2)no1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319593,319593,DB01250,DB09214,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
319636,319636,DB01250,DB01294,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,O=C1O[Bi](O)Oc2ccccc21,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
319637,319637,DB01250,DB06807,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
319638,319638,DB01250,DB09543,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,COC(=O)c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
319639,319639,DB01250,DB14006,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
319709,319709,DB13946,DB01250,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)c1cc(N=Nc2ccc(O)c(C(=O)O)c2)ccc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
319985,319985,DB09167,DB01253,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
319986,319986,DB13114,DB01253,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
319987,319987,DB13225,DB01253,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
319988,319988,DB13246,DB01253,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
320138,320138,DB01367,DB01253,C#CCNC1CCc2ccccc21,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320139,320139,DB01626,DB01253,C#CCN(C)Cc1ccccc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320140,320140,DB04820,DB01253,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320141,320141,DB06654,DB01253,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320164,320164,DB13946,DB01253,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320653,320653,DB09042,DB01255,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320699,320699,DB01618,DB01255,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320700,320700,DB01621,DB01255,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320701,320701,DB01623,DB01255,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320702,320702,DB06077,DB01255,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320703,320703,DB06288,DB01255,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320704,320704,DB11376,DB01255,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320705,320705,DB11540,DB01255,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320706,320706,DB12401,DB01255,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320707,320707,DB12710,DB01255,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320708,320708,DB12867,DB01255,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320709,320709,DB13213,DB01255,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320710,320710,DB13256,DB01255,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320711,320711,DB13273,DB01255,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320720,320720,DB01367,DB01255,C#CCNC1CCc2ccccc21,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320721,320721,DB01626,DB01255,C#CCN(C)Cc1ccccc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320722,320722,DB04820,DB01255,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320723,320723,DB06654,DB01255,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
320804,320804,DB04842,DB01255,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320806,320806,DB06144,DB01255,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320807,320807,DB09225,DB01255,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
320832,320832,DB13946,DB01255,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(Cc1ccccc1)NC(=O)C(N)CCCCN,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
322043,322043,DB16165,DB01263,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCC(C(C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
322399,322399,DB16165,DB01264,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
322830,322830,DB13946,DB01267,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
322838,322838,DB01267,DB06283,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
323328,323328,DB13946,DB01274,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
323441,323441,DB06267,DB01275,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NNc1nncc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
323442,323442,DB12010,DB01275,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NNc1nncc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
323443,323443,DB06237,DB01275,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NNc1nncc2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
324017,324017,DB13946,DB01283,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
324132,324132,DB09042,DB01288,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
324211,324211,DB13946,DB01288,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
324212,324212,DB01288,DB14881,CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
324359,324359,DB13946,DB01291,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)(C)NCC(O)c1ccc(O)c(CO)n1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
324365,324365,DB01294,DB09214,O=C1O[Bi](O)Oc2ccccc21,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
324391,324391,DB01294,DB06807,O=C1O[Bi](O)Oc2ccccc21,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
324392,324392,DB01294,DB09543,O=C1O[Bi](O)Oc2ccccc21,COC(=O)c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
324393,324393,DB01294,DB14006,O=C1O[Bi](O)Oc2ccccc21,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
324482,324482,DB06237,DB01297,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
324483,324483,DB06267,DB01297,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
324484,324484,DB12010,DB01297,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
324548,324548,DB13967,DB01297,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
324671,324671,DB01303,DB04854,C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
324776,324776,DB01319,DB06414,CC(C)CN(CC(OP(=O)(O)O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1,Cc1cc(C#N)cc(C)c1Oc1nc(Nc2ccc(C#N)cc2)nc(N)c1Br,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
325230,325230,DB01320,DB06283,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
325442,325442,DB06237,DB01324,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
325443,325443,DB06267,DB01324,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
325444,325444,DB12010,DB01324,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
325466,325466,DB01351,DB01324,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
325564,325564,DB01324,DB06283,CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
325598,325598,DB01351,DB01325,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
325638,325638,DB01325,DB06283,CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
326307,326307,DB01336,DB01380,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326308,326308,DB01336,DB01410,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326309,326309,DB01336,DB08906,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326310,326310,DB01336,DB09091,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326311,326311,DB01336,DB09378,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326312,326312,DB01336,DB09383,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326313,326313,DB01336,DB11487,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326314,326314,DB01336,DB11529,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326315,326315,DB01336,DB11921,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326316,326316,DB01336,DB13867,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326317,326317,DB01336,DB14512,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326318,326318,DB01336,DB14539,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326319,326319,DB01336,DB14541,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326320,326320,DB01336,DB14545,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326321,326321,DB01336,DB14631,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326322,326322,DB01336,DB14644,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326323,326323,DB01336,DB14646,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326324,326324,DB01336,DB14669,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326325,326325,DB01336,DB14540,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326326,326326,DB01336,DB08971,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326327,326327,DB01336,DB15566,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326328,326328,DB01336,DB09095,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326329,326329,DB01336,DB14643,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326369,326369,DB01336,DB14649,COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)C3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1C(C2)[N+](C)(C)CC3,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326961,326961,DB01339,DB01380,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326962,326962,DB01339,DB01410,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326963,326963,DB01339,DB08906,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326964,326964,DB01339,DB09091,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326965,326965,DB01339,DB09378,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326966,326966,DB01339,DB09383,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326967,326967,DB01339,DB11487,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326968,326968,DB01339,DB11529,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326969,326969,DB01339,DB11921,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326970,326970,DB01339,DB13867,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326971,326971,DB01339,DB14512,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326972,326972,DB01339,DB14539,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326973,326973,DB01339,DB14541,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326974,326974,DB01339,DB14545,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326975,326975,DB01339,DB14631,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326976,326976,DB01339,DB14644,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326977,326977,DB01339,DB14646,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326978,326978,DB01339,DB14669,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326979,326979,DB01339,DB14540,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326980,326980,DB01339,DB08971,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326981,326981,DB01339,DB15566,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326982,326982,DB01339,DB09095,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326983,326983,DB01339,DB14643,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
326994,326994,DB01339,DB14649,CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
327083,327083,DB01592,DB01340,[Fe],CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
327084,327084,DB06237,DB01340,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
327085,327085,DB06267,DB01340,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
327086,327086,DB12010,DB01340,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
327161,327161,DB01345,DB06283,[K+],CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
327251,327251,DB01592,DB01348,[Fe],CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
327252,327252,DB06237,DB01348,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
327253,327253,DB06267,DB01348,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
327254,327254,DB12010,DB01348,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
327310,327310,DB01351,DB13532,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,68,D007022&D007024,increase&increase,1,the risk or severity of hypotension and orthostatic hypotension can be increased when #drug1 is combined with #drug2.
327542,327542,DB06711,DB01351,c1ccc2c(CC3=NCCN3)cccc2c1,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
327569,327569,DB01351,DB06283,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
327727,327727,DB06711,DB01353,c1ccc2c(CC3=NCCN3)cccc2c1,CCCCC1(CC)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
327729,327729,DB01353,DB06283,CCCCC1(CC)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
328019,328019,DB06237,DB01359,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
328020,328020,DB06267,DB01359,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
328021,328021,DB12010,DB01359,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
328197,328197,DB13967,DB01359,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)(C)NCC(O)COc1ccccc1C1CCCC1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
328272,328272,DB09042,DB01364,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328306,328306,DB13946,DB01364,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNC(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328386,328386,DB09042,DB01365,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328433,328433,DB01618,DB01365,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328434,328434,DB01621,DB01365,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328435,328435,DB01623,DB01365,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328436,328436,DB06077,DB01365,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328437,328437,DB06288,DB01365,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328438,328438,DB11376,DB01365,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328439,328439,DB11540,DB01365,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328440,328440,DB12401,DB01365,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328441,328441,DB12710,DB01365,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328442,328442,DB12867,DB01365,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328443,328443,DB13213,DB01365,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328444,328444,DB13256,DB01365,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328445,328445,DB13273,DB01365,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328453,328453,DB01367,DB01365,C#CCNC1CCc2ccccc21,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328454,328454,DB01626,DB01365,C#CCN(C)Cc1ccccc1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328455,328455,DB04820,DB01365,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328456,328456,DB06654,DB01365,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328480,328480,DB04842,DB01365,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328482,328482,DB06144,DB01365,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328484,328484,DB09225,DB01365,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CNC(C)(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
328505,328505,DB13946,DB01365,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNC(C)(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328591,328591,DB09042,DB01366,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328645,328645,DB13946,DB01366,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328670,328670,DB01367,DB06707,C#CCNC1CCc2ccccc21,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328672,328672,DB01367,DB06701,C#CCNC1CCc2ccccc21,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328743,328743,DB01367,DB01576,C#CCNC1CCc2ccccc21,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328744,328744,DB01367,DB01577,C#CCNC1CCc2ccccc21,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328745,328745,DB01367,DB09480,C#CCNC1CCc2ccccc21,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328746,328746,DB01367,DB13624,C#CCNC1CCc2ccccc21,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328747,328747,DB01367,DB01579,C#CCNC1CCc2ccccc21,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328815,328815,DB01367,DB06262,C#CCNC1CCc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328816,328816,DB01367,DB06694,C#CCNC1CCc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328817,328817,DB01367,DB06711,C#CCNC1CCc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
328926,328926,DB13946,DB01367,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C#CCNC1CCc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
329289,329289,DB04834,DB01380,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
329290,329290,DB11156,DB01380,CN1CCCN=C1C=Cc1cccs1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
329843,329843,DB13946,DB01392,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
330365,330365,DB01395,DB06283,CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
330904,330904,DB13946,DB01399,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(Oc1ccccc1C(=O)O)c1ccccc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
331071,331071,DB13946,DB01401,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O.O=C([O-])c1ccccc1O.O=C([O-])c1ccccc1O.[Mg+2],16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
331352,331352,DB12161,DB01403,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,COc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
331411,331411,DB13946,DB01403,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
331415,331415,DB01403,DB06283,COc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
331714,331714,DB16165,DB01406,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,C#CC1(O)CCC2C3CCC4=Cc5oncc5CC4(C)C3CCC21C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
331807,331807,DB09042,DB01407,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
331859,331859,DB13946,DB01407,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
331892,331892,DB01409,DB06155,C[N+]1(C)C2CC(OC(=O)C(O)(c3cccs3)c3cccs3)CC1C1OC12,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
331893,331893,DB01409,DB09061,C[N+]1(C)C2CC(OC(=O)C(O)(c3cccs3)c3cccs3)CC1C1OC12,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
332076,332076,DB01409,DB14881,C[N+]1(C)C2CC(OC(=O)C(O)(c3cccs3)c3cccs3)CC1C1OC12,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
332231,332231,DB04834,DB01410,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
332232,332232,DB11156,DB01410,CN1CCCN=C1C=Cc1cccs1,CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
332815,332815,DB01418,DB06701,CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
332988,332988,DB13946,DB01419,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(OCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccccc1Nc1ccnc2cc(C(F)(F)F)ccc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
333444,333444,DB13946,DB01424,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
333840,333840,DB13946,DB01435,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cc(=O)n(-c2ccccc2)n1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
334044,334044,DB06711,DB01437,c1ccc2c(CC3=NCCN3)cccc2c1,CCC1(c2ccccc2)CCC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
334046,334046,DB01437,DB06283,CCC1(c2ccccc2)CCC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
334266,334266,DB01608,DB01452,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334267,334267,DB01614,DB01452,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334268,334268,DB01621,DB01452,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334269,334269,DB11540,DB01452,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334270,334270,DB12710,DB01452,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334271,334271,DB13213,DB01452,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(=O)Oc1ccc2c3c1OC1C(OC(C)=O)C=CC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334514,334514,DB06711,DB01495,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1cc(=O)n(-c2ccccc2)n1C.OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
334516,334516,DB01495,DB06283,Cc1cc(=O)n(-c2ccccc2)n1C.OC(O)C(Cl)(Cl)Cl.OC(O)C(Cl)(Cl)Cl,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
334555,334555,DB01608,DB01497,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334556,334556,DB01614,DB01497,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334557,334557,DB01621,DB01497,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334558,334558,DB11540,DB01497,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334559,334559,DB12710,DB01497,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334560,334560,DB13213,DB01497,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCCC(C)(O)C1CC23C=CC1(OC)C1Oc4c(O)ccc5c4C12CCN(C)C3C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334836,334836,DB01608,DB01535,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334837,334837,DB01614,DB01535,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334838,334838,DB01621,DB01535,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334839,334839,DB11540,DB01535,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334840,334840,DB12710,DB01535,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
334841,334841,DB13213,DB01535,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCc2ccccc2)CC1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
335227,335227,DB06711,DB01544,c1ccc2c(CC3=NCCN3)cccc2c1,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
335234,335234,DB01544,DB06283,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
335302,335302,DB01608,DB01551,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
335303,335303,DB01614,DB01551,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
335304,335304,DB01621,DB01551,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
335305,335305,DB11540,DB01551,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
335306,335306,DB12710,DB01551,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
335307,335307,DB13213,DB01551,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(O)CCC4C(C2)N(C)CCC341,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
335676,335676,DB06711,DB01558,c1ccc2c(CC3=NCCN3)cccc2c1,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
335678,335678,DB01558,DB06283,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
335844,335844,DB06711,DB01559,c1ccc2c(CC3=NCCN3)cccc2c1,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
336014,336014,DB06711,DB01563,c1ccc2c(CC3=NCCN3)cccc2c1,OC(O)C(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
336016,336016,DB01563,DB06283,OC(O)C(Cl)(Cl)Cl,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
336022,336022,DB09042,DB01576,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336023,336023,DB01618,DB01576,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336024,336024,DB01621,DB01576,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336025,336025,DB01623,DB01576,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336026,336026,DB06077,DB01576,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336027,336027,DB06288,DB01576,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336028,336028,DB11376,DB01576,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336029,336029,DB11540,DB01576,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336030,336030,DB12401,DB01576,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336031,336031,DB12710,DB01576,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336032,336032,DB12867,DB01576,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336033,336033,DB13213,DB01576,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336034,336034,DB13256,DB01576,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336035,336035,DB13273,DB01576,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336037,336037,DB01626,DB01576,C#CCN(C)Cc1ccccc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336038,336038,DB04820,DB01576,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336039,336039,DB06654,DB01576,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336062,336062,DB04842,DB01576,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336063,336063,DB06144,DB01576,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336064,336064,DB09225,DB01576,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CC(N)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336071,336071,DB13946,DB01576,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336111,336111,DB09042,DB01577,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336168,336168,DB01618,DB01577,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336169,336169,DB06077,DB01577,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336170,336170,DB06288,DB01577,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336171,336171,DB11376,DB01577,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336172,336172,DB11540,DB01577,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336173,336173,DB12401,DB01577,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336174,336174,DB12710,DB01577,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336175,336175,DB12867,DB01577,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336176,336176,DB13213,DB01577,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336177,336177,DB13256,DB01577,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336178,336178,DB13273,DB01577,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336183,336183,DB01626,DB01577,C#CCN(C)Cc1ccccc1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336184,336184,DB04820,DB01577,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336185,336185,DB06654,DB01577,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336219,336219,DB04842,DB01577,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336222,336222,DB06144,DB01577,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336234,336234,DB09225,DB01577,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336262,336262,DB01623,DB01577,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336311,336311,DB01621,DB01577,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CNC(C)Cc1ccccc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336354,336354,DB13946,DB01577,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNC(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336489,336489,DB01618,DB01579,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336490,336490,DB01621,DB01579,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336491,336491,DB01623,DB01579,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336492,336492,DB04842,DB01579,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336493,336493,DB06077,DB01579,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336494,336494,DB06144,DB01579,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336495,336495,DB06288,DB01579,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336496,336496,DB09225,DB01579,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336497,336497,DB11376,DB01579,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336498,336498,DB11540,DB01579,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336499,336499,DB12401,DB01579,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336500,336500,DB12710,DB01579,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336501,336501,DB12867,DB01579,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336502,336502,DB13213,DB01579,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336503,336503,DB13256,DB01579,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336504,336504,DB13273,DB01579,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CC1C(c2ccccc2)OCCN1C,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
336505,336505,DB01626,DB01579,C#CCN(C)Cc1ccccc1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336506,336506,DB04820,DB01579,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336507,336507,DB06654,DB01579,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336508,336508,DB09241,DB01579,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336546,336546,DB13946,DB01579,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC1C(c2ccccc2)OCCN1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
336615,336615,DB06237,DB01580,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,C=CCOc1ccccc1OCC(O)CNC(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
336616,336616,DB06267,DB01580,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,C=CCOc1ccccc1OCC(O)CNC(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
336617,336617,DB12010,DB01580,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,C=CCOc1ccccc1OCC(O)CNC(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
336756,336756,DB13967,DB01580,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,C=CCOc1ccccc1OCC(O)CNC(C)C,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
336804,336804,DB06711,DB01580,c1ccc2c(CC3=NCCN3)cccc2c1,C=CCOc1ccccc1OCC(O)CNC(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
337134,337134,DB06711,DB01587,c1ccc2c(CC3=NCCN3)cccc2c1,CC1=CC(=O)N2CC(=O)N(C)c3ccc(Cl)cc3C2(c2ccccc2)O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
337299,337299,DB06711,DB01588,c1ccc2c(CC3=NCCN3)cccc2c1,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
337538,337538,DB06711,DB01589,c1ccc2c(CC3=NCCN3)cccc2c1,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
337543,337543,DB01589,DB06283,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
337969,337969,DB01591,DB06155,O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
337970,337970,DB01591,DB09061,O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
338177,338177,DB13946,DB01591,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
338184,338184,DB01591,DB14881,O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
338215,338215,DB01592,DB09477,[Fe],CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
338216,338216,DB01592,DB13166,[Fe],CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
338348,338348,DB06711,DB01595,c1ccc2c(CC3=NCCN3)cccc2c1,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
338370,338370,DB01595,DB06283,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
338668,338668,DB13946,DB01600,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
339069,339069,DB16165,DB01601,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,Cc1cccc(C)c1OCC(=O)NC(Cc1ccccc1)C(O)CC(Cc1ccccc1)NC(=O)C(C(C)C)N1CCCNC1=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
339202,339202,DB01608,DB09272,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339203,339203,DB01608,DB11609,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339204,339204,DB01608,DB12492,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339205,339205,DB01608,DB15465,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339206,339206,DB01608,DB09049,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339338,339338,DB13946,DB01608,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
339347,339347,DB01608,DB06283,N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
339977,339977,DB01614,DB09272,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339978,339978,DB01614,DB11609,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339979,339979,DB01614,DB12492,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339980,339980,DB01614,DB15465,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
339981,339981,DB01614,DB09049,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
340110,340110,DB13946,DB01614,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
340120,340120,DB01614,DB06283,CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
340280,340280,DB01618,DB09480,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
340281,340281,DB01618,DB13624,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
340385,340385,DB01618,DB06283,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
340498,340498,DB01621,DB09272,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
340499,340499,DB01621,DB11609,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
340500,340500,DB01621,DB12492,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
340501,340501,DB01621,DB15465,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
340502,340502,DB01621,DB09049,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
340523,340523,DB01621,DB09480,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
340524,340524,DB01621,DB13624,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
340675,340675,DB01621,DB06283,CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
340736,340736,DB01623,DB09480,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
340737,340737,DB01623,DB13624,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
340944,340944,DB01623,DB06283,CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
341310,341310,DB13946,DB01624,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(Cl)cc32)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
341316,341316,DB01624,DB06283,OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(Cl)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
341369,341369,DB01625,DB06155,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
341370,341370,DB01625,DB09061,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
341489,341489,DB01625,DB14881,CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
341514,341514,DB01626,DB06707,C#CCN(C)Cc1ccccc1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
341516,341516,DB01626,DB06701,C#CCN(C)Cc1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
341521,341521,DB06237,DB01626,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,C#CCN(C)Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
341522,341522,DB06267,DB01626,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,C#CCN(C)Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
341523,341523,DB12010,DB01626,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,C#CCN(C)Cc1ccccc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
341582,341582,DB01626,DB09480,C#CCN(C)Cc1ccccc1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
341583,341583,DB01626,DB13624,C#CCN(C)Cc1ccccc1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
341655,341655,DB01626,DB06262,C#CCN(C)Cc1ccccc1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
341656,341656,DB01626,DB06694,C#CCN(C)Cc1ccccc1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
341657,341657,DB01626,DB06711,C#CCN(C)Cc1ccccc1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
341679,341679,DB13946,DB01626,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C#CCN(C)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
342016,342016,DB13946,DB01628,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
343027,343027,DB02925,DB06283,NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
343294,343294,DB13946,DB03585,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
343477,343477,DB04571,DB06701,Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
344142,344142,DB13946,DB04743,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344389,344389,DB13946,DB04812,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344554,344554,DB13946,DB04817,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344605,344605,DB04820,DB06707,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344607,344607,DB04820,DB06701,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344668,344668,DB04820,DB09480,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344669,344669,DB04820,DB13624,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344726,344726,DB04820,DB06262,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344727,344727,DB04820,DB06694,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344728,344728,DB04820,DB06711,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
344763,344763,DB13946,DB04820,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
345680,345680,DB04834,DB08906,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345681,345681,DB04834,DB09091,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345682,345682,DB04834,DB09378,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345683,345683,DB04834,DB09383,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345684,345684,DB04834,DB11487,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345685,345685,DB04834,DB11529,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345686,345686,DB04834,DB11921,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345687,345687,DB04834,DB13867,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345688,345688,DB04834,DB14512,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345689,345689,DB04834,DB14539,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345690,345690,DB04834,DB14541,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345691,345691,DB04834,DB14545,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345692,345692,DB04834,DB14631,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345693,345693,DB04834,DB14644,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345694,345694,DB04834,DB14646,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345695,345695,DB04834,DB14669,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345696,345696,DB04834,DB14540,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345697,345697,DB04834,DB08971,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345698,345698,DB04834,DB15566,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345699,345699,DB04834,DB09095,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345700,345700,DB04834,DB14643,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
345732,345732,DB04834,DB14649,C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
346012,346012,DB04839,DB16019,CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,O=C([O-])CCc1ccc(O)c(CN(CCN(CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)[O-])c1.[Ga+3],167,D064907,increase,0,#drug1 may increase effectiveness of #drug2 as a diagnostic agent.
346121,346121,DB06237,DB04840,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,N=C(N)N1CCc2ccccc2C1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
346122,346122,DB06267,DB04840,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,N=C(N)N1CCc2ccccc2C1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
346123,346123,DB12010,DB04840,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,N=C(N)N1CCc2ccccc2C1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
346466,346466,DB04841,DB06283,Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
346690,346690,DB04842,DB09480,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
346691,346691,DB04842,DB13624,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
346700,346700,DB04842,DB06283,O=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
346751,346751,DB04843,DB06155,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
346752,346752,DB04843,DB09061,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
346862,346862,DB04843,DB14881,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
347276,347276,DB09042,DB04846,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
347311,347311,DB06237,DB04846,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
347312,347312,DB06267,DB04846,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
347313,347313,DB12010,DB04846,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
347379,347379,DB13967,DB04846,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
347458,347458,DB14018,DB04854,Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O,Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
347702,347702,DB13946,DB04855,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
347923,347923,DB06267,DB04861,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
347924,347924,DB12010,DB04861,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
347925,347925,DB06237,DB04861,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
347974,347974,DB13967,DB04861,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
348414,348414,DB16165,DB04868,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
349315,349315,DB04908,DB06262,O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
349499,349499,DB13946,DB04908,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
350434,350434,DB04946,DB06283,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
350480,350480,DB06237,DB04948,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
350481,350481,DB06267,DB04948,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
350482,350482,DB12010,DB04948,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
350624,350624,DB13946,DB04948,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
350930,350930,DB04953,DB06283,CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
351410,351410,DB13946,DB05039,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCc1cc2c(cc1CC)CC(NCC(O)c1ccc(O)c3[nH]c(=O)ccc13)C2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
352295,352295,DB05246,DB06283,CN1C(=O)CC(C)(c2ccccc2)C1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
352484,352484,DB05271,DB06262,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
352485,352485,DB05271,DB09097,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
352486,352486,DB05271,DB11273,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
352487,352487,DB05271,DB12313,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
352561,352561,DB13946,DB05271,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCN(CCc1cccs1)C1CCc2c(O)cccc2C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
353357,353357,DB16165,DB05521,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CCCC(NC(=O)C1C2CCCC2CN1C(=O)C(NC(=O)C(NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
353535,353535,DB05541,DB06283,CCCC1CC(=O)N(C(CC)C(N)=O)C1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
354376,354376,DB06016,DB06262,CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
354522,354522,DB13946,DB06016,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
354525,354525,DB06016,DB06283,CN(C)C(=O)NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
354579,354579,DB06077,DB09480,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
354580,354580,DB06077,DB13624,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
354719,354719,DB06077,DB06283,CN1CCN2c3c(cccc31)C1CN(CCCC(=O)c3ccc(F)cc3)CCC12,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
355007,355007,DB06119,DB06283,NC(=O)OC(Cn1ncnn1)c1ccccc1Cl,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
355166,355166,DB06144,DB09480,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
355167,355167,DB06144,DB13624,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
355173,355173,DB06144,DB06283,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
355408,355408,DB13946,DB06148,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CCN2c3ccccc3Cc3ccccc3C2C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
355489,355489,DB09042,DB06152,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
355568,355568,DB13946,DB06152,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
355745,355745,DB13946,DB06153,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CCC(=C2c3ccccc3CCc3sccc32)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
355759,355759,DB06702,DB06155,CC(C)C(=O)Oc1ccc(CO)cc1C(CCN(C(C)C)C(C)C)c1ccccc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355760,355760,DB06787,DB06155,C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355761,355761,DB08801,DB06155,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355762,355762,DB08897,DB06155,O=C(OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355763,355763,DB09076,DB06155,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355764,355764,DB09089,DB06155,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355765,355765,DB09300,DB06155,CCCC[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355766,355766,DB11235,DB06155,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355767,355767,DB11315,DB06155,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355768,355768,DB11855,DB06155,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355769,355769,DB12278,DB06155,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355770,355770,DB12554,DB06155,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
355771,355771,DB13720,DB06155,C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1,Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
356462,356462,DB06201,DB06283,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
357247,357247,DB06212,DB06283,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
357496,357496,DB13946,DB06216,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
357501,357501,DB06216,DB06283,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
357874,357874,DB06218,DB06283,COCC(NC(C)=O)C(=O)NCc1ccccc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358169,358169,DB06237,DB09242,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COc1nc(C)nc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358170,358170,DB06237,DB09477,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358171,358171,DB06237,DB11738,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,C1COC(NC(C2CC2)C2CC2)=N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358172,358172,DB06237,DB12945,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NNc1nnc(NN)c2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358173,358173,DB06237,DB13166,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358174,358174,DB06237,DB13211,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,N=C(N)NCC1COc2ccccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358175,358175,DB06237,DB13532,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358176,358176,DB06237,DB13801,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358177,358177,DB06237,DB06762,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CC(NC(=Nc1ccncc1)NC#N)C(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358178,358178,DB06237,DB08932,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358179,358179,DB06237,DB09026,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358180,358180,DB06237,DB09236,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358181,358181,DB06237,DB08822,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358182,358182,DB06237,DB09237,COc1ccc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1Cl,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358357,358357,DB06684,DB06262,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
358358,358358,DB09061,DB06262,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
358359,358359,DB09068,DB06262,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
358360,358360,DB09128,DB06262,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
358362,358362,DB09167,DB06262,CN(C)CCC=C1c2ccccc2CSc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
358363,358363,DB13114,DB06262,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
358364,358364,DB13225,DB06262,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
358365,358365,DB13246,DB06262,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
358370,358370,DB06654,DB06262,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
358371,358371,DB09241,DB06262,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
358413,358413,DB13946,DB06262,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,NC(C(=O)O)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
358416,358416,DB06267,DB06268,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358417,358417,DB06267,DB06403,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COC(c1ccccc1)(c1ccccc1)C(Oc1nc(C)cc(C)n1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358418,358418,DB06267,DB06762,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(NC(=Nc1ccncc1)NC#N)C(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358419,358419,DB06267,DB08932,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358420,358420,DB06267,DB09026,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358421,358421,DB06267,DB09236,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358422,358422,DB06267,DB09238,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358423,358423,DB06267,DB09242,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,COc1nc(C)nc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358424,358424,DB06267,DB09477,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358425,358425,DB06267,DB11362,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358426,358426,DB06267,DB11738,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,C1COC(NC(C2CC2)C2CC2)=N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358427,358427,DB06267,DB12945,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NNc1nnc(NN)c2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358428,358428,DB06267,DB13166,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358429,358429,DB06267,DB13211,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,N=C(N)NCC1COc2ccccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358430,358430,DB06267,DB13532,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358431,358431,DB06267,DB13801,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358432,358432,DB06267,DB08822,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358489,358489,DB06267,DB09237,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc(=O)c2c([nH]1)c(CCC)nn2C,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358600,358600,DB12010,DB06268,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
358836,358836,DB09117,DB06283,CC1OC(C)OC(C)O1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358837,358837,DB06691,DB06283,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358838,358838,DB06716,DB06283,CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358839,358839,DB06753,DB06283,O=P(O)(O)OCC(Cl)(Cl)Cl,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358840,358840,DB09071,DB06283,CCC(=O)NCC1CC1c1cccc2c1CCO2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358841,358841,DB11376,DB06283,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358842,358842,DB11428,DB06283,Cc1cccc(C(C)c2cnc[nH]2)c1C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358843,358843,DB11477,DB06283,Cc1cccc(C)c1NC1=NCCCS1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358844,358844,DB11543,DB06283,Fc1cccc(Br)c1NC1=NCCN1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358845,358845,DB11556,DB06283,Cc1cccc(Cc2cnc[nH]2)c1C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358846,358846,DB13221,DB06283,C=CCC(C(=O)NC(N)=O)C(C)C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358847,358847,DB13253,DB06283,C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358848,358848,DB13872,DB06283,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358849,358849,DB12404,DB06283,COC(=O)CCC1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358850,358850,DB14185,DB06283,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358851,358851,DB06288,DB06283,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358852,358852,DB09128,DB06283,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358853,358853,DB09225,DB06283,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358854,358854,DB09241,DB06283,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358855,358855,DB11540,DB06283,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358856,358856,DB12401,DB06283,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358857,358857,DB12710,DB06283,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358858,358858,DB12867,DB06283,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358859,358859,DB13213,DB06283,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358860,358860,DB13256,DB06283,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358861,358861,DB13273,DB06283,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358862,358862,DB08815,DB06283,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358863,358863,DB08883,DB06283,N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358864,358864,DB08329,DB06283,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358865,358865,DB09119,DB06283,CC(=O)OC1Cc2ccccc2N(C(N)=O)c2ccccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358866,358866,DB11400,DB06283,COC1CC(OC2C(C)OC(OC3C(C)=CCC4CC(CC5(C=CC(C)C(C6CCCCC6)O5)O4)OC(=O)C4C=C(C)C(O)C5OCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358867,358867,DB11549,DB06283,CCNC1(c2cccs2)CCCCC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358868,358868,DB11859,DB06283,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358869,358869,DB14575,DB06283,NC(=O)N1c2ccccc2CC(O)c2ccccc21,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358870,358870,DB09061,DB06283,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358871,358871,DB09118,DB06283,CC(C)(C)C(O)C=Cc1ccc2c(c1)OCO2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358872,358872,DB08907,DB06283,Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358873,358873,DB11827,DB06283,CCOc1ccc(Cc2cc(C34OCC(CO)(O3)C(O)C(O)C4O)ccc2Cl)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358874,358874,DB06292,DB06283,CCOc1ccc(Cc2cc(C3OC(CO)C(O)C(O)C3O)ccc2Cl)cc1,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358875,358875,DB09015,DB06283,CC12CCC(=O)C=C1C=CC1C2CCC2(C)C1CCC2(O)CCC(=O)O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358876,358876,DB09125,DB06283,O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+],CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358877,358877,DB09401,DB06283,OC1COC2C(O)COC12,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358878,358878,DB13284,DB06283,Cc1cc2c(cc1S(N)(=O)=O)S(=O)(=O)CCC2,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358879,358879,DB13532,DB06283,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358880,358880,DB13801,DB06283,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358881,358881,DB14018,DB06283,Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O,CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
358882,358882,DB14500,DB06283,[KH],CSCCC1NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C2CSSCC3NC(=O)C(CO)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CSSCC(N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCCN)C(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)N2)NC(=O)C(CSSCC(C(N)=O)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC3=O)NC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(O)cc2)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
359175,359175,DB06288,DB09480,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
359176,359176,DB06288,DB13624,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
360051,360051,DB12010,DB06403,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(c1ccccc1)(c1ccccc1)C(Oc1nc(C)cc(C)n1)C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
360881,360881,DB16165,DB06448,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,NC(=O)N1CCC(CC(=O)N2CCC(C3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
361713,361713,DB16165,DB06595,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,COC1C(N(C)C(=O)c2ccccc2)CC2OC1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
363024,363024,DB06654,DB06707,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363025,363025,DB06654,DB06701,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363074,363074,DB06654,DB09480,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363075,363075,DB06654,DB13624,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363120,363120,DB06654,DB06694,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363121,363121,DB06654,DB06711,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363138,363138,DB13946,DB06654,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363480,363480,DB13946,DB06684,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363645,363645,DB13946,DB06690,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,[N-]=[N+]=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363798,363798,DB06711,DB06691,c1ccc2c(CC3=NCCN3)cccc2c1,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
363876,363876,DB09167,DB06694,CN(C)CCC=C1c2ccccc2CSc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
363877,363877,DB13114,DB06694,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
363878,363878,DB13225,DB06694,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
363879,363879,DB13246,DB06694,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
363885,363885,DB09241,DB06694,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
363907,363907,DB13946,DB06694,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
364717,364717,DB13946,DB06701,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COC(=O)C(c1ccccc1)C1CCCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
364718,364718,DB11390,DB06701,CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
364719,364719,DB11419,DB06701,Cc1c(Cl)c(=O)oc2cc(OP(=O)(OCCCl)OCCCl)ccc12,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
364720,364720,DB13155,DB06701,O=c1ccc2cc(OC3OC(CO)C(O)C(O)C3O)c(O)cc2o1,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
364721,364721,DB13279,DB06701,CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1,COC(=O)C(c1ccccc1)C1CCCCN1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
364739,364739,DB06702,DB09061,CC(C)C(=O)Oc1ccc(CO)cc1C(CCN(C(C)C)C(C)C)c1ccccc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
364850,364850,DB06702,DB14881,CC(C)C(=O)Oc1ccc(CO)cc1C(CCN(C(C)C)C(C)C)c1ccccc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
364945,364945,DB09167,DB06706,CN(C)CCC=C1c2ccccc2CSc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
364946,364946,DB13114,DB06706,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
364947,364947,DB13225,DB06706,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
364948,364948,DB13246,DB06706,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,CNC(C)CCC=C(C)C,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
364965,364965,DB13946,DB06706,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNC(C)CCC=C(C)C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
365023,365023,DB09241,DB06707,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
365056,365056,DB13946,DB06707,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(N)C(O)c1ccc(O)c(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
365342,365342,DB09167,DB06711,CN(C)CCC=C1c2ccccc2CSc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
365343,365343,DB13114,DB06711,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
365344,365344,DB13225,DB06711,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
365345,365345,DB13246,DB06711,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,c1ccc2c(CC3=NCCN3)cccc2c1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
365349,365349,DB09241,DB06711,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
365363,365363,DB06711,DB06716,c1ccc2c(CC3=NCCN3)cccc2c1,CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365364,365364,DB06711,DB06753,c1ccc2c(CC3=NCCN3)cccc2c1,O=P(O)(O)OCC(Cl)(Cl)Cl,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365365,365365,DB06711,DB09034,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CCC2C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365366,365366,DB06711,DB09071,c1ccc2c(CC3=NCCN3)cccc2c1,CCC(=O)NCC1CC1c1cccc2c1CCO2,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365367,365367,DB06711,DB09117,c1ccc2c(CC3=NCCN3)cccc2c1,CC1OC(C)OC(C)O1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365368,365368,DB06711,DB11376,c1ccc2c(CC3=NCCN3)cccc2c1,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365369,365369,DB06711,DB11428,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1cccc(C(C)c2cnc[nH]2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365370,365370,DB06711,DB11477,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1cccc(C)c1NC1=NCCCS1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365371,365371,DB06711,DB11543,c1ccc2c(CC3=NCCN3)cccc2c1,Fc1cccc(Br)c1NC1=NCCN1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365372,365372,DB06711,DB11556,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1cccc(Cc2cnc[nH]2)c1C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365373,365373,DB06711,DB13221,c1ccc2c(CC3=NCCN3)cccc2c1,C=CCC(C(=O)NC(N)=O)C(C)C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365374,365374,DB06711,DB13253,c1ccc2c(CC3=NCCN3)cccc2c1,C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365375,365375,DB06711,DB13872,c1ccc2c(CC3=NCCN3)cccc2c1,CN1C(=O)C(O)N=C(c2ccccc2Cl)c2cc(Cl)ccc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365376,365376,DB06711,DB12404,c1ccc2c(CC3=NCCN3)cccc2c1,COC(=O)CCC1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365383,365383,DB06711,DB06797,c1ccc2c(CC3=NCCN3)cccc2c1,CCC(C)C(C)(COC(N)=O)COC(N)=O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365384,365384,DB06711,DB09068,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365385,365385,DB06711,DB11400,c1ccc2c(CC3=NCCN3)cccc2c1,COC1CC(OC2C(C)OC(OC3C(C)=CCC4CC(CC5(C=CC(C)C(C6CCCCC6)O5)O4)OC(=O)C4C=C(C)C(O)C5OCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365386,365386,DB06711,DB11555,c1ccc2c(CC3=NCCN3)cccc2c1,Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C,50,D002492,increase,1,the risk or severity of cns depression can be increased when #drug1 is combined with #drug2.
365387,365387,DB13946,DB06711,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
365388,365388,DB09042,DB06711,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,c1ccc2c(CC3=NCCN3)cccc2c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
366271,366271,DB13946,DB06725,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
366452,366452,DB13946,DB06736,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
366621,366621,DB12010,DB06762,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(NC(=Nc1ccncc1)NC#N)C(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
366709,366709,DB09042,DB06764,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,c1ccc2c(c1)CCCC2C1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
366711,366711,DB09167,DB06764,CN(C)CCC=C1c2ccccc2CSc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
366712,366712,DB13114,DB06764,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
366713,366713,DB13225,DB06764,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
366714,366714,DB13246,DB06764,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,c1ccc2c(c1)CCCC2C1=NCCN1,127,D014662,increase,0,#drug1 may increase the vasopressor activities of #drug2.
366739,366739,DB13946,DB06764,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,c1ccc2c(c1)CCCC2C1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
367535,367535,DB06787,DB09061,C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
367609,367609,DB06787,DB14881,C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
368040,368040,DB06807,DB09214,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
368051,368051,DB06807,DB09543,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,COC(=O)c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
368052,368052,DB06807,DB14006,Nc1ccc(C(=O)Oc2ccccc2)c(O)c1,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
368554,368554,DB13946,DB08439,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
368670,368670,DB13946,DB08797,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,NC(=O)c1ccccc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
368756,368756,DB08801,DB09061,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
368825,368825,DB08801,DB14881,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
369055,369055,DB13946,DB08815,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
369480,369480,DB12010,DB08822,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
370730,370730,DB16165,DB08873,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)(C)NC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
372113,372113,DB13946,DB08893,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Nc1nc(CC(=O)Nc2ccc(CCNCC(O)c3ccccc3)cc2)cs1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
372428,372428,DB08897,DB09061,O=C(OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
372491,372491,DB08897,DB14881,O=C(OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
372553,372553,DB08899,DB16019,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,O=C([O-])CCc1ccc(O)c(CN(CCN(CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)[O-])c1.[Ga+3],167,D064907,increase,0,#drug1 may increase effectiveness of #drug2 as a diagnostic agent.
373134,373134,DB11156,DB08906,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
373481,373481,DB12161,DB08909,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
374444,374444,DB12010,DB08932,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
374690,374690,DB09042,DB08941,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
374722,374722,DB13946,DB08941,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
374805,374805,DB13946,DB08942,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
374854,374854,DB13946,DB08950,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
374918,374918,DB11156,DB08971,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
375092,375092,DB13946,DB08976,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2c(C(F)(F)F)cccc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
375178,375178,DB13946,DB08981,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
375234,375234,DB09042,DB08985,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CCNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
375258,375258,DB13946,DB08985,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCNCC(O)c1cccc(O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
375543,375543,DB12010,DB09026,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COCCCOc1cc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
376221,376221,DB09042,DB09480,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
376222,376222,DB09042,DB13624,Cn1nnc(-c2ccc(-c3ccc(N4CC(COP(=O)(O)O)OC4=O)cc3F)cn2)n1,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
376490,376490,DB11540,DB09049,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
376491,376491,DB12710,DB09049,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
376492,376492,DB13213,DB09049,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
376821,376821,DB09076,DB09061,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376822,376822,DB09089,DB09061,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376823,376823,DB09300,DB09061,CCCC[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376824,376824,DB11235,DB09061,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376825,376825,DB11315,DB09061,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376826,376826,DB12278,DB09061,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376827,376827,DB12554,DB09061,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376828,376828,DB13720,DB09061,C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376833,376833,DB11855,DB09061,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,123,D013610&D000077260,increase&increase,1,the risk or severity of tachycardia and drowsiness can be increased when #drug1 is combined with #drug2.
376942,376942,DB13946,DB09061,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C=C(C)C1CCC(C)=CC1c1c(O)cc(CCCCC)cc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
377346,377346,DB16165,DB09065,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)c1nc(CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
377528,377528,DB13946,DB09068,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
378328,378328,DB09076,DB14881,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
378702,378702,DB13946,DB09080,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc(CC(C)(C)NCC(O)c2cc(O)cc3c2OCC(=O)N3)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
378821,378821,DB13946,DB09082,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,OCc1cc(C(O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
378972,378972,DB13946,DB09084,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
379151,379151,DB09089,DB14881,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
379286,379286,DB11156,DB09091,CN1CCCN=C1C=Cc1cccs1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CS,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
379355,379355,DB11156,DB09095,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
379439,379439,DB09097,DB11273,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
379440,379440,DB09097,DB12313,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
379441,379441,DB09097,DB13520,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
379629,379629,DB16165,DB09101,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2C(CO)C(C)C,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
380061,380061,DB16165,DB09118,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CC(C)(C)C(O)C=Cc1ccc2c(c1)OCO2,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
380354,380354,DB09128,DB11273,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
380355,380355,DB09128,DB12313,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
380356,380356,DB09128,DB13520,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
380434,380434,DB13946,DB09128,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
380817,380817,DB13946,DB09167,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCC=C1c2ccccc2CSc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
381107,381107,DB13946,DB09205,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
381175,381175,DB13946,DB09212,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
381232,381232,DB13946,DB09213,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)Cc1ccc(C(C)C(=O)O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
381237,381237,DB09543,DB09214,COC(=O)c1ccccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
381238,381238,DB14006,DB09214,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,138,D006470&D006471,increase&increase,1,the risk or severity of bleeding and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2.
381259,381259,DB13946,DB09214,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
381328,381328,DB13946,DB09216,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
381418,381418,DB13946,DB09217,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
381585,381585,DB09225,DB09480,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
381586,381586,DB09225,DB13624,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
381638,381638,DB12010,DB09236,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
381837,381837,DB12010,DB09238,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
381947,381947,DB09241,DB15465,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
382141,382141,DB13946,DB09241,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
382192,382192,DB12010,DB09242,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,COc1nc(C)nc(Cl)c1NC1=NCCN1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
382206,382206,DB13946,DB09242,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1nc(C)nc(Cl)c1NC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
382395,382395,DB11540,DB09272,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
382396,382396,DB12710,DB09272,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
382397,382397,DB13213,DB09272,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc(CN(C(=O)C(N)Cc2c(C)cc(C(N)=O)cc2C)C(C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
383034,383034,DB09300,DB14881,CCCC[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
383234,383234,DB13967,DB09351,CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(O)c(S(=O)(=O)O)cc2S(=O)(=O)O)cc1,CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1,101,D006967,increase,1,the risk or severity of hypersensitivity reaction can be increased when #drug1 is combined with #drug2.
383353,383353,DB11156,DB09378,CN1CCCN=C1C=Cc1cccs1,CC12C=CC(=O)C=C1C(F)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
383434,383434,DB11156,DB09383,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
383731,383731,DB12010,DB09477,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
383789,383789,DB11376,DB09480,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
383790,383790,DB11540,DB09480,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
383791,383791,DB12401,DB09480,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
383792,383792,DB12710,DB09480,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
383793,383793,DB12867,DB09480,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
383794,383794,DB13213,DB09480,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
383795,383795,DB13256,DB09480,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
383796,383796,DB13273,DB09480,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CC(C)NC(C)Cc1ccc(I)cc1,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
383815,383815,DB13946,DB09480,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)NC(C)Cc1ccc(I)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
383918,383918,DB09543,DB14006,COC(=O)c1ccccc1O,C[N+](C)(C)CCO.O=C([O-])c1ccccc1O,139,D006470&D007674&D006471,increase&increase&increase,1,"the risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when #drug1 is combined with #drug2."
384174,384174,DB11156,DB11487,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COC(=O)c1ccncc1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384175,384175,DB11156,DB11529,CN1CCCN=C1C=Cc1cccs1,C=C1CC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC2(C)C1(O)C(C)=O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384176,384176,DB11156,DB11921,CN1CCCN=C1C=Cc1cccs1,CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384177,384177,DB11156,DB13867,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)SCF,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384178,384178,DB11156,DB14512,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384179,384179,DB11156,DB14539,CN1CCCN=C1C=Cc1cccs1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384180,384180,DB11156,DB14541,CN1CCCN=C1C=Cc1cccs1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384181,384181,DB11156,DB14545,CN1CCCN=C1C=Cc1cccs1,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384182,384182,DB11156,DB14631,CN1CCCN=C1C=Cc1cccs1,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384183,384183,DB11156,DB14644,CN1CCCN=C1C=Cc1cccs1,CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384184,384184,DB11156,DB14646,CN1CCCN=C1C=Cc1cccs1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384185,384185,DB11156,DB14669,CN1CCCN=C1C=Cc1cccs1,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384186,384186,DB11156,DB14540,CN1CCCN=C1C=Cc1cccs1,CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384187,384187,DB11156,DB15566,CN1CCCN=C1C=Cc1cccs1,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384188,384188,DB11156,DB14643,CN1CCCN=C1C=Cc1cccs1,CCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384193,384193,DB11156,DB14649,CN1CCCN=C1C=Cc1cccs1,CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,83,D009135,increase,1,the risk or severity of myopathy and weakness can be increased when #drug1 is combined with #drug2.
384201,384201,DB11181,DB14881,CN1C2CCC1CC(OC(=O)C(O)c1ccccc1)C2,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
384312,384312,DB11235,DB14881,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
384335,384335,DB11273,DB12313,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
384336,384336,DB11273,DB13520,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
384418,384418,DB13946,DB11273,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)C1C(=O)N2CCCC2C2(O)OC(NC(=O)C3CC4c5cccc6[nH]cc(c56)CC4N(C)C3)(C(C)C)C(=O)N12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
384486,384486,DB13946,DB11278,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C(O)c1ccccc1)N(C)C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
384556,384556,DB11315,DB14881,C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
384617,384617,DB12010,DB11362,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
384869,384869,DB13946,DB11373,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1ccc(N=CN(C)C=Nc2ccc(C)cc2C)c(C)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
384876,384876,DB11376,DB13624,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
385309,385309,DB13946,DB11428,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cccc(C(C)c2cnc[nH]2)c1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
385517,385517,DB13946,DB11455,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCc1ccc(Nc2c(F)c(F)cc(F)c2F)c(CC(=O)O)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
385616,385616,DB13946,DB11466,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc(-n2nc(CCC(=O)N(C)O)cc2-c2ccc(Cl)cc2)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
385731,385731,DB13946,DB11477,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cccc(C)c1NC1=NCCCS1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
385780,385780,DB13946,DB11481,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCC1(c2cnc[nH]2)Cc2ccccc2C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
386102,386102,DB13946,DB11518,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
386196,386196,DB11540,DB11609,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
386197,386197,DB11540,DB12492,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
386198,386198,DB11540,DB15465,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
386207,386207,DB11540,DB13624,CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
386273,386273,DB13946,DB11541,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
386326,386326,DB13946,DB11543,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Fc1cccc(Br)c1NC1=NCCN1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
386497,386497,DB13946,DB11556,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Cc1cccc(Cc2cnc[nH]2)c1C,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
386971,386971,DB13946,DB11587,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCN(C)C(C)C(O)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
387006,387006,DB12710,DB11609,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
387007,387007,DB13213,DB11609,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
387895,387895,DB16165,DB11672,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,COc1cc(C=CC(=O)CC(=O)C=Cc2ccc(O)c(OC)c2)ccc1O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
388504,388504,DB16165,DB11730,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
388606,388606,DB12010,DB11738,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,C1COC(NC(C2CC2)C2CC2)=N1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
388616,388616,DB13946,DB11738,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C1COC(NC(C2CC2)C2CC2)=N1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
389572,389572,DB11853,DB16019,CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1,O=C([O-])CCc1ccc(O)c(CN(CCN(CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)[O-])c1.[Ga+3],167,D064907,increase,0,#drug1 may increase effectiveness of #drug2 as a diagnostic agent.
389659,389659,DB11855,DB14881,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
389806,389806,DB11901,DB16019,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,O=C([O-])CCc1ccc(O)c(CN(CCN(CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)[O-])c1.[Ga+3],167,D064907,increase,0,#drug1 may increase effectiveness of #drug2 as a diagnostic agent.
390275,390275,DB12161,DB11963,[H]C([H])([H])Oc1cc2c(cc1OC([H])([H])[H])C1CC(=O)C(CC(C)C)CN1CC2,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN1CCCCC1,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
390715,390715,DB12010,DB12945,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NNc1nnc(NN)c2ccccc12,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
390716,390716,DB12010,DB13166,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
390717,390717,DB12010,DB13211,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,N=C(N)NCC1COc2ccccc2O1,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
390718,390718,DB12010,DB13532,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
390719,390719,DB12010,DB13801,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC,CC(c1ccc(Cl)c(Cl)c1)N1N=C(N)CC1=O,70,D000959,increase,0,#drug1 may increase the antihypertensive activities of #drug2.
391479,391479,DB13946,DB12278,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
391480,391480,DB12278,DB14881,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
391530,391530,DB12313,DB13520,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,78,Q000009,decrease,1,the risk or severity of adverse effects can be decreased when #drug1 is combined with #drug2.
391538,391538,DB13946,DB12313,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
391697,391697,DB13946,DB12371,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCc1cc(C(C)=NOCc2ccc(C3CCCCC3)c(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
391712,391712,DB12401,DB13624,O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
391922,391922,DB13946,DB12480,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C=C(C)C1CCC2(C(=O)O)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC43C)C12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
391984,391984,DB12710,DB12492,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
391985,391985,DB13213,DB12492,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
392094,392094,DB12554,DB14881,CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
392162,392162,DB12710,DB15465,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
392167,392167,DB12710,DB13624,CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
392281,392281,DB12867,DB13624,O=C(CCCN1CCC(n2c(O)nc3ccccc32)CC1)c1ccc(F)cc1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
392359,392359,DB12941,DB16019,CC(Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)NC(=O)c1cc(C(C)O)[nH]n1,O=C([O-])CCc1ccc(O)c(CN(CCN(CC(=O)[O-])Cc2cc(CCC(=O)NCCCCCC(=O)NCCCCC(NC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)ccc2O)CC(=O)[O-])c1.[Ga+3],167,D064907,increase,0,#drug1 may increase effectiveness of #drug2 as a diagnostic agent.
392511,392511,DB13946,DB13114,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
392578,392578,DB13946,DB13139,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
392631,392631,DB13946,DB13167,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,C=CCOc1ccc(CC(=O)O)cc1Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
392690,392690,DB16165,DB13179,CCOc1ncc(C)c2c1C(c1ccc(C#N)cc1OC)C(C(N)=O)=C(C)N2,COC1CC(OC2C(C)C(=O)OC(C)C(C)C(OC(C)=O)C(C)C(=O)C3(CO3)CC(C)C(OC3OC(C)CC(N(C)C)C3OC(C)=O)C2C)OC(C)C1OC(C)=O,39,D044967&D008660,increase&increase,2,the serum concentration of the active metabolites of #drug1 can be increased when #drug1 is used in combination with #drug2.
392727,392727,DB13213,DB15465,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,COc1ccc2c3c1OC1C(OC(=O)c4ccccc4)=CCC4C(C2)N(C)CCC314,151,D007022&D002492,increase&increase,1,the risk or severity of hypotension and cns depression can be increased when #drug1 is combined with #drug2.
392732,392732,DB13213,DB13624,CCCC(=O)c1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
392808,392808,DB13946,DB13225,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
392843,392843,DB13946,DB13246,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
392879,392879,DB13256,DB13624,CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
392898,392898,DB13273,DB13624,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CNC(C)Cc1ccccc1OC,90,D013268,decrease,0,#drug1 may decrease the stimulatory activities of #drug2.
392950,392950,DB13946,DB13286,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCCC(C(=O)O)C(=O)N(Nc1ccccc1)c1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
392979,392979,DB13946,DB13323,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,ClC=C(Cl)Cl,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
392981,392981,DB16629,DB13323,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,ClC=C(Cl)Cl,137,D006973&D013610,increase&increase,1,the risk or severity of hypertension and tachycardia can be increased when #drug1 is combined with #drug2.
393016,393016,DB13946,DB13345,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(C)C1(NC(=O)C2CC3c4cccc5[nH]cc(c45)CC3N(C)C2)OC2(O)C3CCCN3C(=O)C(Cc3ccccc3)N2C1=O,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393028,393028,DB13946,DB13501,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(O)COc1nn(Cc2ccccc2)c2ccccc12,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393044,393044,DB13946,DB13520,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CN1CC(CNC(=O)OCc2ccccc2)CC2c3cccc4c3c(cn4C)CC21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393110,393110,DB13946,DB13624,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CNC(C)Cc1ccccc1OC,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393131,393131,DB13946,DB13657,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CC(=O)Nc1ccc(OC(=O)c2ccccc2OC(C)=O)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393152,393152,DB13720,DB14881,C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1,COc1ccsc1CNCCC1(c2ccccn2)CCOC2(CCCC2)C1,124,D016055&D005769&D003248,increase&increase&increase,1,"the risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when #drug1 is combined with #drug2."
393170,393170,DB13946,DB13781,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393188,393188,DB13946,DB13783,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393448,393448,DB13946,DB14185,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393449,393449,DB13946,DB14754,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,NC(=O)OCC(N)Cc1ccccc1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393450,393450,DB13946,DB15685,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COc1ccc(CN2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
393451,393451,DB13946,DB16629,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,COC(=O)C(c1ccccc1)C1CCCCN1C(=O)OC[n+]1cccc(C(=O)NC(CO)C(=O)[O-])c1,16,D006973,increase,0,#drug1 may increase the hypertensive activities of #drug2.
